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This thesis presents three different areas of anion or neutral molecule recognition 
chemistry. There is an extensive study of homoleptic and heteroleptic platinum(II) based 
receptors for anion recognition. The homoleptic receptor study revealed that urea ligands 
are  more  effective  than  amido-pyrrole  based  ligands  for  binding  anions  in  DMSO 
solution.  Also,  isoquinoline  based  ligands  form  more  stable  complexes  than  pyridine 
based  ligands  and  their  extra  rigidity  preorganises  the  receptor  for  increased  anion 
affinities.  The  heteroleptic  receptor  (trans-[Pt(isoquinoline-urea)2(pyridine)2](BF4)2) 
exhibited either an up-down or up-up conformation in DMSO solution and the solid state, 
depending on the type and concentration of anion. Two different crystal structures with 
sulfate revealed formation of both the conformations. 
  The properties of a simple benzimidazole cleft receptor for barbiturates and ureas 
are reported. Compared to various control analogues, the receptor binds barbital or urea 
in highly competitive DMSO/MeNO2 solutions. A crystal structure with barbital revealed 
binding through six hydrogen bonds. The synthesis of a more soluble  version of the 
receptor was attempted. The synthesis of a neutral guest templated catenane was also 
attempted in an effort to expand on the simple cleft work. 
  Finally, a new triazole strapped calix[4]pyrrole synthesised by ‘click’ chemistry 
is reported. The receptor shows a high affinity for chloride and bicarbonate in MeCN and 
DCM solutions. It also exhibits strong lipid bilayer chloride transport properties when 
compared to the parent meso-octamethylcalix[4]pyrrole. A brief investigation into the 
use of triptycenes as potential scaffolds for appending hydrogen bond donor groups for 
anion recognition is also reported. DECLARATION OF AUTHORSHIP 
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Chapter 1 – Introduction 
 
1.1 Supramolecular Chemistry 
Supramolecular chemistry is often referred to as ‘chemistry beyond the molecule’.
[1] 
This neatly summarising statement can be deciphered as chemistry that solely focuses on 
the study of non-covalent interactions between molecules. Thus, a supermolecule can be 
thought of as an assembly of two or more chemical species held together by reversible 
intermolecular forces that are much weaker than a covalent bond. These ideas were first 
formally  described  by  Jean-Marie  Lehn  (who  previously  coined  the  term 
‘Supramolecular  Chemistry’)  in  his  Nobel  Prize  in  Chemistry  lecture  in  1987.
[2]  He 
concluded  that  ‘supermolecules  are  to  molecules  and  the  intermolecular  bond  what 
molecules are to atoms and the covalent bond’.
[2] 
There are a range of intermolecular forces at hand to a supramolecular chemist and 
some of the most important ones are as follows:- 
•  Hydrogen bonds – classically defined as an interaction wherein a hydrogen atom 
is attracted to two atoms, X and A to result in a bridge, X–H···A. The interaction 
is a complex conglomerate of electrostatic, Van der Waals and charge transfer 
characteristics.
[3] They can span energies between 4 and 120 kJ mol
-1. In fact the 
strength of a hydrogen bond can be determined by how electronegative the atoms 
either side of the hydrogen bridge are. So the strongest hydrogen bond is F–
H···F. More conventional strong hydrogen bonds include; N–H···O, O–H···O, 
N–H···N and O–H···N bonds. Weak hydrogen bonds include; C–H···O, C–H···π 
and O–H···Metal.
[3] 
•  Van der Waals forces – these are attractive or repulsion forces between molecules 
and  are  the  result  of  induced-dipole-induced-dipole  (London  Dispersions), 
permanent-dipole-permanent-dipole  and  permanent-dipole-induced-dipole 
interactions.
[4] They are very weak compared to hydrogen bonds (<5 kJ mol
-1)   Chapter 1 – Introduction  
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but  as  a  collective,  they  can  considerably  contribute  to  the  stability  of  a 
supramolecular complex. 
•  Electrostatic  forces  –  these  are  Coulombic  attractions  or  repulsions  between 
charges or partial charges on molecules.
[4] They include ion pairs (100-350 kJ 
mol
-1), salt bridges, ion-dipole (50-200 kJ mol
-1) and dipole-dipole (5-50 kJ mol
-
1) interactions (fig. 1.1).
[5] 
 
Figure 1.1 - Types of electrostatic interactions. 
•  Charge transfers – these are donor-acceptor interactions between two molecules; 
one with low energy orbitals (acceptors) and one with high energy filled orbitals 
(donors). When these two orbitals are aligned properly, some extent of charge 
transfer can occur from the donor to the acceptor.
[4] 
•  π-π  Stacking  –  these  are  interactions  between  the  π  systems  on  aromatic 
molecules  and  have  energies  between  0-50  kJ  mol
-1.  There  are  two  different 
types of this interaction, face to face and edge to face (fig. 1.2).
[4, 5] 
 
Figure 1.2 - Types of π-π interactions. 
Supramolecular chemistry is a multidisciplinary field that exploits these interactions 
and  fundamental  concepts  such  as  self-organisation,  self-assembly  and  host-guest 
chemistry. Host-guest chemistry can further be broken down into the following areas; 
anion recognition, cation recognition, simultaneous cation/anion recognition (dual host 
systems) and neutral molecule recognition.   Chapter 1 – Introduction  
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1.2 Anion Recognition 
The development of receptors for the binding of anions is an increasingly vigorous 
area of research but in fact, it is only in the last two decades that this expansion has really 
started  to  gather  momentum.    The  hither  to  slow  growth  of  this  area  is  surprising 
considering how ubiquitous anions are in nature. For example, there are many anions 
present  in  the  oceans  including  chloride  and  carbonates,  and  nitrate  and  sulfate  are 
present in acid rain.
[6] Anions are also critical to the maintenance of life as they are 
involved in a vast array of biological processes. The most important anion in life is the 
poly-anionic species DNA, but anions are also critical in ion transport processes in cells, 
enzyme-substrate interactions and a multitude of other protein interactions. Sadly, the 
failure of certain anion transport mechanisms can be seriously detrimental to our health. 
For instance, the malfunctioning of the CFTR chloride transport channel, the cause of 
cystic fibrosis, is one of the most commonly inherited diseases amongst Caucasians.
[6] 
There are also many anthropogenic anions that can have deleterious effects such as; 
phosphates and nitrates from agriculture, radioactive anions such as pertechnetate from 
nuclear fuel reprocessing, and many other anions from chemical processes, which can 
cause serious pollution hazards.
[6] So with the realisation of the importance anions in our 
world,  the  field  of  anion  recognition  chemistry  has  now  significantly  developed  into 
various  areas,  from  simple  anion  receptors,  to  fluorescent  or  colorimetric  sensors,  to 
anion templated assembly, to anion transporters. A key feature desired in all these areas 
of anion recognition is selectivity. Achieving selectivity has been a difficult challenge 
due to some unique features of anions: 
•  They are much larger when compared to iso-electronic cations (e.g. Na
+ = 1.02 Å, 
F
- = 1.33 Å) which means they have a lower charge to radius ratio. This means 
electrostatic binding interactions are much less effective than they would be for 
the smaller cation.
[7] 
•  Unlike simple metal cations, most anions only exist over a limited pH range; 
becoming protonated and losing their negative charge at lower pH.
[5] 
•  Solvent effects are crucial in anion binding strength and selectivity. This means 
that any anion receptor must effectively compete with the solvent environment in 
which the anion binding event takes place.
[7]   Chapter 1 – Introduction  
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•  Anions have a diverse range of geometries which must be accounted for in the 
design of an anion receptor (fig. 1.3): 
 
       Figure 1.3 – Examples of the geometry of different anions. 
Ion-ion interactions are very strong but they lack directionality which, given the 
diverse  nature  of  anion  geometry,  is  fundamental  to  achieving  selectivity  in  anion 
receptors. So the most exploited molecular interaction for anion binding is the highly 
directional hydrogen bond. This allows design of precise geometry clefts for the binding 
of specific anions. Another vital design challenge is to develop systems which do not 
self-associate,  as  this  competes  with  anion  complexation  and  hence  lowers  their 
effectiveness.  These  last  two  points  have  been  the  key  principles  in  most  research 
towards  anion  receptor  design  in  the  last  two  decades  and  are  still  proving  exciting 
challenges in this emerging area of supramolecular chemistry. 
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1.3 Neutral  Non-Metallic  Amide-,  Urea-  and  Pyrrole-  Based  Anion 
Receptors 
1.3.1 Amides 
  There is an ever expanding arsenal of hydrogen-bond donor groups that one can 
use in the design of an anion receptor but perhaps the most fundamental ones are amides 
and ureas. 
The first anion receptor to incorporate amide hydrogen-bond donor groups was 
the  tricyclic  compound  1  in  1986  by  Pascal  Jr.  and  co-workers  (fig.  1.4).
[8]  It  was 
synthesised  from  an  acid  chloride  condensation  reaction  between  the  corresponding 
triamine and tris-acid chloride in 11% yield. The C3-symmetric receptor consists of 3 
amide groups which were predicted to point into the cavity to accommodate small anions 
such  as  fluoride.  The  crystal  structure  of  the  receptor  did  not  show  the  NH  groups 
pointing  into  the  cavity  but  preliminary 
1H-NMR  and 
19F-NMR  studies  in  highly 
competitive DMSO-d6 solutions did show an interaction with fluoride.
[8] 
    
S
S
S
O
HN
NH
NH
O
O
1  
Figure 1.4 - The first amide receptor by Pascal and co-workers. 
Other  early  work  included  the  tris-amide  receptors  based  on  the  tris(2-
aminoethyl)amine (known as tren) framework of Reinhoudt and co-workers (fig. 1.5).
[9] 
Again, the receptors were C3-symmetric and their designs were inspired by phosphate 
binding proteins seen in nature. Receptors 2-5 were synthesised from the corresponding 
triamine and the appropriate acid chloride in the presence of triethylamine in yields of 
70-90%.  Proton-NMR  binding  studies  with  the  tetrabutylammonium  (TBA)  salts  of 
H2PO4
-,  HSO4
-  and  Cl
-  provided  binding  constants  (Ka)  via  curve  fitting  procedures, 
which showed selectivity for H2PO4
-. For example, compound 2 gave a binding constant 
of 4700  M
-1 with H2PO4
- compared to 36 and 96 M
-1 for HSO4
- and Cl
- respectively.
[9]   Chapter 1 – Introduction  
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Figure 1.5 - Reinhoudt's early tris-amide receptors. 
In 1997 came the now famous work of Crabtree et al. with the first of a set of 
wonderfully simple isophthalamide cleft receptors (fig. 1.6).
[10] 
                         
Figure 1.6 - Crabtree's isophthalamide cleft receptors 6 & 7 (left) and the crystal structure of 6 with 
bromide (right). 
Initially, the bis-amide receptor 6 was synthesised and a crystal structure was 
obtained  with  bromide,  which  reveals  (fig.  1.6)  the  presence  of  two  hydrogen  bond 
interactions between the two amide groups and a single bromide anion (N···Br 3.42 and 
3.71 Å). The structure also shows that the bromide is positioned above the plane of the 
central aryl ring with the amide groups twisted out of plane.  
In order for solution studies to be carried out, the more soluble receptor 7 was 
synthesised which allowed 
1H-NMR binding studies to be carried out in CD2Cl2. These 
studies revealed that the receptor exhibits a high affinity for halides with a 1:1 binding 
stoichiometry and a general trend Cl
- (Ka = 61000 M
-1) > F
- (Ka = 30000 M
-1) > Br
- (Ka = 
7100 M
-1) > I
- (Ka = 460 M
-1).
[10, 11] Later work included a pyridinyl version of 6 which 
interestingly exhibited an increased selectivity in favour of the smaller halide anions (Ka 
= 24000, 1500 and 57 M
-1 for F
-, Cl
- and Br
- respectively).
[11] This was thought
[12-14] to be 
the result of favourable electrostatic interactions between the amide groups (see fig. 1.7) 
and the pyridine nitrogen which pre-organises the structure and does not allow twisting 
out of plane to accommodate the larger anions.   Chapter 1 – Introduction  
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Figure 1.7 - Crabtree's pre-organised version of 6 using a pyridinyl core. 
This work highlights how simplicity in design can still lead to highly efficient and 
selective anion receptors. 
Gale  and  Quesada  et  al.  have  recently  explored  other  ways  in  which  pre-
organisation  could  be  incorporated  into  these  isophthalamide  cleft  type  receptors.
[15] 
They achieved this by appending hydroxyl groups at the 4- and 6-positions on the aryl 
ring (9) and compared its behaviour to some control analogues (10 & 11). It is now well 
known
[12,  14] that 10 predominantly prefers to adopt the syn-anti conformation seen in 
Figure 1.8. It was hoped that the addition of these hydroxyl groups would lead to the 
predominantly syn-syn conformation for 9 and hence enhance its binding properties (see 
fig. 1.8). 
 
Figure 1.8 - Ways of ‘fine tuning’ pre-organisation by Gale and co-workers. 
X-ray crystal structures of 9 and 11 did indeed show that these species adopted 
their predicted conformations with hydrogen bonds between the hydroxyls and carbonyls 
on 9 (O···O 2.55-2.57 Å) and between the amide NH and methoxy-groups on 11 (N···O 
2.67-2.68 Å).
[15]   Chapter 1 – Introduction  
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Figure 1.9 – X-ray crystal structures of 9 & 11 showing the syn-syn and anti-anti structures as 
predicted. 
Subsequently, the same behaviour was observed in solution with far downfield 
shifts for the OH protons (δ = 13.5) in the 
1H-NMR spectrum of 9 in CD3CN, which is 
indicative  of  the  strong  hydrogen  bonding  expected.  Proton-NMR  binding  studies  in 
CD3CN also revealed much higher binding constants for 9 compared to the control 10, 
especially with chloride (Ka = 5230 and 195 M
-1 for 9 and 10 respectively). Addition of 
anion solutions to a solution of 11 caused no changes in the 
1H-NMR spectrum indicating 
no anion binding. This was thought to be due to the hydrogen bond donor groups being 
involved in intramolecular hydrogen bonding.
[15] 
Macrocyclic receptors present a more efficient  way of binding anions as they 
allow for more stable anion-receptor complexes due to the macrocyclic effect. This refers 
to  the  increased  thermodynamic  stability  of  macrocyclic  systems  compared  to  their 
acyclic analogues. They can also have more selectivity than their acyclic analogues by 
excluding specific anions according to size and/or shape. 
In  2001,  Hamilton  and  Choi  provided  a  fine  example  that  demonstrates  the 
macrocyclic  effect  with  a  study  of  a  macrocyclic  amide  receptor  and  its  acyclic 
analogue.
[16,  17]  The  macrocycles  (12  &  13)  were  designed  (with  the  aid  of  energy 
minimisation calculations) to have rigidly organised, convergent hydrogen bond donor 
groups  (three  amide  and  six  aryl)  to  accommodate  tetrahedral  oxyanions  such  as  p-
tosylate (fig. 1.10).   Chapter 1 – Introduction  
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Figure 1.10 - Hamilton and Choi's amide macrocycles (12&13) and acyclic test analogue (14). 
   Binding  constants  were  determined  by 
1H-NMR  titrations  in  2%  DMSO-
d6/CDCl3 solutions. As expected, the binding constants were much lower for 14 than 12 
and  13  with  some  unsual  binding  stoichiometries  observed.  For  example,  at  low 
concentrations of iodide with 13 the authors believed a 1:2 anion/receptor complex was 
formed  with  π-stacking  between  the  macrocycles  to  form  a  ‘sandwich’.  After  0.5 
equivalents of iodide was added, the receptor adopted a simple 1:1 binding stoichiometry 
as  inferred  by  the  NMR  shift  binding  profile.  In  general,  the  binding  affinities  were 
similar for 12 and 13 with the highest binding constants observed with the tetrahedral 
anions, NO3
- and p-tosylate. With HSO4
- and H2PO4
- a slow exchange of anion/receptor 
was observed on the NMR timescale meaning binding constants could not be obtained. 
This is indicative of very strong binding and even changing to the more polar 100% 
DMSO-d6  still  showed  a  slow  exchange  for  H2PO4
-  and  a  high  binding  constant  for 
HSO4
- (Ka = 1700 M
-1).
[16] 
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1.3.2  Ureas and Thioureas 
Ureas and thioureas are widely employed in anion receptor chemistry due to their 
usually  facile  synthesis.  They  are  commonly  generated  in  high  yields  by  a  simple 
reaction of the corresponding amine with a usually highly reactive isocyanate (in the case 
of ureas) or thioisocyanate (in the case of thioureas). Symmetric ureas/thioureas can also 
be  generated  from  condensation  of  an  amine  in  the  presence  of  triphosgene  or 
thiophosgene accordingly. 
They have two parallel NH hydrogen bond donor groups which naturally means 
they  often  (but  not  exclusively)  have  high  affinities  for  ‘Y’  shaped  anions  such  as 
carboxylates  or  nitrates  due  their  complimentary  shapes.  This  principle  can  be 
exemplified by a simple urea system looked at by Fabbrizzi et al.
[18] They synthesised a 
para-nitro  substituted  bis-phenylurea  receptor  (15)  and  studied  its  interaction  with  a 
selection of various ‘Y’ shaped oxyanions, both in the solid state and in solution. An X-
ray  crystal  structure  of  15  was  obtained  with  acetate  which  showed  the  expected 
complementary binding between the two species (fig. 1.11). 
Stability  constants  were  determined  by  UV-vis  titrations  in  acetonitrile  since 
bright colour changes were noted upon addition of the various oxyanions. The results 
showed a 1:1 binding stoichiometry for all the anions tested with an order of selectivity; 
CH3CO2
- (log K 6.61) > C6H5CO2
- (log K 6.42) > H2PO4
- (log K 5.37) > NO2
- (log K 
4.33)  >  HSO4
-  (log  K  4.26)  >  NO3
-  (log  K  3.65).  Interestingly  with  fluoride,  a  1:1 
complex  was  stable  at  low  concentrations,  but  at  higher  concentrations  the  receptor 
became deprotonated generating HF2
- (confirmed by 
1H-NMR and a new UV-vis band 
during titrations).
[18] 
N
H
O
N
H
NO2
O2N
O
O
15
 
Figure 1.11 - Fabbrizzi's bis-phenylurea anion receptor.   Chapter 1 – Introduction  
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Also, Gunnlaugsson and co-workers have shown how a simple thiourea based 
system can fluorescently detect anions in solution (fig. 1.12).
[19]  
 
         Figure 1.12 - Gunnlaugsson's urea based anion receptor. 
The receptors utilise the bisphenyl-thiourea core in a classic fluorophore-spacer-
receptor design with one of them containing an electron-withdrawing CF3- group. The 
fluorescence of the fluorophore (a naphthalimide) is quenched upon binding of anions to 
the  receptor  part.  Stability  constants  were  calculated  by  fluorescence  spectrometry 
titrations in DMSO which showed a 1:1 binding stoichiometry and a trend, F
- > CH3CO2
- 
> H2PO4
-, with slightly higher binding constants for 17. Interestingly, large changes in 
the UV-vis spectra for the receptors with F
- were also observed which was thought to be 
because  of  the  deprotonation  of  the  amine  spacer  unit  next  to  the  fluorophore.  This 
demonstrates  that  this  system  can  be  used  as  a  dual  sensor  where  at  low  anion 
concentrations the fluorescence is quenched and at higher concentrations the absorption 
spectrum is modulated.
[19] 
Recently, Ghosh and co-workers have revisited the familiar theme of using tren- 
type scaffolds to organise ureas for anion recognition (fig. 1.13).
[20] They synthesised a 
small  series  of  these  receptors  with  different  appends  to  the  urea  groups,  the  most 
interesting of which was the pentafluorophenyl version (18).    Chapter 1 – Introduction  
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Figure 1.13 - Ghosh and co-worker’s pentafluorophenyl tripodal urea based receptors. 
Proton-NMR titrations in DMSO-d6 showed a 1:1 binding stoichiometry of 18 
with  H2PO4
-  and  CH3CO2
-  with  binding  constants  (log  Ka)  of  5.52  and  4.45  M
-1 
respectively. Most interestingly, compound 18 formed a phosphate dimer complex in the 
solid state, with the dimer encapsulated in a pseudodimeric cage of the receptor (see fig. 
1.14).
[20] 
 
Figure 1.14 - A H2PO4
− dimer inside the pseudo cage formed by receptor 18 in the solid state.
[21] 
Reproduced by permission of The Royal Society of Chemistry. 
  Remarkably, the crystal structure shows the phosphate dimer binding through a 
total of eighteen hydrogen bonds and anion···π interactions. 
  Often anion receptors are designed with no specific anion to target for selective 
binding. They are simply synthesised and tested with a chosen range of anions to find 
selectivity and interesting phenomena. Recently, Meshcheryakov et al. have tried a more   Chapter 1 – Introduction  
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calculated and rational approach to anion receptor design, by carrying out preliminary 
molecular modelling studies in order to evaluate the best structure required for binding 
the  nitrate  anion.  They  wished  to  further  investigate  oligoureas  and  so  designed  and 
synthesised receptor 21 as part of a series of test analogues (the other analogues are not 
detailed here).
[22] 
    
Figure 1.15 - The rational design of a nitrate receptor by Meshcheryakov et al. 
X-ray suitable crystals were obtained by slow evaporation of a solution of 21 in a 
mixture  of  chloroform/DCM/ethanol  to  give  an  unexpected  structure  (fig.  1.16).  The 
structure showed the urea groups linking the diphenylether unit and the two xanthene 
units adopting a trans-conformation. In addition, the ureas are intramolecularly hydrogen 
bonding to the third urea which is cis-orientated (N···O distances 2.48-2.60 Å). 
     
Figure 1.16 - Crystal structure of 21 showing an unexpected twisted conformation.
[22]   Chapter 1 – Introduction  
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  This result was surprising given that the structure was designed to be rigid and 
pre-organised for optimum binding. They were unable to obtain a crystal structure of 21 
(or any of the analogues) with nitrate. 
  In  solution, 
1H-NMR  studies  were  not  possible  due  to  the  very  broad  peaks 
observed which they were unable to follow, so UV-vis titrations were  carried out in 
acetonitrile.  These  showed  no  interaction  with  nitrate  but  strong  interactions  with 
chloride  (log  Ka  =  11.7)  and  acetate  (log  Ka  =  5.7)  in  a  mixture  of  binding 
stoichiometries. This example clearly shows how rational design, backed by advanced 
computer modelling does not always lead to expected results.
[22] 
1.3.3  Pyrrole Based Systems 
  The use of pyrrole in anion receptor systems has its origins in a serendipitous 
discovery by Sessler and co-workers in 1990. At the time, the workers were trying to find 
a more efficient synthesis of the pentapyrrolic sapphyrin 22 (fig. 1.17).
[23, 24] 
H
N
N
N
H
N
H
N
22
 
Figure 1.17 – The Sapphyrin studied by Sessler and co-workers. 
  During their studies they thought they had obtained X-ray quality crystals of the 
HPF6
- salt of sapphyrin 22. However, the crystal structure revealed that they had actually 
made the diprotonated version of the macrocycle which was binding a fluoride in the 
cavity through five hydrogen bonds. A PF6
- counter-anion was also located in the lattice, 
but  it  was  not  proximate  to  the  sapphyrin  structure.  Other  structures  were  also  later 
solved, such as the 2HCl solvate of 22 which showed the sapphyrin binding two chloride 
anions.  
These initial studies paved the way for development into a significantly large area 
of research with an ever increasing number of varieties of extended sapphyrins, each with 
unique anion binding properties and selectivity.
[23, 25, 26]    Chapter 1 – Introduction  
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  In 2001 a crystal structure of pyrrole with tetramethylammonium (TMA) chloride 
was reported by Gale and co-workers.
[27] It was remarkable because it was the first time a 
single ring pyrrole/anion complex had been reported (fig. 1.18). 
 
Figure 1.18 - X-ray crystal structure of the coordination environment of pyrrole with TMA
+ 
chloride.
[27] 
  The  structure  shows  the  chloride  bound  by  two  pyrroles  via  the  NH  groups 
(N···Cl 3.24 Å) and a slightly weaker interaction through the methyl proton of the TMA
+ 
(C···Cl  3.66  Å).  NH···π  and  CH···π  interactions  were  also  observed  between  the 
pyrroles to form a ‘honeycomb’ network of pyrrole, TMA
+ and Cl
-. 
  Most  significantly,  the  binding  of  chloride  to  the  pyrrole  shows  very  similar 
geometry to the binding of chloride to the first ever neutral pyrrole based anion receptor 
reported; meso-octamethylcalix[4]pyrrole (23, fig. 1.19). The compound was in fact first 
synthesised by Baeyer
[28] in 1886, but it wasn’t until 1996 that it was put forward as an 
anion receptor by Gale and Sessler et al.
[29] 
    
NH
NH HN
HN
23 
Figure 1.19 - The first neutral pyrrole based receptor by Gale and Sessler et al.   Chapter 1 – Introduction  
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  Solution  studies  (
1H-NMR  titrations  in  CD2Cl2)  revealed  that  23  was  highly 
selective for fluoride with a binding constant of 17200 M
-1 when compared to chloride 
(Ka=350 M
-1), bromide (Ka=10 M
-1) and dihydrogen phosphate (Ka=100 M
-1). 
  In the solid state they found that the macrocycle adopts a dramatically different 
structure  upon  anion  complexation;  viz.,  the  free  calixpyrrole  adopts  a  1,3-alternate 
conformation wherein the rings are orientated in opposite directions. However, when the 
macrocycle  is  bound  to  an  anion  such  as  fluoride  or  chloride,  it  adopts  a  cone 
conformation with the four pyrrole NH groups forming hydrogen bonds to the central 
anion (fig. 1.20). It is particularly interesting to see how the larger chloride anion sits 
slightly out of the cleft compared to the ‘snug fit’ of the much smaller fluoride anion. 
                                        
 
 
 
Figure 1.20 - X-ray crystal structure of 23 showing it unbound in the 1,3 alternate conformation 
(top) and bound with fluoride (left) and chloride (right) in the cone conformation. 
Recent studies by Sessler, Schmidtchen and Gale et al.
[30-33] have shed some new 
light on the anion binding behaviour of calix[4]pyrroles in solution and the solid state. 
These intriguing studies on 23 have shown that: 
F
-  Cl
-   Chapter 1 – Introduction  
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1.  The anion selectivity in solution is very reliant on the nature of the solvent the 
studies are conducted in, i.e. the more polar the solvent the less selective the 
receptor is for fluoride.
[30, 32] 
2.  By testing a variety of chloride salts with different counter-cations by isothermal 
calorimetry  (ITC)  and 
1H-NMR  titrations,  the  authors  have  shown  that  the 
binding constants are not reliant on which method is used.
[30] 
3.  Compound 23 can act as a ditopic ion pair receptor. In particular, it has been 
shown to bind caesium chloride in the solid state, with the caesium bound in the 
vacant cup formed by the calixpyrrole upon anion binding. Likewise, it can bind 
organic counter-ions such as triethylammonium  and N-ethylpyridinium cations 
(see fig.1.21).
[30, 31, 33, 34] 
 
Figure 1.21 - Crystal structures of 23 with TEA
+Cl
- (left) and N-ethylpyridinium chloride 
(right) in a space-filling representation. 
  As  a  consequence  of  the  last  point,  it  was  also  discovered  that  when 
dichloromethane  was  used  in  solution  studies,  there  was  a  strong  influence  of  the 
countercation on the stability constants observed. This puts forward a strong antithesis to 
the assumption that when anions are used as TBA salts in solution studies, the anion 
behaves as a free species.
[30] 
This class of receptor has sparked a continuingly growing area of anion receptor 
chemistry, as they are remarkably easy to prepare and fine tune to alter their affinities 
and selectivity for various anions. The synthetic scheme below demonstrates just two of 
the many ways in which this tuning can be achieved (fig.1.22).   Chapter 1 – Introduction  
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Figure 1.22 - Two ways of adding functionality to calixpyrroles. 
  Receptor 23 is made simply with acetone via Route 1. However, any number of 
ketones can be used with varying R groups to add enhanced functionality to the basic 
calixpyrrole unit. One such example is that of Gale and Warriner et al. who used Route 2 
(see fig. 1.22) to generate the calixpyrrole, 26.
[35] 
                
Figure 1.23 - Gale and Warriner's modified calix[4]pyrrole. 
  Proton-NMR  titrations  in  CD2Cl2  showed  much  higher  binding  constants  as 
expected, for example, the binding constant (Ka) for 26  with chloride  was 1042 M
-1 
compared with 350 M
-1 for 23. Surprisingly however, 26 also showed high selectivity for 
carboxylates which was not displayed by 23. The authors attributed this to the ability of 
26 being able to coordinate to both oxygen atoms on the carboxylate simultaneously. 
The first pyrrole based receptor was cyclic but there have also been significant 
advances in the study of acyclic pyrrole based systems, most notably by Gale and co-  Chapter 1 – Introduction  
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workers. Most this work focused around 2,5-bisamidopyrroles which were inspired by 
the work of Crabtree and his isophthalamide receptors (see earlier). Receptors 27 and 28 
were made from the reaction of the appropriate amine with the pyrrole-bisacid chloride in 
yields of 18 and 47% respectively (fig. 1.24).
[36] 
           
Figure 1.24 - Bisamidopyrrole receptors by Gale and co-workers. 
  One of the advantages of exclusively pyrrole based receptors is that they usually 
cannot undergo self-association to form dimers since they lack a hydrogen bond acceptor 
group.  However,  with  these  receptors  (27-30),  the  introduction  of  an  amide  group 
detrimentally allows dimerisation to occur as seen in the crystal structure of 28 shown 
below (fig. 1.25). 
    
Figure 1.25 - X-ray crystal structure of 27 showing the dimer (Npy···H 3.238 Å). 
  A  similar  structure  was  observed  for  30  which  makes  the  solvation  of  these 
receptors problematic. As a consequence of this, 
1H-NMR binding studies were carried 
out in polar solvent systems such as DMSO-d6/0.5% water or acetonitrile-d3. Receptor 27   Chapter 1 – Introduction  
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showed a high selectivity for benzoate in acetonitrile-d3, whilst 28 showed selectivity for 
dihydrogen phosphate in DMSO-d6/0.5% water. 
  Introduction of chloride groups to the pyrrole skeleton were effected (29 and 30) 
to make the pyrrole NH more acidic and hence enhance anion binding. However, one of 
the undesirable effects of this was witnessed with the addition of TBA fluoride to an 
acetonitrile-d3 solution of 30, which resulted in an unusual titration profile whereby the 
pyrrole NH signal completely vanished. This is indicative of deprotonation which was 
supported by the crystal structure of 30 with fluoride which showed the receptor forming 
a so-called ‘narcissistic’ dimer of itself with NH···N
- hydrogen bonds (fig. 1.26).
[36] 
          
Figure 1.26 - X-ray crystal structure of the dimer formed by 30 when deprotonated by fluoride 
anions.
[36] Reproduced by permission of The Royal Society of Chemistry. 
This work shows the challenge involved in trying to strike a fine balance between 
providing the most optimum hydrogen bond donors that at the same time, are not going 
to be prone to deprotonation. 
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1.4 Metal-Organic Anion Receptors 
The  hydrogen  bond  is  arguably  the  most  fundamental  molecular  interaction 
employed in the design of an anion receptor. As has been seen, this is mostly because it 
is a strong and highly directional interaction, with cumulative effects that can lead to 
very high selectivity and binding constants. A key challenge however, is how to arrange 
and position these interactions for optimum effect, and in particular, create binding sites 
for anions of specific geometry. 
One such tool at disposal for arranging hydrogen donors in space is to employ a 
metal centre, to which can be attached organic ligands appended with hydrogen bond 
donor groups. The metal centre or centres can restrict the conformations available to the 
receptor leading to more rigidity  and pre-organisation for anion binding.  In addition, 
these metal centres can potentially contribute electrostatic binding interactions for even 
more enhanced binding affinities (see fig.1.27). 
            
Figure 1.27 - Pictorial representation of how a metal-organic anion receptor can function. 
Other advantages of metal centres include their potential for use as electrochemical, 
luminescent or colorimetric reporter units whereby they are ‘switched on’ or ‘off’ in the 
presence of anions. 
Despite these perceived benefits, the use of metal ions to assemble anion receptors 
has been and remains quite a small growth area in the field of anion recognition. Perhaps 
some of the reasons for this are the inherent difficulties of: 
a)  Finding  a  metal  with  a  suitable  coordination  number  and  preferable 
coordination geometry.   Chapter 1 – Introduction  
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b)  Finding ligands that can coordinate to the metal without being subject to 
substitution in the presence of anions or strong donor solvents. 
c)  Finding a metal complex which is stable under standard conditions, i.e. not 
light, air or solvent sensitive. 
d)  Choosing  a  suitable  counter-anion  for  the  complex,  such  that  it  does  not 
interact  with  either  the  hydrogen-bond  donor  groups  or  interact 
electrostatically to the metal centre. 
The significance of points (b) and (d) can by highlighted by referring to the work 
of Halcrow and co-workers from 2002.
[37, 38] This work involved exploring some novel 
3(5)-tert-butylpyrazole (Bupz) zinc complexes 31-33 (see fig. 1.28 below). 
                              
Figure 1.28 - Zinc pyrazole complexes by Halcrow and co-workers (left), x-ray crystal structure of 31 
(right). 
  The crystal structure of 31 showed the ligands orientated such that they form a 
convergent array of the three NH hydrogen bond donors to the central non-coordinated 
chloride anion (fig. 1.28). To address point (d) they exchanged the halides with large 
counter-anions with delocalised charges such as BF4
-, PF6
- or CF3SO3
-, with which they 
also obtained crystal structures. However in solution, when they added TBA salts of 
halides to these compounds, ligand exchange was observed due to the nucleophilic effect 
of the halides attacking the zinc centre. Perez and Riera et al. have recently tried to 
address this problem by studying analogues of 31 with different metal centres such as 
molybdenum and different counter-anions.
[39, 40]   Chapter 1 – Introduction  
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  Of course, much of the inspiration behind metal-organic receptors has come from 
nature’s  fundamental  biological  processes  involving  metalloenzymes  and  other 
metalloproteins. In particular, Paul Beer and his group used this inspiration to initiate a 
pioneering  research  program  in  the  1990s  which  involved  studying  a  large  range  of 
transition metal based, organometallic receptors for anions.
[41] Some of this early work 
focused on ferrocene and cobaltocene based receptors which were unexplored at the time. 
It was hoped that the cobaltocene units would be able to electrochemically recognise 
anions (observable by cyclic voltammetry) and preorganise the hydrogen bonding units 
for anion binding. Receptors 34 and 35 (see fig. 1.29) are highlights of the early range of 
this class of receptor. In CD3CN solution, 
1H-NMR titrations with TBA salts of anions 
revealed strong perturbations of the amide NH protons. Cyclic voltammetric studies (in 
dry acetonitrile) demonstrated electrochemical sensing; with the redox potential of the 
reducible cobaltocenium moiety cathodically  perturbed ( E = 240 mV with H2PO4
-). 
Essentially,  the  complexed  anion  stabilises  the  positive  charge,  making  the 
cobaltocenium unit more difficult to reduce during the voltammetry.
[41] 
         
Figure 1.29 - An example of two of Beer's original cobaltocene based anion receptors. 
  An  X-ray  crystal  structure  of  34  with  bromide  revealed  two  equivalents  of 
bromide  binding  to  one  receptor  through  not  only  each  amide  NH  but  also  through 
interactions with the Cp and aryl protons (fig. 1.30).   Chapter 1 – Introduction  
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Figure 1.30 - X-ray crystal structure of 34 with bromide showing the anions interacting with the 
NHs, Cp and aryl protons. 
  This work was further developed over the years with more selective and stable 
cobaltocenium and ferrocene compounds (including ditopic and macrocyclic versions) 
reported. 
  Also included in this seminal research effort by Beer and co-workers were some 
ruthenium  bipyridyl  (Ru-bipy)  based  receptors  which  have  the  potential  to  be  both 
electrochemically and optically active. The first one to be synthesised in this series was 
receptor 36 which consists of a ruthenium centre complexed with three bipyridyl units, 
one of which is functionalised with a bis-amide for hydrogen bonding to anions (fig. 
1.31).
[42] 
     
Figure 1.31 - Beer and co-worker's original Ru-bipy receptor.   Chapter 1 – Introduction  
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The ruthenium ion is dipositive which means that electrostatic interactions with 
anions  are  particularly  favourable.  Proton-NMR  titrations  in  DMSO-d6  (a  highly 
competitive solvent) showed strong interactions with chloride and dihydrogen phosphate 
(Ka = 500 and 8000 M
-1 respectively).
[41, 42] 
  Slow evaporation of an acetonitrile solution of 36 with an excess of TBA
+Cl
- 
provided single crystals suitable for an X-ray crystal structure determination (fig. 1.32). 
Remarkably  the  structure  revealed  the  receptor-anion  complex  is  stabilised  by  6 
hydrogen bonds (two amide NHs and four aryl CHs, distances = 2.006-2.033 Å).
[41, 42] 
 
Figure 1.32 - X-ray crystal structure of 36 with chloride. 
  Other work followed which includeded new ditopic and macrocyclic versions of 
these ruthenium complexes for improved binding and selectivity. A highlight of these 
very extensive studies includes the homo-dinuclear twenty six membered macrocycle, 37 
(fig.  1.33).  This  was  found  to  be  particularly  effective  for  acetate  and  dihydrogen 
phosphate in DMSO solution (both association constants > 10
5) as determined by 
1H-
NMR titrations.
[43]   Chapter 1 – Introduction  
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Figure 1.33 - One of Beer and co-worker's dinuclear ruthenium based macrocycles. 
  Slow evaporation of an acetonitrile solution of 37 in the presence of acetate gave 
single crystals suitable for an X-ray crystal structure (fig. 1.34). 
         
Figure 1.34 - X-ray crystal structure of 37 with acetate. 
  The structure showed the two octahedral metal centres linked together through 
the  substituted  bipyridyl  units  to  form  a  planar  macrocycle.  The  macrocycle 
accommodates  two  acetate  anions  without  distortion,  binding  through  two  strong 
hydrogen bonds to the amide NH groups (2.781 – 2.894 Å) and weaker CH···O hydrogen 
bonds (3.022 – 3.408 Å).
[43] 
  One  of  the  most  challenging  goals  in  anion  receptor  chemistry  is  to  design 
systems  that  can  bind  anions  in  water.  The  main  challenge  is  that  water  is  a  very 
competitive solvent for hydrogen bond binding sites. The other problem is designing a 
receptor that is sufficiently water soluble. The anion receptors thus far have been studied   Chapter 1 – Introduction  
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only in organic solvents but all natural processes (e.g. enzymatic or antibody functioning) 
take place in the aqueous media of living organisms. As is a reoccurring theme now, it 
naturally follows that inspiration can be taken from nature in the design of receptors for 
anions in water.
[44] 
  Some elegant examples of metal-organic systems that can recognise phosphate in 
water were put forward by Anslyn and co-workers in 2003.
[45] The designs both feature 
C3v symmetric cavities with copper(II) ions on the C3 axis and encapsulating hydrogen 
bond donor groups (38 and 39, fig. 1.35). 
     
Figure 1.35 - Anslyn and co-worker's copper (II) C3v symmetric receptors. 
  Figure 1.35 shows how the designs of the cavities provide excellent shape, size 
and  charge  complimentarity  to  the  phosphate  anion.  Accordingly,  binding  studies 
(conducted  in  water  at  neutral  pH  and  measured  by  UV-vis  spectroscopy  methods) 
showed a particularly high affinity for HPO4
2- with compounds 38 and 39 (Ka = 25000 
and 15000 M
-1 respectively). It was also interesting that one of the controls (40) studied 
bound HPO4
2- with Ka = 900 M
-1 despite lacking the hydrogen bond donor groups of 38 
and 39 (fig. 1.36).
[45]   Chapter 1 – Introduction  
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Figure 1.36 - One of the control analogues tested against 38 and 39. 
  This  result  suggests  that  the  copper  (II)  metal  centre  plays  a  key  role  in  the 
binding  of  phosphate  to  38  and  39,  which  proves  how  metals  can  be  utilised  to 
complement hydrogen bond donor groups with electrostatic interactions to bind anions. 
  Moyer and co-workers have previously had success binding sulfate with a phenyl 
derivative of receptor 41 (fig. 1.37). This phenyl version bound the anion through twelve 
hydrogen bonds in the crystalline state.
[46] However, their goal was to selectively and 
efficiently separate sulfate from aqueous solutions and this crystalline framework proved 
ineffective because of its low stability and high solubility in water. They reasoned that 
replacing the phenyl groups with stronger coordinating groups such as pyridines, would 
facilitate  the  formation  of  more  robust  crystalline  frameworks,  with  superior  sulfate 
separation abilities. This led to the synthesis of compound 41.
[47]  
 
Figure 1.37 – Moyer and co-worker’s tripodal sulfate receptor. 
X-ray suitable crystals of MgSO4(41)2(H2O)6 composition were obtained from a 1:1 
H2O/MeOH solution of 41 in the presence of MgSO4. The structure showed the sulfate 
bound by six ureas through twelve hydrogen bonds. The complex is incorporated in a 
hydrogen  bonded  capsule  from  twelve  additional  hydrogen  bonds  from  six  water 
molecules.  These  capsules  are  linked  by  2+  magnesium  cations  to  form  a  three 
dimensional framework with distorted NaCl topology (fig. 1.38).   Chapter 1 – Introduction  
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Figure 1.38 – Crystal structure of 41 a) Sulfate encapsulation by the six urea groups. b) Hydrogen 
bonded capsule showing two 41 ligands, one sulfate and six water bridging molecules. c) The 
hydrogen bonded framework from self-assembly of the anionic capsules with Mg
2+ ions. d) 3D 
representation of the octahedral framework.
[47] Copyright Wiley-VCH Verlag GmbH & Co. KGaA. 
Reproduced with permission. 
One of the useful aspects of employing metals (particularly transition metals) in 
anion receptor design is the wide range of geometries that can be accessed according to 
which metal and oxidation state is chosen. For example, palladium (II) has preferential 
geometry to be square planar due its d
8 electron configuration. Recently, Vilar and co-
workers have utilised this metal in the construction of a bis-palladium urea complex for 
anion recognition.
[48, 49]   Chapter 1 – Introduction  
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Figure 1.39 - Vilar and co-worker's palladium based anion receptor. 
  A  single  crystal  X-ray  structure  of  42  was  obtained  which  interestingly 
encapsulates one of the triflate counter-anions (fig. 1.37). As can been, the anion is bound 
by the urea NH groups on the ligand arms to the oxygens of the triflate (N-H···O 3.13 – 
3.23 Å).
[48] 
     
Figure 1.40 - X-ray crystal structure of 42 showing it binding its triflate counter-anion. 
  The  same  workers  have  also  used  a  similar  architecture  to  synthesise  some 
palladium  based  macrocycles  composed  of  bridging,  functionalised  pyridyl  ligands. 
Despite the wealth of literature exploring palladium based cages and boxes there had 
been relatively few studies of metal receptors with bridging ligands that also function as 
hydrogen bonding units.
[50]   Chapter 1 – Introduction  
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Figure 1.41 - Vilar and co-worker's palladium based macrocycles. 
  It was reasoned that the synthesis of 43 and 44 could lead to the formation of a 
range of different acyclic and cyclic products, especially taken into account how labile 
palladium/pyridine  bonds  are.  This  would  mean  that  an  equilibrium  of  different 
assemblies  would  likely  be  established.  X-ray  suitable  crystals  were  grown  from  the 
reaction mixtures which revealed formation of the [2+2] macrocycles for both 43 and 44. 
As seen in their earlier work with receptor 42, 43 encapsulates a triflate counter-anion 
which is interacting with the central cavity whilst the palladium centres are in a distorted 
geometry.
[49, 50] 
 
Figure 1.42 - X-ray crystal structure of 43 showing the encapsulation of a triflate counter-anion.
[21] 
Reproduced by permission of The Royal Society of Chemistry. 
  The same structure was observed for receptor 44, showing the bowl structure with 
a triflate encapsulated inside. However, despite these crystal structures, 
1H-NMR studies 
revealed that more than one species co-existed in solution. In fact, the studies revealed 
that  indeed,  an  equilibrium  did  exist  between  a  [2+2]  and  [3+3]  macrocycle.  Of   Chapter 1 – Introduction  
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significant interest was that this equilibrium was found to be affected by, the solvent 
system,  concentration,  temperature  and  the  presence  of  particular  anions:  viz.  when 
dihydrogen phosphate was added, the [2+2] macrocycle was favoured over the [3+3]. 
The same effect was noticed with the addition of di-carboxylates such as malonate or 
oxalate. Yet with hydrogen sulfate, no significant changes were observed in the relative 
integration of the peaks assigned to the two different assemblies [2+2] or [3+3]. The 
authors  believe  this  work  will  lead  on  to  the  development  of  complex  dynamic 
combinatorial libraries by mixing other hydrogen bonding ligands with the cis-palladium 
centres.
[49] 
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1.5 Neutral Molecule Receptors and Hydrogen Bonded Arrays 
The binding of neutral guests is a particularly challenging task simply because of 
their  lack  of  charge.  When  guests  are  charged  (anionic  or  cationic),  electrostatic 
interactions with the host play a key role in enhancing binding affinity. So unless the host 
is charged, neutral guest binding must rely on other intermolecular interactions.  
As  in  anion  recognition,  the  majority  of  inspiration  in  this  area  has  come  from 
nature. Of course DNA consists of a hydrogen bonded array of neutral complementary 
base  pairs  on  a  poly-anionic  backbone,  which  remarkably  assembles  in  the  most 
competitive  of  solvent  environments,  water.  Indeed  a  lot  of  early  work  in  this  area 
involved developing receptors for binding specific nucleotides or nucleotide base pairs. 
A fine example can be provided by Andew Hamilton who designed a receptor for the 
recognition of thymine derivatives.
[51] As was the theme of most of Hamilton’s seminal 
work, the design of the receptor was remarkably simple, consisting of an easy to prepare, 
amide based macrocycle 45. 
          
Figure 1.43 - Hamilton's macrocyclic receptor for thymine derivatives (left) and its mode of binding 
to butyl-thymine (right). 
The role of the naphthalene unit is to complement the hydrogen bonding by π-π 
stacking with the thymine ring (as depicted in fig. 1.40 right). This was proved by X-ray 
crystal structure analysis (fig. 1.41) which neatly shows the three hydrogen bonds (N···N 
3.06, N···O 2.87&2.99 Å) and naphthalene unit lying parallel to the thymine (inter-plane 
contact 3.37 Å).
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Figure 1.44 - X-ray crystal structure of 45 with butyl-thymine. 
By adding butyl-thymine to a CDCl3 solution of 45 the NH protons on each species 
were  significantly  shifted  downfield  on  the 
1H-NMR  spectrum  (2.6  and  2.25  ppm 
respectively). 
What  this  work  chiefly  highlights  is  the  two  most  important  intermolecular 
interactions implemented in neutral molecule receptor chemistry; hydrogen bonding and 
π-π interactions. Other work which has exploited both these interactions for neutral guest 
recognition includes the early research of Hunter and Purvis. This involved the design of 
macrocycles  46  and  47  for  binding  quinones.  Their  synthesis  was  effected  from  the 
corresponding diamine and bis-acid chloride in a two-step high dilution synthesis.
[12, 52] 
N
O
N
N
O
X
N
O O
H
H
H
H
O O
46 X = CH
47 X = N  
 Figure 1.45 - Hunter and Purvis's macrocyclic receptors for p-benzoquinone. 
  Interestingly the synthesis also yielded [2]-catenane and cyclic tetramer versions 
of 46 and 47, which were later investigated
[53,  54] but are not detailed herein. The p-  Chapter 1 – Introduction  
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benzoquinone can potentially bind to the macrocycles by hydrogen bonding to the four 
amide groups and through π-π interactions from the bis-phenyl linkers (fig. 1.45). 
Proton-NMR binding studies were conducted in CDCl3 with 46 and 47 with p-
benzoquinone  which  gave  remarkably  high  (for  a  neutral  molecule  binding  event) 
binding  constants  of  1200  and  1800  M
-1  respectively.
[12]  A  titration  of  46  with  p-
benzoquinone  in  the  competitive  solvent  mixture,  CDCl3-CD3OD  (9:1),  gave  an 
association constant of only 100 M
-1 which suggests that the π-π interactions must be 
making a sizeable contribution to the binding energy. 
 
1.5.1  Hydrogen Bonded Arrays 
  Hydrogen  bonds  are  believed  to  be  a  complex  conglomerate  of  different 
intermolecular  interactions,  one  of  which  is  electrostatics  (see  earlier).  The  highly 
directional hydrogen bond is the primary interaction between a hydrogen bond donor (D) 
and acceptor (A) but secondary, diagonal electrostatic interactions can also supplement 
this primary interaction to form a strengthened array.
[55] This concept can be realised by 
considering the following triple hydrogen bond arrays:  
      
Figure 1.46 - Dimers between triple hydrogen bond arrays, showing attractive (green) and repulsive 
(red) electrostatic interactions between the donors (D) and acceptors (A). 
  In  the  array,  like  charges  repel  each  other  diagonally,  weakening  the  binding 
whilst opposite charges attract, strengthening the binding. So the DDD.AAA array has 
only attractive electrostatic interactions, hence it forms the most strong complex.
[55] This 
hypothesis was elegantly proven by the research group of Steve Zimmerman through his 
investigations of amino- and ureido-naphthyridines.
[56-58] 
  Recently, Wilson and co-workers have investigated how to strengthen a pyridyl-
urea DDA.AAD array using imidazoles.
[59] Pyridyl-ureas are considered attractive DDA 
building  blocks  because  of  their  ease  of  synthesis  but  they  are  susceptible  to   Chapter 1 – Introduction  
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intramolecular hydrogen bonding interactions, which means they have poor association 
constants due to the entropic energy barrier needed to be overcome (fig. 1.47). 
         
Figure 1.47 - The pyridyl-urea studied and how it can intramolecularly interact. 
  This problem was addressed by using an imidazole instead of the pyridyl- which 
can pre-organise itself through intramolecular hydrogen bonds. An equilibrium would 
still  exist  between  two  conformers  but  each  would  potentially  be  able  to  form  two 
different DDA arrays (see fig. 1.48).
[59] 
                    
 
Figure 1.48 - Wilson and co-worker's proposed DDA.AAD arrays. 
  Compound 50 was initially synthesised but it was not soluble enough to study in 
CDCl3 so the more soluble 51 was made and tested with a complimentary AAD array, 
amidoisocytosine (49). No crystals of the proposed dimers between 50/51 and 49 were 
obtained but crystals of the self-associating dimers of 50 and 49 were. The structure of 
compound  50  revealed  only  the  NH···O  conformer  was  formed  but  a 
1H-NMR  in 
DMSO-d6 showed interconversion between the two conformers (fig. 1.49).
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Figure 1.49 - X-ray crystal structure of the self-associating dimer of 50.
[59] Reproduced by permission 
of The Royal Society of Chemistry. 
  The crystal structure of 49 revealed the presence of the intramolecular binding 
that was predicted, with only weak intermolecular hydrogen bonds (fig. 1.50). 
 
Figure 1.50 - X-ray crystal of the self-associating dimer of 49.
[59] Reproduced by permission of The 
Royal Society of Chemistry. 
  In solution, addition of aliquots of 49 to 51 in CDCl3 produced large shifts of the 
Ha  proton  on  49  (see  fig.  1.48  for  proton  labelling).  Curve  fitting  with  HypNMR
[60] 
produced an exceptionally high binding constant of 8400 M
-1 compared to just 84 M
-1 
with 48 and 49; a nearly three order of magnitude difference. 
  Of course, increasing the number of hydrogen bond donors and acceptors can 
lead  to  even  more  possible  arrays  of  increased  stability.  For  example,  quadruple   Chapter 1 – Introduction  
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hydrogen bonded dimers have six possible arrays, two of which are self-complimentary 
(fig. 1.48).
[61] 
               
Figure 1.51 - The six possible arrays of a quadruple hydrogen bonded dimer.
[61] Reproduced by 
permission of The Royal Society of Chemistry. 
Since 1988 there has been a vast amount of literature on quadruple hydrogen 
bonded  arrays  but  perhaps  the  most  prominent  work  was  that  of  Meijer  and  co-
workers.
[61]  This  group  used  ureidotriazines  for  self-assembling  ‘supramolecular 
polymers’ in alkanes, chloroform and water.
[62] 
     
Figure 1. 52 - Meijer and coworker's supramolecular polymers. 
As can be seen (fig. 1.52), the ureidotriazoles can form the self-complimentary 
DADA array (see fig. 1.51). The bifunctional unit 52 only forms a monomer in polar 
solvents such as DMSO but in CDCl3 can self-assemble into random coil polymers. In 
dodecane, solvophobic interactions induce stacking of the dimerized ureidotriazine units 
to form highly ordered, helical, columnar polymers (see fig. 1.53).
[61, 62]   Chapter 1 – Introduction  
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Figure 1.53 - Pictorial representation of the helical polymer formed by 52 in dodecane.
[61] Copyright 
Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission. 
  The inclusion of chiral oligoethylene chains on 53 renders it water soluble and to 
the authors’ amazement the quadruple hydrogen bond arrays still formed in this highly 
competitive  solvent.  It  was  thought  that  this  was  facilitated  by  the  hydrophobic 
microenvironment created by the stacking of the planar trialkoxyphenyltriazine moieties 
in which disruption of the hydrogen bonds by water molecules is prevented.
[61, 62]  
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1.6 Aims of This Thesis 
This chapter has introduced just a few examples of previous work in each of the 
subject areas of this thesis. The work has predominantly shown that hydrogen bonding is 
the primary tool for efficient and selective anion recognition. Metal based anion receptors 
can potentially provide complementary electrostatic interactions for more enhanced anion 
affinities. This chapter has demonstrated that there are many different functional groups 
and subsequent hydrogen bonding motifs that can be used to bind anions. This thesis will 
build on previous studies with the report of novel hydrogen bonding motifs both for 
binding anions and neutral molecules. Because of the diversity of the topics studied this 
thesis has been divided into three sections: 
1.  The synthesis of platinum(II) based receptors and a study of their anion binding 
properties both in solution and the solid state. 
2.  The synthesis of a simple benzimidazole cleft receptor for barbiturates and ureas. 
This receptor will be tested against several control analogues to probe various 
aspects of the receptor. This section will also include a brief investigation into the 
design and synthesis of a neutral guest templated catenane. 
3.  Finally a new triazole strapped calix[4]pyrrole will be described and its solution 
behaviour investigated. A brief investigation into the novel use of triptycenes in 
anion receptor design will also be included in this section. 
 
 
 
 
 
 
 
   Chapter 2 – Metal-Organic Anion Receptors  
 
41 
 
 
Chapter 2 –  
Metal-Organic Anion 
Receptors 
 
2.1  Introduction 
In  1997,  Steve  Loeb  from  the  University  of  Windsor  (Canada)  reported  the 
synthesis and study of a range of calix[4]arene based  anion receptors; functionalised with 
amides at the 1,3-positions on the upper rim (fig. 2.1).
[63] 
      
Figure 2.1 - Cameron and Loeb's calix[4]arene based anion receptor. 
In CDCl3, 
1H-NMR studies revealed receptor 54 had a selectivity for ‘Y’-shaped 
anions such as the benzoate anion (fig. 2.1) which gave a binding constant (Ka) of 5160 M
-
1.  The  binding  is  accommodated  by  the  calix[4]arene  adopting  a  pinched  cone 
conformation, with the amides arranged in a complimentary fashion for ‘Y’-shaped anions. 
This  work  demonstrates  how  an  organic  scaffold  can  be  utilised  to  organise 
hydrogen bond donors for selective anion recognition. As a progression of this concept, 
Gale  and  Loeb  wanted  to  investigate  an  analogous  ‘inorganic’  scaffold  for  organising 
hydrogen  bond  donors.  In  order  to  acheive  the  right  pre-organised  orientation  of  the 
hydrogen bond donor groups, a transition metal of appropriate geometry with appropriate   Chapter 2 – Metal-Organic Anion Receptors  
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organic ligands was required. At the time, this concept was largely unexplored and in 
particular,  no  research  had  been  done  with  platinum(II)  metal-organic  anion  receptors. 
These 2+ charged metal complexes were considered ideal for the following reasons: 
a)  Because  of  platinum(II)’s  d
8  electronic  configuration,  it  adopts  a  4-coordinate, 
square-planar geometry. 
b)  The complexes were considered inert to ligand substitution. 
c)  They are usually stable complexes in air and moisture. 
d)  They were considered easy to prepare in comparison to organic scaffolds such as 
synthetically challenging calix[4]arenes. 
e)  There is potential for the charge on the metal centre to supplement the hydrogen 
bonding to an anion with electrostatic interactions. 
Initially, it was decided to focus on amide based ligands because of the results from the 
calix[4]arene  work  (see  earlier),  and  so  the  easy  to  prepare,  nicotinamide  ligand  was 
chosen, to result in a homoleptic [PtL4]
2+ complex 56 (fig. 2.2).
[64] 
         
N
O N
H
nBu
N
O N
H
nBu
N
N
nBu
H
O
N
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O
Pt2+
(PF6
 )2
56
 
Figure 2.2 – Gale and Loeb's Pt-nicotinamide based anion receptor. 
  The  large,  charge  diffuse  PF6
-  ion  was  chosen  as  the  counter-anion,  as  it  was 
presumed  it  would  have  minimum  interactions  with  the  receptor.  The  ligand  was 
synthesised from the nicotinamide ethylester and n-butylamine by standard methods.
[64, 65] 
The platinum(II) complex was prepared by reacting one equivalent of PtCl2(EtCN)2 with 
four equivalents of ligand and two equivalents of AgBF4 in MeCN solution at reflux. After   Chapter 2 – Metal-Organic Anion Receptors  
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filtration to remove residual AgCl, the crude product was recrystallised from MeCN/Et2O 
to give the product in 87% yield.
[64] 
  By drawing analogy to calix[4]arene nomenclature, four different conformations 
were conceived for the platinum complex because of free rotation about the Pt-N bonds 
(see fig. 2.3 below). 
          
Figure 2.3 - The four different conformations that receptor 56 can adopt. 
  Single  crystals  of  56  were  obtained  by  recrystallisation  from  a  CH2Cl2/Pr
i
2O 
solvent mixture. These provided an X-ray structure of 56 with two molecules of CH2Cl2 in 
the  structure  (fig.  2.4).  Interestingly  the  complex  adopted  the  1,2-alternate, 
centrosymmetric conformation, with the two CH2Cl2 molecules hydrogen bonding to the 
amide oxygens (CH···O distances 2.40-2.47 Å). The PF6
- counter-anions sit above and 
below the metal centre and do not interact with the amide NH groups. This ratified the 
assumption  that  the  counter-ions  would  not  compete  for  binding  with  anions.  Also, 
because  of  the  1,2-alternate  conformation  adopted,  it  was  considered  that  the  receptor 
would predominantly form 2:1 anion:host species in solution.
[64]   Chapter 2 – Metal-Organic Anion Receptors  
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Figure 2.4 - X-ray crystal structure of 56 with CH2Cl2. 
  Solution studies in the form of 
1H-NMR titrations, were conducted in a variety of 
solvent mixtures due to solubility problems encountered and are shown in Table 2.1. 
Anion  Solvent  Ka (M
-1) 
CF3SO3
- 
ReO4
- 
NO3
- 
HSO4
- 
CH3CO2
- 
H2PO4
- 
CH3CO2
- 
CD3CN 
CD3CN 
CD3CN 
CD3CN/DMSO-d6 3:1 v/v 
CD3CN/DMSO-d6 3:1 v/v  
CD3CN/DMSO-d6 1:9 v/v 
CD3CN/DMSO-d6 1:9 v/v 
129 
150 
K1 = 562, K2 = 132 
149 
Precipitated 
Precipitated 
K1 = 230, K2 = 491 
Table 2.1 - Stability constants (Ka/M
-1) for receptor 56 with tetrabutylammonium salts under standard 
conditions.
[64] 
  The  results  showed  the  receptor  binds  trigonal  planar  oxyanions  such  as 
carboxylate  and  nitrate,  with  the  predicted  2:1  binding  stoichiometry  observed. 
Interestingly the K2 value for acetate is greater than the K1 value, which infers that the 
binding of the first anion has a positive allosteric effect which favours the binding of the 
second. Unfortunately, the solubility problems prevented a direct comparison of all the 
anions in the same solvent, so no selectivity could be deduced. The tetrahedral or pseudo-
tetrahedral anions were found to be more weakly bound in a 1:1 binding stoichiometry, or   Chapter 2 – Metal-Organic Anion Receptors  
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with a K2 too small to calculate. This observation was supported by the resolution of the 
crystal structure of single crystals of 56 with ReO4
- (fig. 2.5).
[64]  
     
Figure 2.5 - X-ray crystal structure of 56 with ReO4
-. 
  The ReO4
- is bound by not only hydrogen bonds from the amide NH groups, but 
also from the CH groups on the aryl rings of the ligands. To do this, the complex distorts 
from centrosymmetry which it was presumed, disfavours the binding of a second anion.
[64] 
  The platinum(II) complex, 56, had shown promise as a receptor for trigonal planar 
anions in a 2:1 binding stoichiometry, with an allosteric effect observed with acetate. So 
the workers reasoned that designing a receptor that was preorganised in a 1,2-alternate 
conformation for 2:1 binding was a natural progression. This resulted in the synthesis and 
study of a second generation receptor; the bipy-tetraamide platinum(II) based receptor 57 
(fig. 2.6).
[66]  The ligand was prepared from a literature procedure
[67], whilst the complex 
was  prepared  by  reaction  of  one  equivalent  of  [PtCl2(4,4’-tBu-2,2’-bipy)]  with  two 
equivalents each, of ligand and AgPF6 at reflux.   Chapter 2 – Metal-Organic Anion Receptors  
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Figure 2.6 - 2
nd generation platinum(II) based anion receptor 57. 
  Proton-NMR studies in MeCN and MeCN/DMSO mixtures showed little change in 
binding constants for the tetrahedral anions when compared to receptor 56 (tbl. 2.2). 
Anion  Solvent  Ka (M
-1) 
CF3SO3
- 
ReO4
- 
NO3
- 
HSO4
- 
CH3CO2
- 
H2PO4
- 
C6H5CO2
- 
CD3CN 
CD3CN 
CD3CN 
CD3CN/5% DMSO-d6 
CD3CN/5% DMSO-d6  
CD3CN/5% DMSO-d6 
CD3CN/5% DMSO-d6 
101 
148 
K1 = 283, K2 = 2 
Decomposed 
Decomposed 
Decomposed 
Decomposed 
Table 2.2 – Association constants for receptor 57 with various anions as tetrabutylammonium salts. 
Values calculated using Win-EQNMR with errors estimated <10%. 
This was expected though, since the conformation of receptor 56 didn’t match the 
shape of these anions. However surprisingly, receptor 57 was less effective for nitrate in 
the same solvent and with the other trigonal planar anions it completely decomposed. They 
attributed this to the fact the complex is inherently less stable because the pyridine ligands 
have two electron withdrawing  amide  groups on them, which makes their Pt-N bonds 
weaker than those on receptor 56. In fact, this theory was proved by the isolation of single 
crystals of the decomposition product in the titration of 57 with benzoate (see fig. 2.7).
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Figure 2.7 - X-ray structure of a decomposition product of the titration of 57 with benzoate. 
  The structure shows the amido ligands have been substituted with benzoate anions 
to form a neutral complex. This clearly demonstrates that some platinum(II) complexes are 
not completely inert to ligand substitution by certain anions. 
  The  lower  values  for  the  binding  of  the  nitrate  anion  to  receptor  57  were  also 
rationalised by a crystal structure (fig. 2.8). The structure of 57 with nitrate shows how the 
binding of the anion to the bottom cavity pinches the amide groups inwards to form two 
hydrogen  bonds  to  it.  This  effectively  pulls  the  top  amides  apart,  which  destroys  the 
second binding site and so the top nitrate only has one hydrogen bond to it. This means 
that the two binding sites are not independent of each other and so it can be concluded that 
the more flexible ligands on 56 are far more effective for accommodating anions.
[66] 
 
Figure 2.8 – X-ray crystal structure of 57 with nitrate, omitting the t-butyl groups for clarity.
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  Clearly the design of a third generation receptor had to take heed of the problems 
encountered  with  receptor  57;  viz.,  a  less  labile  ligand,  with  free  rotation  about  the 
coordinating bond and a stronger hydrogen bond donor group was required.  To these 
ends,  receptor  58  was  designed  and  synthesised,
[68]  which  included  the  following 
improvements: 
1.  Urea groups for more enhanced anion binding. 
2.  More  rigidity  and  pre-organisation  of  the  hydrogen-bond  donor  groups  by  the 
isoquinoline framework. 
N
NH
N
HN
Pt2+
(BF4
 )2
58
O
HN
O
NH
N
NH
O NH
N
HN
O HN
 
Figure 2.9 – Third generation platinum(II) based anion receptor 58. 
  The  ligand  was  prepared  from  the  corresponding  aminoisoquinoline  and  n-
butylisocyanate in 91% yield. The receptor was prepared as a tetrafluoroborate salt by 
refluxing PtCl2(EtCN)2 with two equivalents of AgBF4 and four equivalents of the ligand 
in acetonitrile for 24hrs. After filtration of residual AgCl and further workup, the product 
was isolated as a yellow powder in 60% yield.
[68] 
  Once again, in solution or solid state, the receptor could potentially adopt any of 
the four conformations discussed for receptor 56. The limited solubility of 58 meant the 
solution studies could only be done in the polar, competitive donor solvent, DMSO-d6. In   Chapter 2 – Metal-Organic Anion Receptors  
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this solvent there were negligible interactions with the weakly coordinating anions, ReO4
-, 
CF3SO3
-  and  NO3
-.  Nevertheless, 
1H-NMR  titrations  with  other  anions  in  this  solvent 
showed promising results and these are shown in Table 2.3. The halides all bound in a 2:1 
anion-receptor stoichiometry, potentially in the 1,2- or 1,3-alternate conformation. The K2 
values  are  lower  than  the  K1  values,  indicating  that  there  could  be  a  reduction  in 
electrostatic  interactions  upon  the  first  anion  binding;  this  is  known  as  a  negative 
cooperative  effect.  However,  more  likely,  is  that  the  lower  K2  value  is  due  to  a  non-
cooperative or statistical effect. That is, the binding of the first equivalent of anion limits 
the number of binding sites available for the binding of a second equivalent of anion. This 
would statistically lower the probability of binding a second equivalent of anion which 
would make K2 lower than K1. 
Anion  Ka (M
-1) 
Cl
-  K1 = 11700 
  K2 = 2220 
Br
-  K1 = 1360 
  K2 = 450 
I
-  K1 = 1430 
  K2 = 52 
SO4
2-  > 10
4* 
H2PO4
-  > 10
4ǂ 
Table 2.3 – Stability constants (Ka/M
-1) for receptor 58 with tetrabutylammonium anion salts (unless 
stated otherwise) in DMSO-d6 at 300 K. 
* SO4
- added as K2SO4 with the effects of ion pairing ignored. 
ǂ 
Estimated value – saturation is seen on addition of 1 equiv. of anion.
[68] 
The binding constants for SO4
2- and H2PO4
- were very high, which is remarkable 
considering how competitive the solvent is. The value for H2PO4
- is estimated since NMR 
methods
[69] cannot accurately calculate binding constants above 10
4 M
-1. The interaction 
with sulfate was slow on the NMR timescale. This results in a broad spectrum at sub-
stoichiometric amounts of anion addition and peaks representing both the complexed and 
uncomplexed receptor. At equimolar amounts of receptor and anion the complexed peaks 
become sharp, the uncomplexed peaks disappear and no further change in chemical shift is 
observed. 
Determination of the X-ray crystal structure of the chloride complex of receptor 58, 
revealed adoption of a 2:1 anion-receptor stoichiometry in a 1,2-alternate conformation. 
The  anions  are  each  bound  slightly  off-set  from  the  central  axis,  through  four  urea 
NH···Cl
- (in the range N···Cl 3.33-3.40 Å) and two aromatic CH···Cl
- (in the range C···Cl   Chapter 2 – Metal-Organic Anion Receptors  
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3.50-3.53  Å)  hydrogen  bonds.  Interestingly,  the  aromatic  CH  interactions  were  also 
observed in the solution studies with particularly large shifts with chloride (1.44 ppm).  
The X-ray structure of the sulfate complex of 58, showed the binding of the anion in a 1:1 
cone conformation with a full complement of eight urea NH···SO4
- (in the range N···O 
2.89-3.23 Å) and four CH···SO4
- (in the range C···O 3.03-3.36 Å) hydrogen bonds. The 
anion sits tightly in the cavity, shielded from interactions with surrounding solvent and 
with possible strong electrostatic contributions from the complimentarily charged 2+ metal 
centre.
[68] 
                                                          
Figure 2.10 – X-Ray crystal structure of receptor 58 with chloride (left) and sulfate (right), omitting 
non-coordinating hydrogens for clarity. 
  These  structures  go  a  significant  way  towards  explaining  what  is  happening  in 
solution,  especially  the  high  stability  of  the  sulfate  complex  and  slow  complexation-
decomplexation kinetics relative to the NMR timescale.
[68] 
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2.2  A Platinum(II) Tetra(urea-pyridine) Complex: Investigating Pre-
organisation and Ligand Rigidity 
 
As part of our collaboration with the Loeb group, we wished to further explore the 
designs and behaviour of the platinum(II) based anion receptors just discussed. Initially it 
was decided to investigate how fundamental it was to have an isoquinoline based ligand, 
for  both  pre-organising  the  hydrogen  bond  donor  groups  and  rigidifying  the  ligand 
structure. To this end, receptor 59 was designed, with methyl-pyridine ligands replacing 
the isoquinolines of receptor 58 (fig. 2.11). 
 
Figure 2.11 - The design principle of receptor 59. 
  Receptor 59 lacks the rigid backbone provided by the second aromatic ring (red 
lines  in  fig.  2.11)  of  the  isoquinoline  on  58.  In  addition  to  this,  59  lacks  the  pre-
organisation of the urea group by the intramolecular hydrogen bonding of the isoquinoline 
ring. It was hoped further insights into the behaviour of homoleptic Pt-L4 complexes could 
be gained by the study of this system. 
2.2.1  Synthesis 
  The  synthesis  of  the  methyl-pyridine  ligand  for  receptor  59,  was  achieved  by 
reaction of 3-aminomethylpyridine with n-butylisocyanate in dry DCM for 5 days at room 
temperature, to afford the product as a fine white powder in 89% yield (sch. 2.1).   Chapter 2 – Metal-Organic Anion Receptors  
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Scheme 2.1 – Synthesis of methyl-pyridine ligand 60, for the preparation of receptor 59. 
  The platinum starting material, cis-[PtCl2(EtCN)2], needed for the preparation of 
the  receptor,  was  made  according  to  a  literature  procedure.
[70]  This  involved  allowing 
propionitrile to diffuse into a concentrated aqueous solution of K2PtCl4 over period of 3 
days to crystallise the product as large yellow crystals. 
  The receptor was prepared by refluxing four equivalents of the ligand with one 
equivalent of cis-[PtCl2(EtCN)2] and 2.2 equivalents of AgBF4 in darkness for 24 hours 
(sch. 2.2). After cooling and filtration of residual AgCl, the crude product was recovered 
by precipitation of the MeCN solution by addition of Et2O. This was further purified by 
recrystallisation via a slow evaporation of a MeNO2 solution of the crude receptor, to leave 
the product as grey crystals in 35% yield. 
 
Scheme 2.2 – Synthesis of receptor 59. 
2.2.2  Solution Studies 
  Stability constants for receptor 59 were obtained by 
1H-NMR titration experiments 
in DMSO-d6 at 300 K, using the anions tested with 58
[68] as their tetrabutylammonium 
salts. Changes in the chemical shift of one of the binding proton resonances, upon addition 
of increasing aliquots of anion solution, were recorded and the data fitted to a 1:1 or 2:1 
binding  model  with  Win-EQNMR.
[69]  The  results  were  compared  with  those  from  the 
studies with 58 and are shown in Table 2.4.   Chapter 2 – Metal-Organic Anion Receptors  
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  Receptor   
Anion  58
a  59 
Cl
-  K1 = 11700  Decomposed 
  K2 = 2220   
Br
-  K1 = 1360  K1 = 137 
  K2 = 450  K2 = 14 
I
-  K1 = 1430  Ka < 10 
  K2 = 52   
SO4
2-  Ka > 10
4  No data 
H2PO4
-  Ka > 10
4  K1 = 10059 
    K2 = 62 
CH3CO2
-  No data  K1 > 10
4 
    K2 = 54 
CF3CO2
-  Ka < 10  Ka < 10 
NO3
-  Ka < 10  Ka < 10 
ReO4
-  Ka < 10  Ka < 10 
HSO4
-  No data  Ka < 10 
Table 2.4 – Stability constants (Ka/M
-1) for receptors 58 and 59 with tetrabutylammonium anion salts 
in DMSO-d6 at 300 K. All data fitted with Win-EQNMR and errors estimated ≤10%. 
aData from 
reference 68. 
  The results show that 59 forms much less stable complexes with anions than 58. 
The receptor completely decomposed after addition of one equivalent of TBA chloride, 
which is thought to be the result of chloride displacement of the ligands. Bromide showed 
only weak 2:1 coordination to the receptor, in stark contrast to the strong binding observed 
with 58. The results for 58 with sulfate were obtained by step-wise addition of solid K2SO4 
to the receptor solution, followed by sonication and observation of the proton resonances, 
which showed a slow interaction relative to the NMR timescale. A binding constant could 
not  be  obtained  with  59  using  this  method  since  the  peaks  became  too  broad  and 
untraceable. 
  The binding constant was still high with H2PO4
- and interestingly it bound in a 2:1 
conformation. Although not tested with 58, the acetate anion was titrated with 59 and 
showed a particularly high 2:1 binding. 
  These results clearly show how vital it is to have the rigidifying and pre-organising 
components of the isoquinoline version. Without these factors, the entropy of the system is 
increased,  which  leads  to  weaker  anion  complexes  with  lower  stability  constants.  The 
isoquinoline  ligand  has  also  been  shown  to  be  less  susceptible  to  ligand  substitution   Chapter 2 – Metal-Organic Anion Receptors  
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compared  to  this  methyl-pyridine  analogue,  which  is  also  an  important  observation  to 
consider in the designs of these systems. 
2.2.3  Solid State Analysis 
X-ray quality crystals of the hydrogen sulfate complex of 59 were obtained by slow 
evaporation of a MeNO2 solution of 59 in the presence of excess TBA
+HSO4
- (fig. 2.12). 
 
Figure 2.12 – X-ray crystal structure of the HSO4
- complex of receptor 59. Non-acidic protons have 
been omitted for clarity. 
  The structure shows the flexible nature of the pendant arms of the pyridine ligands, 
have allowed them twist and intramolecularly hydrogen bond to their neighbouring ligands 
(N2···O2 2.893(12) Å, N1···O2 2.873(14) Å). The HSO4
- anions are only coordinated via 
one hydrogen bond to one of the urea NH groups (N5···O5 2.849(11) Å). A clearer idea of 
what is happening can be gained by looking at the hydrogen bonded ladder of 59 (fig. 
2.13). This shows that the urea groups are also intermolecularly hydrogen bonding to urea 
groups on neighbouring complexes, to form a hydrogen bonded network interlaced with 
HSO4
- anions (intermolecular N···O 2.798(14) & 3.272(12) Å). 
 
O2 
N1 
N2 
N5 
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Figure 2.13 - Hydrogen bonded ladder of 59 running down the b axis. 
  Looking at the top view of the ladder (fig. 2.14), the hydrogen sulfate anions can be 
seen off-set from the ideal axial position that is running through the platinum metal centre. 
 
Figure 2.14 – Top view of the hydrogen bonded ladder. 
  The high degree of twisting of the ligands in the solid state can certainly support 
the theory that the ligands are too flexible with little pre-organisation in solution, which 
leads to greater disorder in the system and hence poor anion complexation. 
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2.3  Changing The Hydrogen Bond Donor Group: Platinum(II) Based 
Receptors with Pyrrole Functionalised Ligands 
 
  The next progression was to investigate changing the hydrogen bond donor group 
from the urea or amide systems previously investigated. From extensive research over the 
last decade, both within our group and others, the pyrrole motif has emerged as a highly 
important tool for binding anions.
[23] We therefore wished to investigate the inclusion of 
this  functionality  in  the  platinum(II)  based  receptors.  This  resulted  in  the  design  of 
receptor 60 and the control analogue 61 (fig. 2.15). 
N
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Figure 2.15 – Design of receptors 60 and 61. 
  Because of the nature of the pyrrole carboxamide group, the pyrrole NH converges 
with the amide NH, which could hopefully form a more encapsulated cavity for binding 
spherical anions such as chloride. 
2.3.1  Synthesis 
The ligand for 60 was  synthesised  from the corresponding 8-aminoisoquinoline 
(used in the synthesis of 58) and the pyrrole acid chloride. The 8-aminoisoquinoline (64) 
was  prepared  from  5-aminoisoquinoline  by  literature  procedures  as  shown  in  Scheme 
2.3.
[71, 72]   Chapter 2 – Metal-Organic Anion Receptors  
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Scheme 2.3 – Synthesis of 8-aminoisoquinoline 64. 
  The next step involved the generation of the unstable pyrrole acid chloride, by 
activation of pyrrole-2-carboxylic acid with thionyl chloride. This was then coupled to 64 
in the presence of triethylamine (TEA) and a catalytic amount of dimethylaminopyridine 
(DMAP) to give 65 in 41% yield (sch. 2.4). 
 
Scheme 2.4 – Synthesis of ligands 65 and 66. 
  The ligand for 61 was generated using the same method as for 65, except using the 
commercially available 3-aminomethylpyridine and was made in 25% yield. 
The synthesis of 60 and 61 was unsuccessful using the one-pot method (sch. 2.2) 
used for the preparation of receptor 59. So an improved two-step method was developed 
which involved generation of a reactive intermediate (sch. 2.5).   Chapter 2 – Metal-Organic Anion Receptors  
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Pt
Cl
EtCN NCEt
Cl
Pt EtCN NCEt
2+
2BF4
 
Pt
L
L L
L
2+
2BF4
 
2.2 eqv. AgBF4, MeNO2
120oC, 3hrs, dark
4 eqv. Ligand, MeNO2
120oC, 3hrs
L = ligand
= solvent
 
Scheme 2.5 – Two-step synthesis of homoleptic [PtL4]2BF4 complexes. 
  This method involves refluxing the starting material with AgBF4 in the absence of 
ligand,  followed by  removal of the  AgCl generated, before  addition of the ligand and 
further refluxing. This synthetic route proved far more successful, generating receptor 59 
and 60 in 61% and 48% yields respectively. 
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2.3.2  Solution Studies 
  Proton-NMR titration experiments were conducted on receptors 60 and 61 with a 
variety of different anions as their TBA salts in DMSO-d6 solution at 300 K. The resulting 
data was fitted to either a 1:1 or 2:1 binding model using Win-EQNMR
[69] and the results 
are presented in Table 2.5 below. 
  Receptor   
Anion  60
  61 
Cl
-  K1 = 6840
a  Decomposed 
  K2 = 60
a   
Br
-  Ka < 10  Ka < 10 
I
-  Ka < 10  Ka < 10 
HSO4
-  Ka < 10  Ka < 10 
NO3
-  Ka < 10  Ka < 10 
H2PO4
-  K1 = 1920  Poor fitting 
  K2 = 30   
C6H5CO2
-  K1 = 15200  K1 = 7800 
  K2 = 39  K2 = 41 
CH3CO2
-  K1 = 1662
b  K1 = 181
b 
  K2 = 197
b  K2 = 46
b 
Table 2.5 – Stability constants for receptors 60 and 61 in DMSO-d6 with anions as their TBA salts at 
300 K. Data was fitted using the pyrrole NH unless otherwise stated. All errors estimated ≤ 10%. 
aDecomposition occurred after addition of 1.5 eqv. of anion in this case. 
bData fitted to chemical shift 
of pyridine or isoquinoline CH at 2-position due to broadening of pyrrole NH resonance. 
Surprisingly, 60 and 61 were ineffective for binding halides, even decomposing in 
the presence of chloride in both cases. Receptor 60 showed interaction with the tetrahedral 
H2PO4
- anion but, despite repeated attempts, a good set of data could not be collected for 
61 with this anion. 
Nevertheless,  the  receptors  showed  a  good  selectivity  and  stability  with  the 
carboxylate anions, binding in a 2:1 anion-receptor binding stoichiometry. In the case of 
acetate, the pyrrole NH resonances on both receptors moved considerably downfield upon 
first addition of anion, with the peaks quickly becoming too broad to fit data with.  This 
indicates a particularly strong binding interaction. 
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2.4  Investigating  The  Sulfate  Binding  and  CH  Interactions:  Trans-
functionalised Platinum(II) Complexes 
2.4.1  Introduction 
  Receptor 58 had proved to be particularly effective for binding sulfate, both in 
solution and the solid state, with the receptor adopting the desired cone shape. Recently, 
there has been an intense interest in the recognition of sulfate,
[25, 26, 73-77] not least because 
of the importance of this anion in biological systems. For example, the sulfate binding 
protein  (fig.  2.16)  found  in  Salmonella  typhimurium,  binds  sulfate  through  just  seven 
hydrogen bonds with very high selectivity (binding constant Ka ≈ 10
6  M
-1 in water).
[78, 79] 
 
Figure 2.16 – Active site of the sulfate binding protein of Salmonella typhimurium showing the 
encapsulation of the anion by seven residues.
[78] 
  What is remarkable about the binding, is that the 2
- charged sulfate is deeply buried 
and completely inaccessible to solvent and appears to have no surrounding (i.e. within Van 
der  Waals  distance)  neutralising  or  stabilising  positive  charge.
[78]  Following  this 
crystallographic  report,  researchers  have  sought  to  design  selective  receptors  for  oxo-
anions such as sulfate that mimic natural hosts.
[80] Compounds which can bind sulfate are 
also of interest because of their applications in sulfate extraction processes, such as its 
removal from nuclear waste.
[81] 
Trp192 
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Progress to towards synthetic sulfate recognition hosts, includes the tren-based tris-
urea receptor, highlighted earlier (see Chapter 1), which can coordinate sulfate through 
twelve hydrogen bonds. Receptor 58 can also coordinate sulfate through twelve hydrogen 
bonds  (8  NH  and  4  CH),  which  is  postulated  to  be
[82]  the  maximum  coordination 
preference for sulfate by urea based receptors.  
A key point about the sulfate complex of 58 is that four of the twelve hydrogen 
bonds  to  the  anion  are  CH···O  interactions.  There  were  also  CH···anion  interactions 
observed  between  the  halides  and  58,  both  in  solution  and  the  solid  state.  These 
observations  motivated  previous  members  of  our  group  to  investigate  the  role  these 
CH···anion hydrogen bonds play in stabilising anion complexes in solution, by studying a 
test series of platinum (II) based receptors (fig. 2.17).
[83] 
 
Figure 2.17 – The platinum(II) receptors used in the CH vs. NH hydrogen bond study.
[83] 
  As can be seen, one of the receptors offers only CH hydrogen bond donors (67), 
whilst the others (68 and 69), offer a choice of hydrogen bond donor (NH or CH) as the 
pyrrole is free to rotate about the pyridine-pyrrole bond.
[83] 
  The anion binding properties of these complexes were explored using 
1H-NMR 
techniques in DMSO-d6 and the results are shown in Table 2.6. 
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  Receptor     
Anion  67
  68  69 
Cl
-  195  960  216 
Br
-  121  796  211 
I
-  50  462  113 
HSO4
-  < 10  837  < 10 
NO3
-  -  29  < 10 
CH3CO2
-  84  K1= 216
ǂ  117
ǂ 
  -  K2 = 2400
ǂ  - 
C6H5CO2
-  132  Precipitated  111
ǂ 
MeSO3
-  45  1115  < 10 
Table 2.6 – Stability constants for receptors 67 – 69 with anionic guests as TBA salts in DMSO-d6 at 
298 K. Data fitted to a 1:1 binding model using the shift of the CH at the α-position on the pyridine 
ring unless otherwise stated. 
ǂFitted using the pyrrole NH proton shift.
[83] 
  Despite 67 not having any NH hydrogen bond donor groups there were significant 
shifts downfield of the α-proton on the pyridine ring and a set of stability constants could 
be calculated. The interaction was strongest with chloride and the receptor bound 1:1 in all 
cases.
[83] 
  Receptor 69 does not contain any convergent binding site that would utilise all four 
pyrrole NH groups. The lower stability constants reflect this, with only the α-proton on the 
pyridine  moving  downfield  during  the  titrations.  The  only  exception  was  with  the 
carboxylate  anions  which  shifted  the  pyrrole  NH  resonance  0.61  and  0.85  ppm  for 
benzoate and acetate respectively.
[83]  
However,  the  most  interesting  behaviour  was  observed  with  68,  whereby  the 
pyrrole NH proton did not significantly shift as expected, upon addition of Cl
-, Br
-, I
-, 
HSO4
-, MeSO3
- or NO3
-. Only with the most basic anions (benzoate and acetate), did the 
NH  resonance  shift  downfield  by  1.03  and  1.36  ppm  respectively.  Conversely,  the 
resonance of the CH at the 3-position on the pyrrole ring moved downfield with the former 
anions but not with the latter anions. By changing the solvent to MeNO3-d3, more typical 
behaviour was observed with 68 upon the addition of anions. For example upon addition 
of TBA methanesulfonate, the pyrrole NH resonance moved downfield by up to 1.77 ppm. 
This led to the conclusion that a solvent competition mechanism (see fig.  2.18) may have 
been  operating  in  the  DMSO  solution.  In  the  good  hydrogen  bond  acceptor  solvent, 
DMSO, less basic anions such as MeSO3
- will bind to the less acidic CH, with the more 
acidic  NH  binding  the  DMSO.  Whereas  in  the  poor  hydrogen  bond  acceptor  solvent,   Chapter 2 – Metal-Organic Anion Receptors  
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MeNO2, the MeSO3
- will bind to the more acidic NH with the less acidic CH interacting 
with the solvent. However, if the anion is more basic, such as a carboxylate, then it will 
bind the more acidic NH even in DMSO solution.
[83] 
 
Figure 2.18 – Binding modes of one equivalent of MeSO3
- (A
-) to 68 in (a) nitromethane-d3 and (b) 
DMSO-d6 solution.
[83] Reproduced by permission of The Royal Society of Chemistry. 
Crystals of the MeSO3
- salt of 68 were  grown by slow evaporation of a nitromethane 
solution of the complex (fig. 2.19). The comlex adopted a 1,2-alternate conformation with 
the anion binding through the pyrrole NH groups and the protons at the α-positions on the 
pyridine rings (N···O 2.926(8) & 2.850(8) Å and C···O 3.542(7) & 3.100(6) Å). 
 
Figure 2.19 – X-ray crystal structure of the MeSO3
- salt of 68. Reproduced by permission of The Royal 
Society of Chemistry.   Chapter 2 – Metal-Organic Anion Receptors  
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This crystal structure serves to prove that the binding observed in the solid state 
does not always reflect what may happen in solution as there is no evidence of the pyrrole 
NH groups interacting with this anion in DMSO solution.
[83] 
Since  the  publication  of  this  work  there  have  been  extensive  computational 
molecular modelling investigations into CH···anion interactions by Hay and Bryantsev.
[84, 
85]  This  theoretical  work  involved  studying  various  arene  systems  (even  as  simple  as 
benzene) and their interaction with various anions. 
As a continuum of this body of work, we thought it interesting to investigate the 
role of CH···anion binding in stabilising the anion complexes of receptor 58. In particular, 
we  also  wished  to  further  explore  the  binding  conformation  of  sulfate  to  this  class  of 
receptor.  To  these  ends,  a  trans-functionalised,  heteroleptic  version  of  the  homoleptic 
receptor 58 was prepared (receptor 70, fig. 2.20). 
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Figure 2.20 – The trans-functionalised receptor used for this study. 
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2.4.2  Synthesis 
The ureido-isoquinoline ligand  required for the synthesis was prepared from 8-
aminoisoquinoline
[71, 72] and n-butylisocyanate in 58% yield (sch. 2.6).
[68] 
 
Scheme 2.6 – Synthesis of ligand 71.
[68] 
The receptor was prepared using a similar two-step method to that of 60 and 61, 
except using trans-dichlorobis(pyridine)platinum(II)
[86] as the starting material (see sch. 
2.7).  
Pt
Cl
Py Py
Cl
Pt Py Py
2+
2BF4
 
Pt
L
Py Py
L
2+
2BF4
 
2.2 eqv. AgBF4, MeNO2
120oC, 3hrs
2 eqv. Ligand,
MeNO2
120oC, 3hrs
L = ligand
= solvent
Py = pyridine
 
Scheme 2.7 – Synthesis of heteroleptic trans-[Pt(Py)2L2]2BF4 complexes. 
  The crude material was purified by washing with acetonitrile, followed by repeated 
hot-filtration of a DCM/Et2O slurry of the material to give the product in 48% yield.   Chapter 2 – Metal-Organic Anion Receptors  
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2.4.3 Solution Studies 
As with receptor 58, anion binding studies were conducted by 
1H-NMR titration 
techniques in highly competitive DMSO-d6. Where possible, Win-EQNMR
[69] was used to 
curve-fit the titration data and the results are compared with those for 58 in Table 2.7. 
  Receptor   
Anion  58
a  70 
Cl
-  K1 = 11700  K1 = 2350 
  K2 = 2220  K2 = 450 
Br
-  K1 = 1360  K1 = 942 
  K2 = 450  K2 = 131 
I
-  K1 = 1430  K1 = 161 
  K2 = 52  K2 = 16 
SO4
2-  Ka > 10
4  K1 > 10
4b 
    K2 = 7800
c 
H2PO4
-  Ka > 10
4  Ka > 10
4d 
Table 2.7 – Stability constants (Ka/M
-1) for receptors 57 and 70 with anions as their TBA salts in 
DMSO-d6 at 300 K. All errors estimated < 10%. 
aData from reference 6. 
bEstimated value. 
cEstimated 
using a single point method. 
dSaturation is seen upon addition of 1 eqv. of anion, further addition of 
anion causes precipitation which infers strong binding. 
  As expected, the binding constants are lower than for receptor 70 than 58 due to the 
lower  number  of  hydrogen-bond  donor  groups  in  this  system.  However,  the  same  1:2 
receptor-halide stoichiometry with a high K1 and lower K2 was observed. This can be 
interpreted as the receptor adopting an up-up conformation at low anion concentrations 
wherein the anion is bound by two urea groups orientated in the same direction on one face 
of the complex. Whereas as at higher anion concentrations, the receptor switches to an up-
down conformation, with the urea groups oriented on different faces of the complex and 
each urea binding a different anion. 
  With dihydrogen phosphate, a slow exchange relative to the NMR timescale was 
observed. This can best be explained by referring to the NMR titration stack-plot shown in 
Figure 2.21 below.   Chapter 2 – Metal-Organic Anion Receptors  
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Figure 2.21 – Proton NMR titration stack-plot of 70 with TBA dihydrogen phosphate, see page 64 for 
the proton numbering scheme used. 
  At sub-stoichiometric amounts of anion addition there are peaks (although they are 
very broad in this case) representing both the complexed and uncomplexed receptor. At 
equimolar  amounts  of  receptor  and  anion  the  complexed  peaks  become  sharp,  the 
uncomplexed peaks disappear and no further change in chemical shift is observed. Upon 
excess addition of the anion, the complex precipitates. This suggests a very strong binding 
interaction with a stability constant >10
4 M
-1. 
  It was discovered
[87] that it is possible to prepare anhydrous tetrabutylammonium 
sulfate  for  titrations.  This  was  done  by  taking  a  50  wt.  %  aqueous  solution  of 
tetrabutylammonium  sulfate  and  reducing  it  to  a  gel  in-vacuo.  Further  drying  over 
phosphorous pentoxide on a high-vacuum line produced the salt as a crystalline material 
suitable for 
1H-NMR titrations. 
Sulfate had a very strong interaction with 70 in DMSO-d6, with a fast exchange 
process observed up to one equivalent of added tetrabutylammonium sulfate. Fitting this 
portion of the NMR titration using a 1:1 binding model in Win-EQNMR
[69] gave a binding 
constant K1 > 10
4 M
-1. 
ppm 
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Figure 2.22 - Proton NMR titration stack-plot of 70 with (TBA)2 sulfate, see page 64 for proton 
numbering system used. 
  Interestingly, at this point, further additions of anion result in a slow exchange 
process whereby peaks representing a new 2:1 complex appear with the 1:1 complex peaks 
at sub-stoichiometric amounts of anion (see fig. 2.22). So in Figure 2.22, two sets of peaks 
for the two different complexes can be clearly seen at 1.5 equivalents of anion addition. At 
2 equivalents the 1:1 complex peaks disappear leaving just the peaks for the 2:1 complex. 
This process is summarised in Scheme 2.8 below. 
 
Scheme 2.8 – Proposed model for the behaviour of 70 in the presence of sulfate in DMSO solution. 
1/2 5 
3  4 
6 
1/2 
5  3  4  6 
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  A stability constant (K2) for this slow exchange process was calculated by taking a 
single point in the titration at 1.7 equivalents of anion addition and applying some simple 
mathematic methodology:- 
By assuming a simple equilibrium (where R = 1:1 receptor/anion complex and A = anion): 
 
K2 can be expressed as: 
 
Where: 
[R] = Concentration of 1:1 receptor/anion complex. 
[A] = Concentration of anion. 
[RA] = Concentration of 1:2 receptor/anion complex. 
At a single point in the NMR titration: 
 
So using the bottom urea proton peaks on the isoquinoline ligands at 1.7 eqv. of anion 
addition for 1:1 and 1:2 receptor: 
 
The following relationships are also known at 1.7 eqv: 
 
 
Where: 
[Rtotal] = Total concentration of receptor at 1.7 eqv. of anion.   Chapter 2 – Metal-Organic Anion Receptors  
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[Atotal] = Total concentration of anion at 1.7 eqv. of anion. 
By rearranging equation (3) and substituting [RA] into equation (4): 
 
and doing likewise for equation (5): 
 
So from equations (6) and (7): 
 
and by rearranging (3): 
 
So finally: 
 
So K2 ≈ 7800M
-1 
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2.4.4  Solid State Analysis 
  Crystals  of  the  bromide  complex  of  70  were  grown  by  slow  evaporation  of  a 
nitromethane  solution  of  the  receptor  in  the  presence  of  excess  tetrabutylammonium 
bromide (fig. 2.23). 
 
Figure 2.23 – X-ray crystal structure of the bromide complex of 70, omitting non-coordinating protons 
for clarity. 
  The structure reveals that the receptor adopts an up-down conformation in the solid 
state, binding each bromide anion via four CH···Br
- hydrogen bonds (C14···Br21 3.654(4) 
Å, C5···Br21 3.775(5) Å) and a single urea NH···Br
- hydrogen bond (N4···Br21 3.474(4) 
Å). The other urea NH appended to the isoquinoline does not interact with the bromide but 
instead forms an intermolecular hydrogen bond to an adjacent complex in the crystal (see 
fig. 2.24). 
O1 
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Figure 2.24 – Hydrogen bonded network of the bromide complex of 64, showing the intermolecular 
hydrogen bonds between N3 and O1. 
  Remarkably,  it  was  possible  to  obtain  two  different  crystal  structures  of  the 
complex of 70 with sulfate. The first crystals were grown by a slow evaporation of a 
nitromethane  solution  of  70  in  the  presence  of  one  equivalent  of  tetrabutylammonium 
sulfate (fig. 2.25). 
 
Figure 2.25 – X-ray crystal structure of the sulfate complex of receptor 70 from a 1:1 nitromethane 
solution. Sulfate and tetrafluoroborate have been shown in a space filling representation and non-
coordinating hydrogens have been omitted for clarity.   Chapter 2 – Metal-Organic Anion Receptors  
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The  structure  reveals  the  formation  of  a  3:2  receptor-sulfate  complex  with 
tetrafluoroborate  anions  also  coordinating  to  the  platinum  complexes  via  CH···F 
interactions  at  the  periphery  of  the  structure.  The  existence  of  the  two  different 
conformations of the receptor can be observed, whereby the central complex adopts an up-
down conformation with each urea group bound to a sulfate anion. Each of these sulfate 
anions  is  also  bound  to  another  platinum  complex  adopting  the  up-up  conformation. 
Hence, each sulfate is bound to three urea groups. In addition, the aromatic CH groups in 
the α-position of the isoquinoline and pyridine rings of two platinum  complexes form 
CH···O  hydrogen  bonding  interactions  with  the  sulfate  ions.  So  in  total,  there  an 
unprecedented fourteen  NH and CH hydrogen-bond donor groups binding each sulfate 
anion.  This  is  more  coordination  than  was  theoretically  calculated  to  be  the  optimum 
coordination number for sulfate by Hay and co-workers.
[82] By referring to the fragmented 
depiction of the complex in Figure 2.26, it is possible to see more clearly the two different 
binding modes and their associated hydrogen bonds in the crystal. 
         
Figure 2.26 – Breakdown of the 3:2 crystal structure of 70 with sulfate, showing the periphery up-up 
platinum complex binding the sulfate (left) and the central up-down complex binding sulfate (right). 
The second crystals were grown by a slow evaporation of a DMSO solution of 70 
in  the  presence  of  excess  tetrabutylammonium  sulfate  and  these  gave  a  completely 
different X-ray crystal structure (fig. 2.27).   Chapter 2 – Metal-Organic Anion Receptors  
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Figure 2.27 – X-ray crystal structure of the sulfate complex of 70 from a DMSO solution of the 
receptor in the presence of excess sulfate. Non-coordinating hydrogens have been omitted for clarity. 
  This structure reveals each sulfate is coordinated to two platinum complexes which 
are each in the up-down conformation. There is no presence of the up-up conformation 
seen in the other structure and each sulfate is coordinated by two urea groups. In addition 
there are eight CH···O interactions with the sulfate ions from the α-position CH groups on 
the isoquinoline and pyridine rings. In total there are twelve NH and CH hydrogen-bond 
interactions  with  each  sulfate  anion.  Also  there  are  no  tetrafluoroborate  anions  in  this 
crystal structure. 
  The  achievement  of  obtaining  two  different  crystal  structures  for  the  sulfate 
complex  of  70  is  quite  remarkable  and  suggests  there  can  be  potential  for  designing 
specific  platinum(II)  based  architectures  for  binding  sulfate.  For  example,  receptor  58 
could be co-crystallised with receptor 70 and sulfate in various stoichiometric ratios. Or a 
new heteroleptic receptor with one isoquinoline ligand and three pyridine ligands can be 
co-crystallised  with  70  or  58  and  sulfate.  This  can  then  lead  to  the  creation  of 
combinatorial crystallographic libraries to study the binding behaviour of sulfate to this 
class of receptor. 
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2.5  Conclusions 
  This chapter has documented the extensive further investigations into the original 
platinum(II) based anion receptors developed by our collaborators in Canada. Different 
variables  have  been  studied,  such  as  changing  the  rigidity  and  pre-organisation  of  the 
hydrogen-bond donor groups of the ligands relative to those of receptor 58. In solution, 
this resulted in a much less stable complex in the presence of certain anions. In addition, 
the binding constants were drastically much lower than those for receptor 58 in the same 
solvent and conditions. The crystallographic studies revealed a twisting of the pendant urea 
arms which were intermolecularly hydrogen bonded instead of discretely complexing the 
hydrogen sulfate anion. The greater disorder in this system meant entropic barriers were 
greater to overcome which lead to weaker anion complexation. 
  Changing the hydrogen-bond donor group to a pyrrole-amide produced a sub-class 
of  receptors  with  surprisingly  different  properties  to  receptor  58.  With  the  different 
functionality, even the isoquinoline version (60) was not stable in the presence of chloride 
in solution. Both receptors 60 and 61 were not effective for halides in DMSO solution as 
expected. They were however effective for the carboxylate anions benzoate and acetate, 
with high binding constants and strong broadening of the pyrrole peak on the 
1H-NMR 
titration spectra. 
  Synthesis of the trans-functionalised bis-pyridyl version of receptor 58 allowed 
further  investigation  into  the  sulfate  binding  conformation  and  explored  the  role  of 
CH···anion interactions in these complexes. The solution studies revealed an interesting 
interaction of 70 with sulfate, whereby at low anion concentration a fast exchange strong 
1:1 binding in an up-up conformation was observed. After addition of one equivalent of 
this anion, a slow exchange process was observed with the complex switching to a 2:1 
anion-receptor system in an up-down conformation. 
  In the solid state, receptor 70 could form two different crystal structures depending 
on the crystallisation conditions. By slow evaporation of a nitromethane solution of 70 in 
the  presence  of  one  equivalent  of  tetrabutylammonium  sulfate,  a  unique  3:2  receptor-
sulfate complex formed with the anion bound in a pocket lined with fourteen NH and CH 
hydrogen  bond  donor  groups.  By  slow  evaporation  of  a  DMSO  solution  of  70  in  the 
presence of an excess of sulfate, a 2:1 sulfate-receptor complex formed with the sulfate 
anions also binding to adjacent receptors through a total of twelve hydrogen bonds. These   Chapter 2 – Metal-Organic Anion Receptors  
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findings leave scope for further crystallographic investigations into this class of receptor’s 
complexation with sulfate. 
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Chapter 3 –  
Benzimidazole Based 
Receptors for Neutral 
Guest Complexation 
3.1  Introduction 
  Since the late 1980s there have been many reports of artificial receptors for neutral 
molecules such as ureas and barbiturates. It was the early investigations of Hamilton’s 
group that particularly focused on the molecular recognition of barbiturates which were 
considered attractive targets due to their biological activity.
[88] 
  Hamilton’s  approach  was  to  use  an  isophthalamide  core  with  two  appended 
diamidopyridine units to provide the basis of some elegant macrocycles 72 and 73 (fig. 
3.1).
[88, 89] 
 
Figure 3.1 – Hamilton’s macrocycles for barbiturates showing the expected binding mode of barbital 
to receptor 73. 
  The synthesis of the macrocycles was remarkably facile, involving two steps from 
isophthaloyl  dichloride  and  producing  macrocycles  72  and  73  in  12  and  14%  yields   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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respectively.
[89]  The  complexation  properties  of  the  receptors  were  tested  by 
1H-NMR 
titrations (in CD2Cl2 or CDCl3), or by UV-vis titrations (in CH2Cl2) where the association 
constants were too high to measure by 
1H-NMR. The results showed that the macrocycles 
bound barbital (5,5-diethylbarbituric acid) in a 1:1 stoichiometry with very high affinities 
(Ka = 6x10
5 and 2.5x10
5 M
-1 for 72 and 73 respectively). Such high binding constants are 
remarkable  considering  that  both  species  in  the  complex  are  neutral.  Characteristic 
changes in the 
1H-NMR spectra during titrations of the macrocycles with barbital, revealed 
the guest binds through six hydrogen bonds as shown in Figure 3.1.
[89] 
The  binding  behaviour  observed  in  solution  was  supported  by  X-ray 
crystallographic analysis of the barbital complex of 73 (fig. 3.2). The structure shows the 
barbital  in  the  centre  of  the  macrocycle  forming  three  hydrogen  bonds  to  each 
diamidopyridine  unit  (N···O  distances  2.87-3.23  Å  and  N···N  2.95  and  3.00  Å).  The 
barbital is not coplanar to the macrocycle but lies at 27
o angle relative to the plane of the 
pyridine rings.
[89] 
 
Figure 3.2 – X-Ray crystal structure of the barbital complex of macrocycle 73. 
  Hamilton further developed this motif to make receptors with specific functions 
such as catalysts
[90] or multi-component chromophores.
[91] 
  At the same time Whitesides and later Reinhoudt initiated their extensive studies 
into melamine based receptors for barbiturates which they used to assemble a vast array of 
hydrogen bonded crystalline architectures.
[92-94] One of the more simple architectures was   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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the tris-melamine based [2x2] hydrogen bonded grid of Reinhoudt and co-workers.
[95] The 
components, 74 and 75, could potentially form three different structures including a [1x1] 
grid and a polymer. However, the 
1H-NMR spectrum of a 1:1 mixture of 74 and 75 in 
CDCl3  confirmed  the  exclusive  formation  of  the  [2x2]  grid  (74)2•(75)2.  Proton-NMR 
studies also confirmed the increased kinetic and thermodynamic stability of the grid when 
compared with the 1:2 barbital complex of 74.
[95] 
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Figure 3.3 – The components for Reinhoudt’s [2x2] hydrogen bonded grid. 
  Other  groups  have  further  explored  melamine  based  frameworks  for  the 
recognition of barbiturates. For example Champness and co-workers have looked at the 
effects on barbital binding when hydrogen bond donors are removed from bis-melamine 
cleft receptors.
[96] Also, Kondo and co-workers have borrowed from Hamilton, Whitesides 
and Reinhoudt’s ideas and used melamines to synthesise a series of macrocycles (77-79) 
for barbiturates (fig. 3.4).
[97] The acyclic receptor 76 was prepared as a control analogue, 
macrocycle 77 has an alkyl spacer, 78 has the spacer used in Hamilton’s macrocycles
[88] 
and 79 is a symmetrical tris-melamine analogue.   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Figure 3.4 – Kondo and co-worker’s melamine based macrocycles 77-79 and an acyclic analogue 76. 
  An anthryl chromophore substituted barbiturate (80) was synthesised to test the 
compounds by UV-vis titrations since none of the compounds were UV-vis active. 
 
Figure 3.5 – The barbiturate guests used for the study of compounds 76-79. 
  The  UV-vis  titrations  (conducted  in  CHCl3)  revealed  very  high  association 
constants for all the compounds with barbiturate 80, including the acyclic receptor 76, with 
the largest value found for receptor 78 (Ka = 1.29x10
5 M
-1). The binding constant for 79 
(Ka = 43500 M
-1) was similar to that of 76 (Ka = 50000 M
-1) suggesting that the steric 
hinderance presented by the 5,5-substituents on the barbiturate prevents efficient binding 
with  this  macrocycle.  Proton-NMR  titrations  in  CDCl3  were  also  carried  out  with  the 
receptors and barbiturate 81 to compliment the UV-vis studies. 
  An X-ray crystal structure of compound 79 with barbiturate 81 was obtained which 
showed two of the melamines binding a barbiturate through six hydrogen bonds. Whilst 
the other melamine unit was orientated out of the cavity and binding another barbiturate   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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through three hydrogen bonds which was bound to another macrocycle to form a dimer. 
This resulted in the formation of a 2:4 receptor:barbiturate complex. 
  Since  1997,  Tucker  and  co-workers  have  synthesised  many  ferrocene  and 
cobaltocene based receptors for neutral molecules such as bis-carboxylic acids
[98, 99] and 
later ureas  and barbiturates.
[100,  101] The latter work included  a study  of 1,1’-  and 1,3-
substituted  ferrocene  receptors  (82-87)  based  on  Hamilton’s  diamidopyridine 
frameworks
[88] discussed earlier.
[101] 
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Figure 3.6 – Tucker and co-worker’s organometallic neutral guest receptors. 
  It was thought that introduction of the ferrocene spacer groups would serve to both 
allow control of the binding strength of the receptor through oxidation of the metal centre, 
and allow the binding event to be monitored by cyclic voltammetry.
[101] 
  Proton-NMR  titrations  were  conducted  on  receptors  82-87  in  CDCl3  with  the 
selection of guests shown in Figure 3.6 and the association constants obtained using WIN-
EQNMR.
[69]  With  the  exception  of  receptors  82  and  85,  the  results  showed  all  the 
receptors to have the strongest interaction with barbital. Receptors 82 and 85 had higher 
binding constants with pyrimidone (Ka = 600 & 240 M
-1 respectively) compared to barbital 
(Ka = 195 & 200 M
-1 respectively) which they thought was due to unfavourable secondary 
hydrogen bond interactions. Another unsual result was that the association constants for 
the amide receptors (84 & 87) were lower than those for the amine receptors (83 & 86).   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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This was thought due to either; unfavourable steric effects or that the pyridine nitrogen is a 
better  hydrogen  bond  acceptor  when  the  more  electron  rich  amine  is  attached  to  the 
pyridine ring.
[101] 
  X-Ray  crystals  of  the  barbital  complex  of  receptor  84  were  obtained  by  slow 
diffusion of diethyl ether into a chloroform solution of the complex. The structure (fig. 3.7) 
shows the formation of a 1:1 complex with the barbital bound through six hydrogen bonds 
as expected. The barbital lies at a 38
o angle relative to the plane of the pyridine rings 
which is similar to the effect observed in Hamilton’s isophthaloyl macrocycles described 
earlier.
[100] 
 
Figure 3.7 – X-Ray crystal structure of receptor 84 with barbital. 
  Cyclic voltammetry experiments in dry DCM were conducted on all the receptors 
except  the  amine  based  receptors  83  and  86,  since  these  posed  problems  which  was 
thought to be possibly due to them being absorbed onto the electrode surface. The tested 
receptors  all  showed  reversible,  one  electron  reduction  processes  with  similar  formal 
potentials  (E
o’).  To  test  their  behaviour  in  the  presence  of  the  guests,  at  least  twenty 
equivalents of guest was added to the host solution. In all cases (except where poorly 
defined  voltagrams  were  encountered),  E
o’  shifted  negatively  relative  to  that  of  the 
receptor alone. Shifts of up to -60 mV were observed. These negative shifts are consistent 
with the hydrogen bond between the receptor’s amide NH groups and the oxygen of the 
guest increasing the electron density on the receptor, which makes the ferrocene unit easier 
to oxidize.
[101]   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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  There have been many other studies into barbiturate and urea receptors including 
chiral,
[102] indole based
[103] and metal based
[104] receptors which further demonstrate the 
scope and depth of this field of chemistry. 
3.2  Simple Benzimidazole Based Clefts 
Previous work in the Gale group has involved the extensive synthesis and study of 
novel  hydrogen  bonding  motifs  for  anion  recognition.  In  particular,  intramolecular 
hydrogen bonding has been used to preorganise receptors for enhanced anion binding as 
seen  in  our  macrocyclic  receptors  for  carboxylate  recognition
[13,  105]  and  in  acyclic 
membrane  transporters  for  chloride
[15]  and  HCl.
[106]  In  the  case  of  the  latter, 
methylimidazole groups were employed and the success with this approach prompted a 
further search for analogous functionalities such as benzimidazoles. The ready commercial 
availability  of  2-aminobenzimidazoles  led  to  the  design  of  a  simple  symmetric 
bisamidobenzimidazole cleft receptor 88 (fig. 3.8). 
            
Figure 3.8 – Original benzimidazole cleft receptor 
  The 
1H-NMR of receptor 88 in DMSO-d6 revealed the benzimidazole NH proton to 
be  shifted  unusually  far  downfield  to  a  remarkable  12.87  ppm.  This  suggests  that  in 
solution the receptor adopts the syn-syn conformation depicted in  Figure 3.8, with the 
benzimidazole  NH  protons  intramolecularly  hydrogen  bonding  to  the  amide  carbonyl 
which preorganises the structure. A 
1H-NMR titration of 82 with TBA
+Cl
- revealed no 
binding of chloride, which is likely due to the lone pair electrons on the benzimidazole 
nitrogens projecting into the cleft and repelling the anion. 
  However,  it  was  immediately  apparent  that  compound  88  had  the  DADDAD 
hydrogen bond donor (D)/acceptor(A) array which is complimentary for neutral guests 
such  as  barbiturates  and  ureas.  In  order  to  study  the  interaction  of  such  guests  with 
receptor 88, some control analogues (89-92) were synthesised to probe various aspects of 
the receptor (fig. 3.9).   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Figure 3.9 – Model compounds for the study of receptor 88. 
  Compound 89 has an isophthaloyl core in place of the pyridine one on 88 which 
removes a degree of preorganisation and may twist the structure because of the CH on the 
iosphthaloyl ring pointing into the cleft. Compound 90 lacks the benzimidazole NH group 
and hence possesses a lower degree of preorganisation than 88. Asymmetric compound 91 
lacks one of the amidobenzimidazole groups thus removing both a hydrogen bond donor 
and acceptor. Compound 92 is a pyridine analogue of compound 88 and again lacks the 
same degree of preorganisation as 88. 
 
 
 
 
 
 
   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
 
85 
 
3.2.1  Synthesis 
  Compounds 88-90 were synthesised by the condensation of 2-aminobenzimidazole 
or  2-amino-1-methylbenzimidazole  with  either  2,6-pyridinedicarbonyl  dichloride  or 
isophthaloyl dichloride in yields of 81, 54 and 86% respectively (sch. 3.1). 
 
Scheme 3.1 – Synthesis of compounds 88-90. 
  Compound  91  was  synthesised  according  to  Scheme  3.2  with  the  last  step 
proceeding in 54% yield. The synthesis of intermediate 94 was carried out according to a 
literature procedure.
[107] This involved esterification of 2,6-pyridinedicarboxylic  acid in 
methanol in the presence of a catalytic amount of sulphuric acid. Treatment of the bisester 
with one equivalent of potassium hydroxide at 0 
oC afforded predominantly the monoester-
monoacid  which  was  purified  by  recrystallisation  from  isopropanol.  Intermediate  95 
proved unstable to treatment with thionyl chloride so a suitable coupling agent route was 
employed instead.   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Scheme 3.2 – Synthesis of compound 91. 
  Finally, compound 92 was synthesised according to a literature procedure
[108] from 
2-aminopyridine and 2,6-pyridinedicarbonyl dichloride. 
3.2.2  Solid State Analysis 
X-ray quality crystals of compound 88 were obtained by the slow evaporation of a 
DMSO solution of the receptor. The structure (fig. 3.10) shows the receptor adopting a 
syn-syn conformation with a DMSO molecule bound to the amide NH groups. 
 
Figure 3.10 – X-Ray crystal structure of the DMSO solvate of compound 88. Non-acidic hydrogen 
atoms have been omitted for clarity. 
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  In  addition,  there  are  intramolecular  hydrogen  bonding  interactions  N1···O1 
(2.666(2) Å) and N7···O2 (2.741(2) Å) which presumably stabilise the structure in the 
solid state. This observation supports the similar findings in DMSO solution, confirming 
the reasoning behind the high downfield shift of the benzimidazole NH proton. 
  It was not possible to obtain X-ray quality crystals of compound 90 from a DMSO 
solution. However, crystals of the compound were instead obtained by slow evaporation of 
a DMF solution of the compound. 
 
Figure 3.11 – X-ray crystal structure of the DMF/H2O solvate of compound 90. 
  The structure (fig. 3.11) shows the compound adopting an anti-anti conformation 
with a water molecule bound (O1···O5 2.856(2) Å & O2···O5 2.872(2) Å) to the amide 
carbonyls. This result is quite remarkable considering that it has been well documented 
that this is the most high energy conformation.
[12, 14] As briefly mentioned (Chapter 1), 
2,6-pyridine  diamides  usually  prefer  to  adopt  a  syn-syn  conformation  because  of 
stabilising,  favourable  electrostatic  interactions  between  the  amide  protons  and  the 
pyridine nitrogen atom. The anti-anti conformation has unfavourable electron repulsions 
between the pyridine nitrogen lone pair (l.p) electrons and carbonyl oxygen l.p electrons, 
making it higher energy (fig. 3.12). 
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Figure 3.12 – Favourable and unfavourable conformations of 2,6-pyridine diamides. The energies are 
quoted from Reference 12 and were calculated using a CHARMm force field with no solvent included 
in the calculations.
[12] 
  However  in  this  case,  the  hydrogen  bonded  water  molecule  is  presumably 
stabilising the anti-anti conformation in the solid state. 
Single crystals of compound 91 were grown by slow evaporation of a methanolic 
solution of the compound (fig. 3.13). 
 
Figure 3.13 – X-Ray crystal structure of compound 91. 
  The structure shows the compound adopting a syn-syn conformation with a water 
molecule bound to the amide protons in the cleft (N1···O3 3.055(4) Å & N3···O3 2.908(3) 
Å).  The  benzimidazole  NH/carbonyl  intramolecular  hydrogen  bond  is  also  present 
(N4···O2 2.781(3) Å). 
Crystals of the barbital complex of receptor 88 were grown by the slow evaporation 
of a DMSO solution of the complex (fig. 3.14). The barbital is held by  a total of six 
hydrogen bonds; N2···N9 (2.7700(4) Å),  N3···O3 (2.9769(4) Å), N5···O3 (2.172(3) Å), 
N6···N8  (2.7406(4)  Å),  C5···O3  (3.4011(5)  Å)  and  C17···O4  (3.3921(6)  Å). 
Intramolecular hydrogen bonds N1···O1 (2.6906(3) Å) and N7···O2 (2.7198(4) Å) are 
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also present in the complex and, interestingly, each benzimidazole NH group also forms a 
hydrogen bond to a DMSO molecule. 
 
 
Figure 3.14 – X-Ray crystal structure of the barbital complex of receptor 88. Non-coordinating/acidic 
hydrogens have been omitted for clarity. 
3.2.3  Solution Studies 
  The  compounds  were  tested  against  the  neutral  guests  shown  in  Figure  3.15. 
Compounds 88-90 were only completely soluble in more polar solvents such as DMF or 
DMSO. In particular compound 89 was only soluble in warm DMSO. Preliminary 
1H-
NMR  titrations  in  DMSO  revealed  none  of  the  compounds  interacted  with  the  guests 
chosen for the study. 
 
Figure 3.15 – The neutral guests used in the solution studies. 
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However,  compounds  88  and  90  were  found  to  be  soluble  in  the  less  polar 
nitromethane,  but  the  only  guest  soluble  in  this  solvent  was  barbital.  Addition  of  a 
nitromethane solution of barbital to receptor 88 resulted in precipitation which is indicative 
of  strong  binding.  So  the  binding  studies  were  conducted  by 
1H-NMR  titrations  in 
solutions of nitromethane-d3 diluted with DMSO-d6 (either MeNO2-d3/20% DMSO-d6 or 
MeNO2-d3/30% DMSO-d6). Only compound 89 was not soluble in these solvent systems 
so no data was collected for it. The stability constants were determined using the WIN-
EQNMR program.
[69] 
The crystal structure of receptor 88 shows that DMSO binds to the amide groups. 
Hence, it is reasonable to expect that, in solution, the neutral guests must compete with this 
solvent for the guest binding site. The results for the titrations are shown in Table 3.1. 
  88  88
a  90  91  92 
Thiourea  0  0  0  0  0 
Urea  28  <10  0  0  0 
Imidazolidone  45  13  0  0  0 
Barbital  Precipitate  59  0  0  0 
Table 3.1 – Binding constants Ka (M
-1) for compounds 88, and 90-92 with a selection of neutral guests 
in 20% DMSO-d6/MeNO2-d3 unless noted otherwise at 298 K. All errors are estimated to be <10%. 
a In 
30% DMSO-d6/MeNO2-d3. 
  In  20%  DMSO-d6/MeNO2-d3,  receptor  88  was  found  to  bind  urea  and 
imidazolidone but precipitate upon the addition of barbital. Switching to 30% DMSO-
d6/MeNO2-d3 allowed a stability constant of 59 M
-1 to be determined for the formation of 
the  88-barbital  complex  under  these  more  polar  solvent  conditions.  Compounds  90-92 
showed no interaction with the guests under these conditions. Compound 91 was able to be 
tested in acetonitrile with barbital and even in these less polar solvent conditions it still 
showed no interaction with the guest. Interestingly, thiourea does not interact with receptor 
88 under either set of solvent conditions, whereas urea is bound (albeit very weakly). This 
is presumably due to the poor hydrogen bond acceptor ability of the thiourea sulphur atom 
compared to the urea oxygen. 
  The achievement of binding these neutral guests in such a polar solvent system is 
quite significant since, to the best of our knowledge, previous studies have only bound 
such guests in non-polar mediums such as DCM.   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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3.3  Towards a More Soluble Simple Cleft Receptor 
  Given  the  solubility  problems  encountered  with  receptors  88-92,  we  thought  it 
necessary to try and make a more soluble version of receptor 88.  This can feasibly be 
done by appending a ‘greasy’ alkyl chain to either the benzimidazole groups or the 4-
position  on  the  pyridine  ring.  Receptor  96  employed  the  latter  with  a  butyloxy  chain 
appended onto the pyridine ring (fig. 3.16). 
 
Figure 3.16 – Butyloxy substituted version of receptor 88. 
3.3.1 Synthesis 
  Receptor 96 was synthesised from chelidamic acid monohydrate in 5 steps (sch. 
3.3). The first step involved a simple esterification of the carboxylic acid in methanol with 
a catalytic amount of sulfuric acid as described in the literature.
[109] The butyloxy chain 
was  appended  by  reacting  the  bisester  with  butyl  iodide  in  the  presence  of  potassium 
carbonate  as  described  in  Dr.  Joachim  Garric’s  thesis.
[110]  Conversion  of  the  pyridine 
bisester  into  the  bisacid  was  followed  by  treatment  with  thionyl  chloride  and  finally 
reaction with 2-aminobenzimidazole in the presence of triethylamine to afford the product 
in 82% yield. 
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Scheme 3.3 – Synthesis of receptor 96. 
3.3.2  Solid State Analysis 
Crystals of the barbital complex of receptor 96 were grown by the slow evaporation 
of a DMSO solution of the complex (fig. 3.17). As expected, the barbital is held by six 
hydrogen  bonds  as  with  the  receptor  88  complex;  N2···N8  (2.779(4)  Å),    N3···O4 
(2.985(3)  Å),  N5···O4  (3.019(4)  Å),  N6···N9  (2.783(4)  Å),  C2···O5  (2.668  Å)  and 
C17···O6 (2.757 Å). Again, the intramolecular hydrogen bonds are also present; N1···O1 
(2.660(4) Å) and N7···O2 (2.686(4) Å) as is a hydrogen bond from a benzimidazole NH to 
a DMSO molecule.   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Figure 3.17 – X-Ray crystal structure of the barbital complex of receptor 96. Non-coordinating/acidic 
protons have been omitted for clarity. 
3.3.3  Solution Studies 
  In solution it was discovered that receptor 96 had the same solubility properties as 
receptor 88. The addition of the butyloxy chain appeared to have little or no effect on 
making the receptor more soluble in less polar solvents. Nevertheless, binding studies, in 
the form of 
1H-NMR titrations, were carried out in the same solvent conditions as those for 
the previous study (tbl. 3.2). 
  88 (20%)  88 (30%)
  96 (20%)  96 (30%)  96 (40%) 
Thiourea  0  0  0  0  0 
Urea  28  <10  33  <10  0 
Imidazolidone  45  13  51  <10  0 
Barbital  Precip.  59  Precip.  Precip.  Precip. 
Table 3.2 - Binding constants Ka (M
-1) for receptor 96 and their comparison to receptor 88 with a 
selection of neutral guests in DMSO-d6/MeNO2-d3 solutions with the percentage of DMSO used in 
brackets. All at 298 K and all errors estimated to be <10%.  
  In  20%  DMSO-d6/MeNO2-d3,  receptor  96  gave  the  same  results  (within  error 
limits) as those for receptor 88 in these solvent conditions, with addition of barbital again 
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causing precipitation. Changing to 30% DMSO-d6/MeNO2-d3 also gave the same results 
with thiourea, urea and imidazolidone. However, addition of the barbital solution resulted 
in precipitation and so it was decided to switch to even more concentrated DMSO. In 40% 
DMSO-d6/MeNO2-d3, precipitation was still observed which was surprising considering 
the butyloxy chain on this receptor was supposed to make the free receptor and resultant 
barbital complex more soluble. 
3.4  A Bis(aminobenzimidazole) Analogue That Functions as an Anion 
Receptor 
 
  An analogue of receptor 88 which lacks the amide groups was prepared (compound 
100, fig. 3.18). Studies with this receptor would investigate the importance of the amide 
groups in preorganising the receptor through intramolecular hydrogen bonding. 
 
Figure 3.18 – Bisaminobenzimidazole analogue of receptor 88. 
  The favourable electrostatic interactions between the amine NH groups and the 
pyridine nitrogen atom should still be present which may preorganise the receptor into a 
cleft. However, without the amide groups, the benzimidazole groups are free to rotate in 
solution which should affect the neutral guest binding. 
3.4.1  Synthesis 
  The  synthesis  of  compound  100  was  effected  in  three  steps  from  2,6-
pyridinedimethanol. The first step involves oxidation of the alcohol to the aldehyde using 
selenium dioxide according to a literature procedure (sch. 3.4).
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Scheme 3.4 - Synthesis of the aldehyde required for the preparation of 100. 
  The aldehyde was then reacted with two equivalents of 2-aminobenzimidazole to 
generate the Schiff base version of compound 100 which is immediately reduced using 
borohydride reducing agents to yield the product (sch. 3.5). 
 
Scheme 3.5 - Synthesis of compound 100. 
3.4.2  Solution Studies 
  Receptor 100 had similar solubility properties as receptor 88 being only soluble in 
more polar solvents such as nitromethane or DMSO. Proton-NMR titrations with receptor 
100 and barbital in MeNO2-d3/DMSO-d6 solutions showed no interaction between the two 
species.  This  finding  confirms  that  without  the  amide  groups  the  receptor  is  more 
disordered and cannot complex with neutral guests. 
  Although  receptor  100  showed  no  interaction  with  barbital  we  reasoned  that 
without the preorganisation of the benzimidazole groups the receptor might now be able to 
function as an  anion receptor. Receptor 100 was titrated with a selection of anions in 
DMSO-d6/0.5% H2O solution (tbl. 3.3). 
The results show the receptor is not very effective for binding anions in DMSO 
solution with even the more basic anions such as acetate giving a low association constant. 
And with the very basic fluoride anion, the receptor is deprotonated. However, the receptor 
did show a very high affinity for the tetrahedral 2
- charged sulfate anion. The affinity was 
so strong that it could not be measured by 
1H-NMR methods.
[112] 
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Anion  Ka 
F
-  Deprotonation 
Cl
-  < 10 
Br
-  < 10 
I
-  < 10 
NO3
-  < 10 
SO4
2-  >10
4 
C6H5CO2
-  66 
CH3CO2
-  94 
Table 3.3 - Binding constants Ka (M
-1) for receptor 100 with a selection of anions as their TBA salts in 
DMSO-d6/0.5% H2O solution. All at 298 K and all errors estimated to be <10%. 
  Figure 3.19 shows the titration profile of sulfate with receptor 100 which plots 
concentration of anion (mol dm
-3) against chemical shift (ppm). The graph shows how the 
curve rises very steeply up to one equivalent of anion added  and then levels out to a 
plateau. This is typical behaviour for a very strong 1:1 binding event. 
 
Figure 3.19 – Titration binding profile for receptor 100 with (TBA)2SO4 in DMSO-d6. 
  Such a high selectivity for this anion compared to the other anions is remarkable 
and may not have arisen simply because it 2
- charged. This prompts a need for further 
binding studies to be carried out with this receptor and other tetrahedral anions, such as 
phosphates and 2
- charged anions, such as carbonate. 
   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
 
97 
 
3.5  Towards a Neutral Guest Templated [2]-Catenane 
  The complexation of a barbiturate to receptor 88 in such a polar solvent system was 
an encouraging result. This motivated us to consider using this system in an attempt to 
construct a neutral guest templated [2]-catenane. This concept was intriguing because there 
are no catenanes reported (to the best of the author’s knowledge) that have been templated 
using a neutral guest. 
3.5.1  Catenane Design and the Synthetic Routes Attempted 
 
  It  was  decided  to  synthesise  an  extended  version  of  receptor  88  to  use  as  a 
precursor  that  could  be  macrocyclised  to  form  the  catenane  rings.  A  ring  closing 
metathesis  using  Grubb’s  catalyst  was  chosen  to  perform  this  macrocyclisation  and 
interlock the rings upon guest templation, since it is well documented
[113] and usually high 
yielding. This route would require pendant arms with terminal alkenes. 
An  ideal  neutral  template  for  this  system  was  thought  to  be  a  spirobarbiturate 
species such as compound 103 (fig. 3.20). This spiro-compound is the smallest way to 
design the template and the twist in the structure at the 5-position on the barbiturate rings 
would provide the ideal shape to template the catenane formation. 
 
Figure 3.20 - Design of the neutral guest required for the templation of a [2]-catenane. 
 
3.5.1.1  Preliminary Investigations 
  It  was  decided  that  adding  better  hydrogen-bond  donor  groups  such  as  amide 
groups to receptor 88 would likely coordinate to the carbonyls at the 4- and 6-positions on 
the barbiturate rings. This would enhance binding and provide a way of appending the 
arms required for macrocyclisation. Compound 104 (fig. 3.21) was therefore hypothesised 
which would require the synthesis of a novel 2-aminobenzimidazole.   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Figure 3.21 – Initial idea for the design of the catenane macrocycle. 
  In  general,  substituted  2-aminobenzimidazoles  can  be  synthesised  according  to 
Scheme 3.6 which involves reaction of the corresponding benzene diamine with cyanogen 
bromide.
[114] 
 
Scheme 3.6 – General synthesis of 2-aminobenzimidazoles. 
  Clearly  the  synthesis  of  compound  104  could  proceed  through  2-amino-4-
nitrobenzimidazole  105  which  could  then  be  reacted  with  2,6-pyridinedicarbonyl 
dichloride and reduced to the bisamine 106 (sch. 3.7). 
 
Scheme 3.7 – Proposed first step in the synthesis of compound 98. 
  However, reaction of 105 with the acid chloride did not work as it was found that 
with the nitro group on the benzene ring, the benzimidazole NH position was now more 
reactive than the amine. Subsequently, the benzimidazole NH was protected with a BOC 
group.  Reaction  of  the  protected  benzimidazole  with  the  acid  chloride  followed  by 
deprotection did work but in very low yield and the product was very difficult to purify.   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Nevertheless, it was possible to recrystallise the crude material from the reaction by slow 
evaporation of a DMSO solution of the crude solid.  
 
Figure 3.22 – X-Ray crystal structure of the nitro-product of the reaction to make compound 106. 
Non-acidic hydrogens have been omitted for clarity. 
  The structure (fig. 3.22) shows the compound binding a DMSO molecule with the 
expected  intramolecular  hydrogen  bonding  observed  (N7···O2  2.723(5)  Å,  N5···O1 
2.653(5) Å, N2···O101 2.834(5) Å, N3···O101 2.797(5) Å). Interestingly, the nitro-groups 
are both orientated out  of the cleft rather than  one in/one out or both in.  It would be 
reasonable to assume that this conformation is also the most stable in solution. The nitro-
groups  would  therefore  be  poorly  aligned  for  the  subsequent  reduction  and 
macrocyclisation. 
  Another approach was to reduce the nitro-group on the benzimidazole and form the 
amide before attaching it to the pyridine core. This required the BOC protection of the 
amine and benzimidazole groups. Stirring compound 99 with di-
tbutyl dicarbonate at room 
temperature only resulted in BOC protection at the benzimidazole NH position, so heat 
and a base catalyst was needed to protect the amine as well. Subsequent reduction of the 
nitro-group did not work as the amine seemed to be unstable and would not react cleanly 
in the next step so this approach was abandoned. 
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3.5.1.2  Final Ideas 
  The second approach tried, required the attachment of ethylene glycol chains with 
terminal  alkenes  to  the  5-position  on  the  benzimidazole  ring  to  result  in  macrocycle 
precursor 107 (fig. 3.23). 
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Figure 3.23 – Macrocycle precursor 107 and the benzimidazole numbering system. 
In-house molecular modelling using SPARTAN revealed that the optimum number 
of atoms required to fit around the guest template and opposing catenane ring was 24 
atoms. It was reasoned that even if there were tautomers where the glycol chains were 
attached to the 6-position, the precursor would still be able to macrocyclise. 
Figure 3.24 shows how the catenane structure  was envisaged showing how the 
spirobarbiturate guest would bind. 
 
Figure 3.24 – Proposed catenane design. 
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It was thought that the macrocycle precursor could be accessed through 2-amino-5-
hydroxybenzimidazole 109 (sch. 3.8).  Its methoxy-precursor 108,  could be synthesised 
according to the general method (see sch. 3.6). 
 
Scheme 3.8 – Synthesis of compound 109 and the alternative starting material 110. 
  However, it proved very difficult to purify the amino-alcohol and the next steps 
would require more BOC protections. So it was decided to start with the commercially 
available  compound  110  which  could  be  functionalised  before  conversion  into  the 
aminobenzimidazole (sch. 3.9).   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Scheme 3.9 – Alternative proposal for the synthesis of precursor 107. 
The  first  step  in  the  proposed  synthesis  worked  well  in  high  yield  but  there  were 
immediately apparent problems with the synthesis. The second step worked in low yield 
because  of  substitution  of  allyl  bromide  onto  the  amine  as  well  as  the  alcohol.  BOC 
protecting  the  amine  group  could  have  solved  this  problem  but  the  synthesis  was  not 
continued for the following reasons: 
i)  It  was  envisaged  there  would  be  problems  reducing  the  nitro-group  without 
saturating the alkene. 
ii)  It was also realised that the cyanogen bromide used to treat the diamine would also 
react with the alkene groups.  
The first problem could be solved by using the nitro-selective tin(II)  chloride as a 
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to  reduce  compound  111  and  form  the  benzimidazole  to  make  a  hydroxyl-version  of 
compound 107. This did not work in sufficient yield or purity to perform any studies with. 
The synthesis of the spirobarbiturate 103 was also attempted. From a literature review 
it was discovered that there were two approaches that could be taken to synthesise this 
compound. 
 
Scheme 3.10 – First route attempted for the synthesis of 103. 
The first route was based on the realisation that the CH2 position on barbituric acid 
could easily be deprotonated by a standard base such as potassium carbonate. So a 5,5-
substitution of ethoxy-esters could be carried out (sch. 3.10). The reaction worked but the 
bis-substituted  version  (115)  was  not  stable  and  decayed  to  the  more  stable  mono-
substituted version. Repeating the reaction and taking it straight through to the next step 
did not result in the product, presumably due to the unstable nature of compound 115.   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Scheme 3.11 – Second route attempted for the synthesis of 103. 
  The second route involves the generation of a urea bis-acid chloride (117) which is 
reported in the literature.
[115, 116] The final product was insoluble in all organic solvents and 
this was thought to be because it may have been isolated as a lithium salt. Subsequent 
washing  with  HCl  solution  to  remove  the  lithium  did  not  make  the  compound  more 
soluble, which made it difficult to characterise and confirm the product. A 
1H-NMR of the 
material in warm DMSO-d6 revealed one peak for the four urea NH groups and a 
13C-
NMR revealed the correct number of carbon atoms. A mass spectrum from DMSO also 
revealed a peak for the product but an accurate elemental analysis could not be obtained. 
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3.6  Conclusions 
  This  chapter  has  explored  the  properties  of  some  simple  benzimidazole  based 
receptors for neutral guest recognition. Building upon these results, we have then tried to 
exploit these simple clefts for the design of a more complex structure in the form a neutral 
guest templated [2]-catenane. 
  The structurally simple bis-benzimidazole functionalised 2,6-diamidopyridine 88 is 
capable of binding neutral guests in a highly polar solvent mixture such as 30% DMSO-
d6/MeNO2-d3.  Whereas  compounds  possessing  similar  hydrogen  bonding  arrays  but 
lacking some of the intramolecular hydrogen bonding interactions present in compound 88 
do  not,  under  these  conditions,  interact  with  the  neutral  guests  studied.  For  example, 
removing the amide groups (compound 100), methylating the benzimidazoles (compound 
90) or removing one of the benzimidazole (compound 91) groups resulted in no interaction 
with the guests studied. 
  Unfortunately, more substituted benzimidazoles proved more difficult to work with 
due  to  their  reactivity,  difficulty  to  purify  and  sometimes  their  associated  solubility 
problems. This made construction of the more complex catenane architecture a significant 
challenge. 
  Ideas for further work with these systems should include further investigations into 
their  potential  for  use  as  HCl,  chloride  or  bicarbonate  membrane  transporters.  An 
encouraging  preliminary  investigation  of  compound  91  involved  crystalising  it  in  the 
presence of HCl which resulted in the crystal structure shown in Figure 3.25.   Chapter 3 – Benzimidazole Based Receptors for Neutral Guest Complexation  
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Figure 3.25 – HCl complex of compound 91. Non-acidic hydrogens omitted for clarity. 
  The crystals were grown by a slow evaporation of a methanolic HCl solution of 
compound  91.  The  structure  shows  a  chloride  anion  bound  in  the  cleft  through  three 
hydrogen bonds (N1···Cl1 3.365(2) Å, N3···Cl1 3.150(2) Å, N4···Cl1 3.041(2) Å) with an 
intramolecular  hydrogen  bond  between  the  benzimidazole  NH  and  the amide  carbonyl 
(N5···O2 2.743(3) Å). One of the hydrogens involved in the complexation is from the 
protonated benzimidazole nitrogen group. The complex actually forms a hydrogen bonded 
dimer through hydrogen bonded methanol molecules in the structure (fig. 3.26). 
 
Figure 3.26 – Hydrogen bonded dimer of the HCl complex of compound 85. 
  Although  the  crystal  structure  result  was  encouraging,  unfortunately,  vesicle 
transport screening studies in our group (conducted by Dr. Joachim Garric) revealed that 
the HCl complex of 91 did not remain soluble in the medium (water/DMSO) used in the 
study. 
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  It  seemed  that  much  of  the  problems  with  this  chemistry  arose  from  lack  of 
solubility  of  the  compounds.  An  attempt  to  rectify  this  problem  with  the  synthesis  of 
receptor 96 failed. However, more can be done to make these compounds more soluble, 
such  as  attaching  longer,  branched  alkyl  chains  to  the  receptors  or  appending  glycol 
chains. 
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Chapter 4 – Triazoles in 
Anion Receptor Chemistry 
4.1  Introduction 
  In  1963  Rolf  Huisgen  published  an  extensive  review  of  1,3-dipolar 
cyclocadditions., which included a synthesis for a 1,2,3-triazole from alkyne and azide 
precursors.
[117, 118] It followed that these syntheses became known as Huisgen 1,3-dipolar 
cycloadditions and the 1,2,3-triazole synthesis is shown in Figure 4.1. 
 
Figure 4.1 – Synthesis of triazoles by Huisgen 1,3-dipolar cycloaddition. 
  However, the problem with the reaction was that it requires prolonged heating to 
work and results in both the 1,4- and 1,5-substituted products in roughly equal proportions 
which somewhat limited its application. 
  In  2001  K.  Barry  Sharpless  and  co-workers  introduced  the  concept  of  ‘click’ 
chemistry  which  was  supposed  to  be  a  ‘guiding  principle’.
[119]  The  principle  revolved 
around the endeavour to generate substances by simple reactions from readily available 
starting materials under kinetic control, with high yields, inoffensive by-products and very 
simple non-chromatographic workup.
[119] It was inspired by nature’s processes and was 
devised to meet the demands of modern day chemistry and in particular, the demands of 
drug discovery.
[119, 120] The Huisgen synthesis of triazoles provided an excellent example 
of a reaction that could potentially meet these stringent requirements: the starting materials 
are usually easily synthesised or commercially available, kinetically stable and tolerant to a 
wide range of functional groups and reaction conditions.
[120] It was then discovered
[121, 122] 
that this reaction could be greatly accelerated by a copper(I) catalyst in the presence of 
water to form exclusively the 1,4-substituted product, usually in high yields. In addition,   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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the  products  of  these  reactions  usually  require  a  very  simple  work-up  with  no 
chromatography. It is obvious that this near perfect reaction fits all the principles of ‘click’ 
chemistry, so the term has evolved to become synonymous with the copper(I) catalysed 
Huisgen synthesis of 1,4-substituted 1,2,3-triazoles. 
  The  1,2,3-triazole  heterocycle  has  interesting  properties  that  give  rise  to  a 
fascinating array of applications.
[120,  123] These properties were neatly summarised in a 
recent paper by Li and Flood
[124] as follows:  
i)  it can be deduced that the electronegativities of the three nitrogens combine to 
polarise the CH bond and, 
ii)  the lone pairs of electrons on the nitrogen atoms act to establish and orient along 
the CH bond to create a large dipole (~5D) whose positive end points towards to 
the hydrogen atom.  
These features make the CH group a remarkably good hydrogen bond donor whilst 
the nitrogens at the 2- or 3-positions are good hydrogen bond acceptors. As a result of 
these  characteristics,  triazoles  have  been  thought  of  as  candidates  for  amide  bond 
surrogates.
[124] 
  Given these properties, one of the useful applications of the triazole group would 
be to employ it in a receptor for anions. One of the first examples of such an application, 
reported in 2008 by Li and Flood, was a 1,2,3-triazole-phenyl based macrocycle (118) 
which has a high affinity for chloride in DCM.
[125] 
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Figure 4.2 – Triazole macrocycle for chloride.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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  The macrocycle consists of eight conjoined ring systems wherein four triazoles 
alternate with four phenyl rings. The design allows for minimal deviations from ideal bond 
angles and minor steric interactions between hydrogens on adjacent ring systems.
[125]  
  The synthesis of 118 was efficient; proceeding in 27% yield over seven steps using 
Sharpless-Meldal click chemistry and standard Sonogashira coupling reactions. A UV-vis 
titration  of  the  macrocycle  in  DCM  revealed  a  1:1  binding  stoichiometry  and  an 
association  constant  (Ka)  of  130000  M
-1.  A 
1H-NMR  titration  of  118  with 
tetrabutylammonium chloride in CD2Cl2 resulted in a shift of the triazole CH peaks and the 
phenyl CH peaks pointing into the cleft which confirms there are eight CH···Cl
- hydrogen 
bonds. It is important to note that the binding affinity relies heavily on the fact that the 
triazoles are rigidly preorganised in this example, as suggested by a much lower binding 
constant (7M
-1) of an acyclic analogue of 118. 
Further studies
[124,  126] with this macrocycle revealed that it had a selectivity for 
chloride over other halides in DCM as follows; Cl
- (1.1x10
7 M
-1) > Br
- (7.5x10
6 M
-1) >> F
- 
(2.8x10
5 M
-1) >> I
- (1.7x10
4 M
-1),
[124]  which infers that the fluoride anion was too small 
for the cavity, whilst the iodide anion was too large for the cavity. And in fact it was 
found
[126] that the iodide anion forms a sandwich complex with two equivalents of the 
macrocycle in solution. 
  Other examples which illustrate the versatility of the 1,2,3-triazole-phenyl motif in 
foldamers
[127] and linear nonamers
[128] have been reported by other authors.  
The first anion receptor to employ ‘click’ chemistry in its construction was that of 
Pandey and co-workers who united click chemistry with the established
[129,  130] tool of 
using  steroid  based  frameworks  to  append  hydrogen  bond  donor  groups  for  anion 
recognition.
[131] They first synthesised two bis-triazole macrocycles and then treated them 
with methyl iodide, followed by ammonium PF6
- to form the charged methyl-triazolium 
macrocycles 119 and 120 (fig. 4.3). An acyclic analogue (121) of the macrocycles was also 
prepared as a control compound. 
Proton-NMR  titrations  of  the  compounds  were  conducted  in  CDCl3  with  a 
selection  of  anions  as  their  tetrabutylammonium  salts.  The  results  showed  that  all  the 
receptors bound in a 1:1 stoichiometry with similar binding constants in the range 100-690 
M
-1 for the halides.
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Figure 4.3 – Pandey and co-worker’s triazolium-steroid macrocycles and an acyclic control analogue. 
  Interestingly, macrocycle 120 and the acyclic 121 showed a slight selectivity for 
H2PO4
- (Ka = 1100 and 1920 M
-1 respectively), whereas the meta-substituted 119 did not 
show any interaction with this anion. The authors hypothesised that the para-substituted 
120  presents  a  larger  cavity  so  it  is  able  to  accommodate  the  larger  anion,  whilst  the 
acyclic  121  has  more  flexibility  to  arrange  around  the  anion.
[131]  Overall,  the  results 
showed that there was no significant advantage to having a macrocyclic framework in the 
case of these receptors. 
4.1.1  Strapped Calix[4]pyrroles 
  Given the useful properties of triazoles and interesting applications of  them by 
other groups, particularly  in anion recognition, it was thought interesting to apply this 
chemistry  to  our  lines  of  work.  Gale  and  Sessler  have  reported  that  meso-
octamethylcalix[4]pyrrole  (23,  fig.  4.4)  is  a  highly  efficient  receptor  for  fluoride  and 
chloride  (see  Chapter  1).  Ways  of  functionalising  the  basic  calix[4]pyrrole  framework 
followed and some of the possible modifications are shown in Figure 4.4.
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Figure 4.4 – Schematic representation of possible ways to modify the basic calix[4]pyrrole core.
[132] 
  Early modifications of calix[4]pyrrole involved functionalising the β-pyrrolic or 
meso-positions since these are the easiest changes to effect. Whilst highly versatile, these 
systems  have  some  limitations,  particularly  with  regard  to  potential  enhancements  in 
selectivity and affinity.
[132] Further developments led to the single armed versions which 
were inspired by similar modifications applied to sapphyrin based receptors.
[23] However, 
the idea of strapped or capped calix[4]pyrroles was most attractive, because they would 
have added preorganisation which would improve anion binding and allow selectivity for 
specific  sized  anions.  Research  has  particularly  focused  on  the  former  because  it  was 
considered
[132]  that  capped  calixpyrroles  could  be  too  rigid,  which  may  reduce  anion 
affinity. In addition, they are inherently more complex to synthesise.  
  It was not until 2002 that Lee and co-workers first reported the successful synthesis 
of a strapped calixpyrrole 122 (fig. 4.5).
[133] The role of the CH in the anion binding with 
these strapped calix[4]pyrroles was studied by comparing 122 to pyrrole (123) and furan 
(124)  strapped  analogues.
[134]  Binding  constants  were  determined  by  isothermal 
calorimetry (ITC) in dry acetonitrile with tetrabutylammonium chloride for 122, 123 and 
124 and compared against the original octamethylcalix[4]pyrrole 23 (shown in fig. 4.4 and 
discussed in Chapter 1).   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Figure 4.5 – The first strapped calixpyrrole (122) and the recent pyrrole (123) or furan (124) strapped 
versions for comparative analysis. 
  The results showed that 122 had a ten-fold increase in affinity for chloride (Ka = 
2.2x10
6 M
-1), whilst 123 had an 80 fold increase (Ka = 1.8x10
7 M
-1) when compared to the 
parent calix[4]pyrrole 23 (Ka = 2.2x10
5M
-1). Conversely, compound 124 had a slightly 
lower binding constant (Ka = 1.9x10
5 M
-1), which suggests the significant role the CH 
plays in binding the anion. 
  The  crystal  structure  (fig.  4.6)  of  calixpyrrole  122  with  tetraethylammonium 
chloride revealed the binding of the anion via a total of five hydrogen bonds; four pyrrole 
NH···Cl
- (average N···Cl
- distance 3.285 Å) and a CH···Cl
- (C···Cl
- 3.793 Å). The phenyl 
group of the strap is canted ~70° relative to the centre of the calix[4]pyrrole ring. This is 
because of the need to accommodate a tetraethylammonium cation which is not shown in 
this representation.
[135]   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Figure 4.6 – X-ray crystal structure of 122 with chloride. 
  Studies that vary the length of the strap on compound 122, to investigate the effects 
on binding affinity, have shown that selectivities for certain size anions can be achieved by 
simply  making  the  strap  larger  or  smaller  in  the  case  of  these  isophthaloyl  strapped 
calixpyrroles.
[135]   
The synthesis of strapped calixpyrroles is particularly versatile which has lead to 
many  other  variations  of  strapped  calixpyrroles  not  detailed  here.
[132,  136,  137]  As  a 
progression of this body of work, we introduced a triazole strap into the calix[4]pyrrole 
using ‘click’ chemistry. 
4.2  ‘Clicked’-calix[4]pyrrole 
  Initially  it  was  decided  to  introduce  one  triazole  into  the  strap  to  keep  the 
complexity of the receptor to a minimum. The length of the strap was also an important 
consideration: most strapped calix[4]pyrroles reported to date have a strap length of 17±1 
atoms  (see  fig.  4.7  for  strap  length  numbering  system  used).  Indeed,  Sessler  and  co-
worker’s study into varying the strap length on their strapped calix[4]pyrroles had shown 
this to be the optimum length for binding chloride.
[135] Finally, using simple alkyl chains in 
the strap construction, ‘clicked’-calix[4]pyrrole 125 was envisaged (fig. 4.7).   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Figure 4.7 – ‘Clicked’-calix[4]pyrrole design and the parent calix[4]pyrrole 23. 
  The additional CH hydrogen-bond donor provided by the triazole, was expected to 
increase  the  affinity  for  anions  of  interest  (compared  to  23),  and  produce  interesting 
complexation behaviour in solution and the solid state. 
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4.2.1  Synthesis 
  In general, the synthesis of strapped calix[4]pyrroles can potentially be achieved by 
two ways: either initial construction of the calixpyrrole core, followed by spanning with a 
strap  or,  creation  of  a  linked  precursor  (incipient  strap)  followed  by  calixpyrrole  ring 
formation.
[132] The latter method was adopted for the synthesis of 125 because it was the 
first
[133] and most successful approach used to date. The main drawback to this synthetic 
route is that the final step (calixpyrrole ring formation) is often extremely low yielding 
(typical yields reported; 4-16%). 
The  ‘clicked’-calix[4]pyrrole  125  was  successfully  synthesised  according  to  the 
route outlined in Scheme 4.2. The first step involves generating the appropriate terminal 
alkyne  and  azide  linkers  which  can  be  ‘clicked’  together  to  form  the  strap.  This  was 
achieved by first synthesising a bromoketone precursor according to a literature procedure 
(sch. 4.1).
[138] 
 
Scheme 4.1 – Synthesis of the bromoketone. 
  The ketone was protected as a cycloketal
[139] then converted to the alkyne (129a) 
and azide (129b) by nucleophilic substitution of the bromine using NaCCH3 and NaN3 
respectively (sch. 4.2). The triazole was formed by reacting 129a and 129b in the presence 
of a copper(I) catalyst. There are a range of different methods
[140] of sourcing copper(I) for 
the cycloaddition; although it can be sourced directly (e.g. copper(I) iodide), it is better 
generated in-situ by reduction of copper(II) salts, which are less costly and often purer than 
copper(I) salts.
[121] We employed the most widely used method; copper(II) sulfate mixed 
with sodium ascorbate as the reductant.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Scheme 4.2 – Synthesis of ‘clicked’-calix[4]pyrrole 119. 
  The appended triazole 130 was deprotected to yield the diketone and was reacted in 
pyrrole  with  a  TFA  catalyst  to  form  the  ‘dipyrromethane’  precursor  131.  Finally,  the 
‘clicked’-calix[4]pyrrole  125  was  generated  by  reaction  by  reaction  in  acetone  with  a 
catalytic amount of BF3OEt2.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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This synthesis is efficient because it is convergent and, with the exception of the 
last step, is moderately high yielding. The ‘clicked’-calixpyrrole 125 could not be purified 
by column chromatography and so required recrystallisation from methanol which isolated 
a methanol solvate of the pure material. 
4.2.2  Solid State Analysis 
  Single  crystals  of  compound  125  were  prepared  by  recrystallisation  from 
methanol/diethyl ether.  The structure (fig. 4.8) reveals the calixpyrrole  adopting a 1,2-
alternate conformation in which two methanol molecules are each bound to two pyrrole 
NH groups. 
 
Figure 4.8 – X-ray crystal structure of the methanol solvate of compound 125 showing the calixpyrrole 
macrocycle adopting the 1,2-alternate confirmation. 
  Compound 125 also spontaneously crystallised by wetting the material with a few 
drops of DMSO. Again, the structure (fig. 4.9) shows the calixpyrrole adopting a 1,2-
alternate  confirmation  with  two  molecules  of  DMSO  each  bound  to  two  pyrrole  NH 
groups and one bound to the triazole CH. The triazole ring in the structure is disordered. 
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Figure 4.9 – X-ray crystal structure (left) of the DMSO solvate of compound 125 from the minimum 
amount of DMSO. Also shown, is the structure with the DMSO molecules depicted in a space filling 
representation (right).  
  From the space filling representation it can be seen that the strap is tilted off at an 
angle in order to accommodate the DMSO molecule. This is similar to the effect observed 
with Sessler and Lee’s strapped calix[4]pyrroles.
[133, 135] 
  X-ray  quality  crystals  of  a  pseudopolymorph  of  the  DMSO  structure  described 
above  were  obtained  from  dilute  solutions  of  125.  In  this  structure  (fig.  4.10)  the 
calixpyrrole still adopts the 1,2-alternate conformation but binds three DMSO molecules 
instead of two: one molecule of DMSO binds the triazole CH and the other two each bind 
to two of the pyrrole NH groups. The triazole ring is also not disordered in contrast to the 
other structure. 
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Figure 4.10 – X-ray crystal structure of the pseudopolymorph of the DMSO solvate of compound 125 
from a dilute DMSO solution. 
4.2.3  Binding Studies in Solution 
It was predicted that the binding constants would be too high (Ka > 10
4 M
-1) to 
accurately measure by NMR techniques.
[112, 135] However, it was fundamental to use this 
technique to demonstrate that the triazole CH is involved in hydrogen bonding to anions in 
solution. So the anion binding properties of 125 were studied by 
1H-NMR titrations in 
acetonitrile-d3 solution at 298 K. Under these conditions addition of tetrabutylammonium 
chloride resulted in slow exchange on the NMR timescale, with peaks representing both 
complexed  and  uncomplexed  receptor  at  0.5  equivalents  of  chloride  addition  (see  fig. 
4.11). At 1 equivalent of anion addition, the uncomplexed peaks disappear and further 
addition of anion results in no further change in the spectrum. The triazole CH peak shifted 
significantly downfield (by 1.33 ppm) in this process which suggests strong hydrogen-
bond formation. In addition, the β-pyrrole CH groups shift upfield slightly which may be 
due to the presence of tetrabutylammonium in the vacant ‘cup’ under the calixpyrrole. 
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Figure 4.11 – Partial 
1H-NMR spectrum of compound 125 upon addition of tetrabutylammonium 
chloride in acetonitrile-d3 solution at 298 K. 
  Proton-NMR  titrations  with  bromide,  dihydrogen  phosphate,  acetate  and 
bicarbonate all revealed strong binding events, with triazole CH hydrogen bonding in all 
cases  (see  Appendix  for  NMR  stack  plots  with  these  anions).  Addition  of 
tetrabutylammonium nitrate to compound 125 resulted in weak enough binding to allow an 
association constant (Ka) of 3790 M
-1 to be calculated. 
  Work  by  the  groups  of  Sessler
[135]  and  Schmidtchen
[32]  has  determined  that 
isothermal calorimetry (ITC) is the most reliable method for determining binding constants 
for  calix[4]pyrrole  species,  especially  when  Ka  >  10
4  M
-1.  Hence  ITC  titrations  with 
compound  125  were  conducted  by  Professor  Franz  P.  Schmidtchen  at  the  Technical 
University of Munich (Germany). 
  The preliminary ITC titrations were conducted with various tetraalkylammonium 
anion salts in absolute (<10 ppm water) acetonitrile at 303 K. The molecular weights were 
calculated on the basis of two additional molecules of methanol (as observed in the crystal 
structure and 
1H-NMR spectrum) per host compound. Absolute concentrations in the cell 
ranged from 0.3 mM to 1 mM with the concentrations in the syringe being about tenfold 
higher.  Two  types  of  measurements  were  conducted;  the  first  (tbl.  4.1)  involved  the 
β-CH 
CH  NH 
β-CH 
CH 
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titration of guest into host solution, whilst the second (tbl. 4.2) involved the titration of 
host into guest solution. 
Salt  Kass  
(M
-1) 
∆G
o 
(cal K
-1 mol
-1) 
∆H
o   
(cal K
-1 mol
-1) 
∆S
o   
(cal K
-1 mol
-1) 
TEA
+Cl
-  1.3 e6  -8.47 e3  -12.0 e3  -11.6 
TEA
+BnO
-  6.0 e3  -5.23 e3  -9.90 e3  -15.4 
TBA
+H2PO4
-  8.2 e3  -5.42 e3  -4.61 e3  +2.7 
TEA
+NCO
-  1.1 e6  -8.38 e3  -13.35 e3  -16.3 
TEA
+HCO3
-  2.0 e5  -7.36 e3  -11.40 e3  -13.3 
Table 4.1 – ITC titration results for compound 125 and various tetraalkylammonium salts in absolute 
acetonitrile at 303 K. In these experiments anionic guests were titrated into a solution of the host. 
  The results show that, with the exception of dihydrogenphosphate, all the host-
guest  interactions  appear  as  clean  1:1  stoichiometric  binding  processes.  An  unusual 
binding stoichiometry is exhibited with dihydrogenphosphate. This could potentially be 
because the protons on this anion are acidic which means it can be deprotonated by the 
receptor. This can often lead to strange binding stoichiometries and complicates the fitting 
of data to an ideal model. 
Salt  Kass  
(M
-1) 
∆G
o 
(cal K
-1 mol
-1) 
∆H
o   
(cal K
-1 mol
-1) 
∆S
o   
(cal K
-1 mol
-1) 
TEA
+Cl
-  2.6 e6  -8.89 e3  -11.88 e3  -9.8 
TBA
+F
-  1.6 e5  -7.19 e3  -11.34 e3  -13.6 
TBA
+AcO
-  1.6 e5  -7.23 e3  -13.12 e3  -19.4 
TBA
+pNO2BnO
-  1.3 e3  -4.32 e3  -8.45 e3  -13.9 
Table 4.2 – ITC titration results for compound 125 and various tetraalkylammonium salts in absolute 
acetonitrile at 303 K. In these experiments the host was titrated into solutions of the anionic guests. 
  In general, the smaller anions bind a lot more intensely to compound 125 than to 
the parent calix[4]pyrrole 23.
[32] Only if the steric bulk on the anion becomes too large, 
then the stabilities suffer substantially due to unfavourable association entropies. 
  Further preliminary ITC titrations were conducted in dry DCM with compound 125 
by titrating a host solution into a selection of tetraalkylammonium anion solutions at 303K. 
Again, the molecular weights were calculated on the basis of two additional molecules of 
methanol per host compound. Absolute concentrations in the cell were ~0.6 mM with the 
concentrations in the syringe being about tenfold higher. 
  In the case of chloride, the results (tbl. 4.3) revealed that the association constants 
are reliant on the type of countercation, with tetraethylammonium chloride possessing an   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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affinity  five  times  higher  than  tetrabutylammonium  chloride.  This  phenomenon  has 
recently been observed with the parent calixpyrrole 23 and various chloride salts.
[30] 
Salt  Kass  
(M
-1) 
∆G
o 
(cal K
-1 mol
-1) 
∆H
o   
(cal K
-1 mol
-1) 
∆S
o   
(cal K
-1 mol
-1) 
TEA
+Cl
-  2.7 e6  -8.91 e3  -13.2 e3  -14.2 
TBA
+Cl
-  4.7 e5  -7.86 e3  -11.8 e3  -13.0 
TEA
+NO3
-  6.1 e5  -8.38 e3  -7.68 e3  -8.0 
TEA
+HCO3
-  1.8 e3  -7.27 e3  -9.93 e3  -8.7 
Table 4.3 - ITC titration results for compound 125 and various tetraalkylammonium salts in dry DCM 
at 303 K. 
  The results also show that, in contrast to compound 23, the complex stabilities of 
125 are not greatly enhanced in the less polar DCM when compared to the more polar 
acetonitrile. For example, in the case of TEA chloride (tbl. 4.4), the parent compound 23 in 
DCM binds chloride weaker than in the more polar acetonitrile because of an unfavourable 
complexation entropy overcompensating the more exothermic enthalpy output. However 
with  the  ‘clicked’-calixpyrrole  125,  there  is  an  almost  ideal  balance  of  the 
enthalpic/entropic gains and losses which attests to the less significant role of solvation in 
this case. However it must be noted that the high error values encountered during the ITC 
measurements of 125 in DCM (see appendix) may have distorted these results somewhat. 
These errors may have arisen from evaporation of the highly volatile solvent or electrical 
interference  with  the  equipment  during  those  measurements.  Future  experiments  could 
involve using a less volatile chlorinated solvent such as DCE in place of the DCM to 
overcome these problems. 
  Acetonitrile  Dichloromethane 
Host  Kass  
[M
-1] 
∆G
o/ 
kcal mol
-1 
∆H
o/
 
kcal mol
-1 
T ∆S
o/
 
kcal mol
-1 
Kass 
[M
-1] 
∆G
o/
 
kcal mol
-1 
∆H
o/
 
kcal mol
-1 
T ∆S
o/
 
kcal mol
-1 
23  1.9 e5  -7.19  -10.1  -3.07  4.9 e4  -6.33  -10.96  -4.63 
125  2.6 e6  -8.89  -11.9  -2.96  2.7 e6  -8.91  -13.2  -4.3 
Table 4.4 – Comparison of ITC titration results for compounds 23
[30] and 125 with TEA chloride in 
dry solvents at 303 K. In all cases the host is titrated into a solution of the guest. 
  The comparison (tbl. 4.4) also shows that the enthalpy of the complexation with 
125 is substantially more negative than that with 23 as is expected from the participation of 
an extra triazole CH···Cl
- hydrogen bond. This improved stickiness of 125 over 23 is also 
complemented  by  a  depletion  of  the  entropy  component  resulting  in  an  outcome  that 
improves affinity due to the triazole strap by an order of magnitude.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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4.2.4  Membrane Transport Studies 
  Gale and co-workers have previously shown that meso-octamethylcalix[4]pyrrole 
23 functions as a CsCl co-transporter across lipid bilayer membranes.
[34] In fact much of 
the research in our group is geared towards the search for synthetic anion carriers.
[34, 106, 
141] So we decided to test the anion transport properties of ‘clicked’-calix[4]pyrrole 125. 
4.2.4.1 Introduction to Membrane Transport 
  It has already been mentioned (Chapter 1) that cystic fibrosis is caused by the 
malfunction of the CFTR chloride channel in lung epithelia. However, there are many 
other diseases that have been associated with anion channel malfunction including, Best 
disease,  Startle  disease  and  Angelman  syndrome.
[142]  So  there  is  a  great  need  for 
therapeutic agents that can provide an alternative transport system to the malfunctioning 
anion channels.  
There  are  two  strategies  of  research  at  present;  i)  is  to  develop  artificial  anion 
carriers to transport anions across membranes and ii) is to create synthetic anion channels 
to mediate anion transport. The latter will not be detailed here but progress towards both 
strategies has recently been reviewed by Smith and co-workers.
[142] 
There are a range of different methods to detect and quantify anion transport and 
they generally fall into two categories: 
a)  Methods  employing  vesicle  suspensions  in  which  transport  in  and  out  of  the 
vesicles is examined. This is a ‘bulk method’ whereby macroscopic quantities of 
ions are transported across large areas of membrane (typically ~1 m
2).
[142] 
b)  Conductance measurements on patches of synthetic or natural membranes, whole 
cells or sheets of tissue. This is a highly sensitive method which uses very small 
patches of membrane (~10
-8 m
2).
[142] 
Vesicle methods are the most easily accessible methods to utilise in a chemical 
laboratory and so have been employed by our group. They are also the most suitable for 
studying charge neutral transport processes such as M
+X
- or H
+X
- cotransport (known as 
symport) or X
-/Y
- anion exchange (known as antiport).
[142] Both  mechanisms are depicted 
in Figure 4.12.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Figure 4.12 – Pictorial representation of symport and antiport mechanisms operating across the lipid 
bilayer of vesicles in a typical chloride/nitrate system where M is a group 1 metal. 
Most vesicle methods employ unilamellar vesicles and, for our studies they are 
extruded through a nanoporous filter to a size of 200 nm. In a typical experiment the initial 
solution contains the components to be trapped inside the vesicles, such as NaCl or CsCl 
etc. The remaining material outside the vesicle is removed and replaced by a different salt, 
such as NaNO3 or Na2SO4 by dialysis. This sets up a concentration gradient across the 
membrane that can be released by anion transporters. So far, two techniques have been 
developed to measure the transport of anions across the lipid bilayer: 
i)  By the use of dyes that respond to the appearance or disappearance of anions. The 
most common dye methods are; the pH sensitive pyranine dye, the fluorescing 
lucigenin dye and the electro-sensitive safranin O dye. 
ii)  By commercially available, specialist ion-selective electrodes. 
We have so far employed the second method by  means of  a chloride selective 
electrode,  capable  of  detecting  chloride  anions  released  by  a  transporter  but  not  those 
encapsulated in the vesicles.
[143] This method is the most direct and its only drawback is 
that  kinetic  experiments  are  limited  due  to  the  relatively  slow  response  time  of  the 
electrode. 
   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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4.2.4.2 Results 
  Gale and co-workers used the chloride electrode method to measure the membrane 
transport  properties  of  compound  23.
[34]  Similar  membrane  transport  studies  with 
‘clicked’-calix[4]pyrrole 125 were  conducted by  Dr. Christine Tong from our research 
group and compared to the results with 23. 
In the first instance, separate samples of unilamellar POPC vesicles loaded with 
CsCl, RbCl, KCl and NaCl were prepared and suspended in an external NaNO3 solution. A 
sample  of  either  calixpyrrole  125  or  23  (4%  carrier  to  lipid)  was  added  as  a  DMSO 
solution and the resultant Cl
- efflux monitored using a chloride selective electrode. After 
five minutes the vesicles were lysed by addition of detergent and the final reading of the 
electrode used to calibrate the 100% release of chloride. 
  The  results  (fig.  4.13)  show  that  calixpyrrole  125,  in  contrast  to  the  parent 
calixpyrrole 23, is capable of transporting chloride from sodium, potassium and rubidium 
chloride containing vesicles with fastest release of the larger group 1 metal cation salts. It 
is also evident that the release of chloride from the caesium salt with 125 is slightly faster 
than the release with 23.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Figure 4.13 - Chloride efflux promoted by 23 (open symbols) and 125 (closed symbols), at 0.04 molar 
equivalents of carrier to lipid, across unilamellar POPC vesicles loaded with 489 mM MCl (M = Na, K, 
Cs, Rb) buffered to pH 7.2 with 5 mM phosphate. The vesicles were dispersed in 489 mM NaNO3 
buffered to pH 7.2 with 5 mM phosphate. 
The influence of the composition of the external media on the transport activity 
shown  by  125  was  also  investigated.  For  this  purpose  group  1  metal  chloride  loaded 
vesicles were suspended in a Na2SO4 buffer. The results (fig. 4.14) show that transport 
activity  is  essentially  maintained  although  there  is  an  increasing  difference  in  the 
efficiency of transport as the metal ion size decreases. Sulfate is an extremely hydrophilic 
anion and it is not normally possible to extract this anion from an aqueous phase into a 
lipid bilayer membrane. In the case of the release of chloride mediated by compound 125 
from caesium chloride containing vesicles, there is little difference between the rate of 
chloride release as the exterior anion is changed from nitrate to sulfate. However, as the 
cation size decreases there is an increasing difference in rate of release with, in the case of 
potassium and sodium, a considerably faster release of chloride from vesicles suspended in 
nitrate solution compared to those suspended in sulfate solution. This would suggest that 
both ion-pair co-transport and chloride/nitrate antiport mechanisms are responsible for the 
release of chloride. As the cation size decreases, the transport mechanism changes from a 
□  23 Na 
   23 Cs 
■  125 Na 
●  125 K 
▲  125 Cs 
♦  125 Rb 
   Chapter 4 – Triazoles in Anion Receptor Chemistry 
 
128 
 
predominantly  ion-pair  transport  mechanism  in  the  case  of  caesium  chloride  to  a 
predominanty  chloride/nitrate  antiport  process  in  the  cases  of  sodium  and  potassium. 
Therefore the mechanism of transport responsible for chloride efflux with RbCl loaded 
vesicles is unclear. 
 
Figure 4.14 – Chloride efflux promoted by 125 at 0.04 molar equivalents of carrier to lipid, across 
unilamellar POPC vesicles loaded with 489mM NaCl (□/■), KCl ( /▲), RbCl (◊/♦) and CsCl (○/●) 
buffered to pH 7.2 with 5 mM phosphate dispersed in 489 mM NaNO3 (open symbols) or 167 mM 
Na2SO4 (filled symbols) buffered to pH 7.2 with 5 mM phosphate. 
  In contrast, compound  23 only transports CsCl and when the external solution was 
changed to Na2SO4 the carrier activity was still maintained, which means this compound 
functions solely as a CsCl co-transporter. The CsCl selectivity and symport mechanism 
exhibited by both compounds was thought to be the result of the receptors being able to 
accommodate the caesium cation in the cup formed by the pyrrole rings upon chloride 
complexation. This ion pairing between compound 23 and CsCl has also been observed in 
solution
[144] and the solid state
[31] by Sessler and co-workers. 
  Finally, it was necessary to provide evidence to demonstrate that a mobile carrier 
mechanism  was  operating  rather  than  an  ion  channel  mimic  mechanism.  To  do  this,   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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transport assays were performed using vesicles composed of a 70:30 mixture of POPC and 
cholesterol. The presence of the steroid in the bilayer membrane significantly reduces its 
fluidity  and  so  transport  by  a  carrier  should  be  reduced  with  the  POPC-cholesterol 
vesicles; for transport by an anion channel, chloride efflux should be the same or similar to 
the results with the POPC vesicles.  
 
Figure 4.15 - Chloride efflux promoted by 125, at 0.04 molar equivalents of carrier to lipid, across 
unilamellar vesicles made of POPC (￿ ￿ ￿ ￿) or POPC with 30 mol% of cholestrol (￿ ￿ ￿ ￿) loaded with 489 mM 
NaCl buffered to pH 7.2 with 5 mM phosphate. The vesicles were dispersed in 489 mM NaNO3. 
The results shown in Figure 4.15 clearly indicate a significant reduction of the 
transport activity of 125 when the vesicle bilayer composition includes cholesterol. This 
result confirms the mobile carrier mechanism is operating. The same result was found with 
compound 23.
[34] 
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4.4  ‘Click’ Chemistry and Triptycenes 
4.4.1  Introduction 
  Jeff Davis and his group recently reported the synthesis and membrane transport 
properties of a C3-symmetric triphenoxymethane (TPM) based receptor 132 (fig. 4.16).
[145] 
 
Figure 4.16 – Davis and co-worker’s TPM based receptor for nitrate. 
  Proton-NMR  titrations  with  compound  132  in  CD2Cl2  revealed  formation  of  a 
stronger complex with chloride (as a TBA salt, Ka = 816 M
-1) than with nitrate (as a TBA 
salt, Ka = 326 M
-1). However, membrane transport studies revealed that the compound 
selectively transports nitrate across liposomal membranes in preference to chloride. The 
nitrate transport was effectively achieved by a H
+/NO3
- co-transport process.
[145] 
  It was primarily this C3-symmetric framework (but also others discussed in Chapter 
1)  that  inspired  us  to  consider  the  use  of  the  more  rigid  C3-symmetric  triptycene 
framework  (fig.  4.17)  as  a  scaffold  for  appending  hydrogen-bond  donors  for  anion 
recognition. 
 
Figure 4.17 – Triptycene and the standard numbering of the ring systems. 
  The triptycene framework is similar to TPM, except it has an extra linkage for the 
benzene  rings  which  makes  it  more  rigid  and  thus  allows  the  development  of  anion 
receptors  with  different  binding  properties.  To  the  best  of  the  author’s  knowledge,   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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triptycenes have not been used for anion receptors although they have been exploited for 
other  supramolecular  endeavours  such  as  in  molecular  tweezers
[146],  rotaxanes
[147]  and 
motors.
[148] 
  Our specific goal was to synthesis triptycenes that were substituted at the 1-, 8- and 
13-positions  (syn-triptycenes)  as  supposed  to  the  undesired  1,8,16-substituted  anti-
triptycenes. Rogers and Averill published an extensive paper on the synthesis of these 
triptycenes
[149]  of  which  the  most  interesting  version  was  the  1,8,13-
tris(methoxycarbonyl)triptycene  133  (sch.  4.3).  From  this,  the  synthesis  of  ‘clicked’-
triptycene 136 was envisaged. 
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Scheme 4.3 - Proposed synthesis of ‘clicked’-triptycene 136. 
  It was proposed that if compound 136 did not function well as an anion receptor 
then  it  could  easily  be  converted  into  the  tris-triazolium  version  by  treatment  with 
methyliodide.
[131] It was also possible that intermediate 133 could be used to synthesise a 
tris-amide based anion receptor. 
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4.4.2  Synthesis 
  The  synthesis  for  this  section  was  carried  out  with  assistance  from  an 
undergraduate project student (Becky Leithall). In general, the synthesis of triptycenes is 
achieved  by  an  interesting  type  of  Diels-Alder  cycloaddition  between  corresponding 
benzyne and anthracene precursors (fig. 4.18). 
 
Figure 4.18 – Synthesis of triptycenes. 
  Just as with standard Diels-Alder reactions, the ability of the reaction to proceed or 
the ratio of isomers (syn:anti) obtained, is greatly affected by the nature of the R groups on 
the precursors. 
  For the synthesis of intermediate 133, the anthracene precursor was first prepared 
via literature procedures (sch. 4.4).
[149, 150] The benzyne for the reaction is generated in-situ 
from the corresponding amino acid and amyl nitrite.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Scheme 4.4 – Synthesis of anthracene precursor. 
  The amino acid 144 was also synthesised according to Rogers and Averill (sch. 
4.5).
[149]  However,  given  the  complexity  of  the  synthesis  of  144  and  its  instability, 
exploratory reactions were done with the model compound anthranillic acid (sch. 4.6). 
 
Scheme 4.5 – Synthesis of the amino acid for generation of the benzyne.
[149] 
  The synthesis
[149] (sch. 4.6) of this test compound (145) proved unsuccessful and 
changing the solvent/reaction conditions did not solve the problem. It was later discovered 
that  this  could  have  been  due  to  an  impure  batch  of  the  commercially  available  amyl 
nitrite.    Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Scheme 4.6 – Attempted synthesis of test compound 145. 
  Success was achieved by changing to a more recent procedure
[147] which involved 
isolating the reactive diazonium salt (146);
[151] in older procedures
[149, 152] the diazonium 
salt (146) is generated in-situ (sch. 4.7). 
 
Scheme 4.7 – Synthesis of test compound 145. 
  Isolating this intermediate salt and purifying it for the next step resulted in a good 
yield for the reaction (82%), so this method was extended to the synthesis of 133 by first 
preparing the diazonium salt of 138 (sch. 4.8). 
 
Scheme 4.8 – Synthesis of the diazonium salt of 144. 
  Subsequent reaction with the anthracene 141 only proceeded in 15% overall yield 
and resulted in both the syn- and anti- products with the undesired anti-product as the   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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major isomer. These isomers were difficult to separate by column chromatography as they 
had similar Rf values. The low yield and preference for the anti-isomer was thought due 
the steric hinderance of the cycloaddition by the bulky ester groups. Nonetheless, syn-133 
and anti-133 were isolated in 3 and 12% yields respectively and both recrystallised from 
DCM:ethyl acetate (1:1 v/v). 
         
Figure 4.19 – X-ray crystal structures of syn-133 (left) and anti-133. 
  The structures (fig. 4.19) reveal the rigid triptycene framework with two of the 
carbonyl  groups  on  each  triptycene  hydrogen  bonding  to  the  central  CH.  From  these 
structures, we reasoned that if amide groups were appended, they would preorganise in the 
same way (in solution and the solid state) and not form a desired cavity for binding anions. 
However, the tris-triazole version (136) would not have this problem so proceeding with 
the  synthesis;  the  next  step  was  to  reduce  the  tris-ester  to  the  tris-alcohol  (134)  for 
conversion  to  the  tris-azide  (135).  Sodium  borohydride  was  tried  first  but  resulted  in 
incomplete reduction of all three esters so lithium aluminium hydride was found to be the 
reagent of choice. However the reaction only proceeded in moderate yield (45%) which 
limited this synthesis. 
  At this stage it was decided to stop work with triptycenes for the following reasons: 
1.  The synthesis of the anthracene (141) and diazonium (147) intermediates was not 
as straightforward as first perceived.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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2.  The reaction to form the triptycene was too low yielding and the preference for the 
anti-isomer  was  a  major  drawback  in  the  synthesis.  The  synthesis  of  the 
tris(methoxycarbonyl)triptycene was also too low yielding. 
3.  A potential solution was to simply append amide groups to the triptycene. However 
it was reasoned that this would not result in an efficient anion receptor since the 
carbonyl groups would hydrogen bond to the central triptycene CH. With all the 
amide NH groups pointing outwards, a desired cavity for binding anions would not 
be formed (fig. 4.20). 
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Figure 4.20 – Predicted preorganisation by intramolecular hydrogen bonding in a tris-amide 
triptycene. 
4.  In  retrospect,  the  synthesis  of  ‘clicked’-triptycene  136  would  involve  11  steps 
which  was  not  economically  viable  for  the  synthesis  of  an  anion  receptor, 
especially considering the low yields encountered. 
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4.5  Conclusions 
  Building  on  very  recent  investigations  by  other  groups,
[124-128]  this  chapter  has 
documented an innovative exploration into the further application of triazoles in anion 
recognition  chemistry.  Their  ease  of  synthesis  by  Sharpless/Meldal
[121,  122]  ‘click’ 
chemistry,
[119] versatility and interesting properties has made them attractive candidates to 
exploit as hydrogen bond donors for anion binding. 
  In  particular,  we  have  united  ‘click’  chemistry  with  the  already  established 
chemistry  of  ‘strapped’-calix[4]pyrroles.  This  resulted  in  ‘clicked’-calix[4]pyrrole  125 
which functions as a highly efficient chloride transporter in POPC vesicles. We proposed it 
did this by two mechanisms depending on the nature of the counter cation; viz. with larger 
cations such as caesium, a co-transport mechanism operated. Whereas with smaller cations 
such as sodium, a chloride/nitrate antiport mechanism operated. This is in contrast to the 
parent calix[4]pyrrole 23 which functions as caesium chloride co-transporter only. 
  Proton-NMR titrations with compound 125 in acetonitrile-d3 with a selection of 
anions revealed that, in addition to the pyrrole NH groups, the triazole CH was involved in 
hydrogen bonding to the guest anion in all cases. 
  Isothermal  calorimetry  titrations  with  125  in  acetonitrile  revealed  that  the 
compound had an affinity for chloride that was a degree of magnitude greater than that of 
the parent calixpyrrole 23. They also showed that compound 125 has a high affinity for 
bicarbonate  which  allows  scope  for  using  this  receptor  as  a  membrane  transporter  for 
bicarbonate and indeed, this should be a feature of future studies with this compound. 
  Other future work with ‘clicked’-calixpyrroles should also include synthesising a 
version with two triazoles in the strap (148) and forming the triazolium version (149) of 
125  (fig.  4.21).  Both  these  receptors  should  have  significantly  enhanced  affinities  and 
selectivities for anions compared to compound 125.   Chapter 4 – Triazoles in Anion Receptor Chemistry 
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Figure 4.21 – Proposed future work with ‘clicked’-calixpyrroles. 
  The potential use of the rigid C3-symmetric triptycene framework for appending 
hydrogen  bond  donor  groups  for  anion  recognition  has  also  been  investigated  in  this 
chapter. With click chemistry in mind, we envisaged synthesising a tris-triazole tripodal 
receptor.  However,  after  preliminary  investigations,  the  synthesis  of  1,8,13-substituted 
triptycenes proved too long, complicated and low yielding to be viable in the design of an 
anion receptor. 
Click chemistry has only had a short period of existence but it is already having a 
diverse  impact  in  many  areas  of  chemistry  and  the  versatility  of  it  can  only  lead  to 
exponential growth in this area. 
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Chapter 5 – Experimental 
Methods 
 
5.1  General 
  Where  necessary  solvents  were  dried  and  purified  prior  to  use.  DCM  and 
acetonitrile  were  distilled  over  calcium  hydride.  Anhydrous  DMF  and  DMA  on 
molecular sieves were purchased from Fluka. Triethylamine was distilled over KOH and 
stored  under  argon  on  KOH  pellets.  Thionyl  chloride  was  distilled  from  10%  (w/w) 
triphenyl  phosphate  and  stored  under  argon.  Commercial  grade  chemicals  were 
purchased  from  either,  Aldrich  Ltd.,  Alfa  Aesar  or  Fluka  and  used  without  further 
purification unless otherwise stated. Reagents prepared in accordance with the literature 
have been referenced accordingly. Trans-dichlorobis(pyridine)platinum(II) was prepared 
by  Roberto  Quesada  according  to  a  literature  procedure
[86]  at  the  University  of 
Southampton.  All syntheses have been carried out under an inert atmosphere of either 
argon or nitrogen. Tetrabutylammonium salts of the anions used for 
1H-NMR titration 
experiments were thoroughly dried overnight on a high vacuum. Pyrrole from Aldrich 
Ltd. was distilled under argon prior to use. 
5.2  Instrumental Methods 
  NMR data were recorded on Bruker AM300, AC300 and DPX400 spectrometers. 
The data were referenced internally using the residual protio-solvent (
1H) or the signals 
of  the  solvent  (
13C)  with  the  chemical  shifts  reported  in  ppm.  Low  resolution  mass 
spectra were recorded on a Micromass Platform II Single Quadrupole spectrometer or a 
Waters ZMD Single Quadrupole mass spectrometer. High resolution mass spectra were 
recorded on a VG 70-250-SE normal geometry double focusing mass spectrometer by the 
mass spectrometry service at the University of Soutampton. Melting points were carried   Chapter 5 – Experimental Methods 
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out  using  an  Electrothermal  9100  melting  point  apparatus.  Elemental  analyses  were 
performed in duplicate by Medac Ltd. 
5.3  Titration Methods 
1H-NMR titrations were carried out by two methods: 
1.  Old Method (used for Chapter 2) 
This involves preparation of 500 µl of a 0.01 M solution of host in an NMR tube 
and 1 ml of a 0.1 M solution of guest. The guest is titrated in suitable aliquots into 
the  host  solution  and  the  NMR  taken  after  each  addition.  This  results  in  an 
increasing  guest  concentration  and  decreasing  host  concentration  in  the  NMR 
tube. The NMR spectra are referenced to residual protio-solvent peaks and the 
shifts of the relevant peaks recorded at each titrant. The data is input into the 
WIN-EQNMR computer program
[69] to solve the association constant(s). 
2.  Updated Method (Other Chapters) 
This  involves  preparation  of  1.5  ml  of  a  0.01  M  solution  of  host.  From  this 
solution, 500 µl is added to the NMR tube. The rest of the solution (1 ml) is used 
to make a 0.15 M solution of guest. The host/guest solution is titrated in suitable 
aliquots into the host solution and the NMR taken after each addition. This results 
in a constant host concentration with increasing guest concentration in the NMR 
tube. The NMR spectra are referenced to residual protio-solvent peaks and the 
shifts of the relevant peaks recorded at each titrant. The data is input into the 
WIN-EQNMR computer program
[69] to solve the association constant(s). 
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5.4  Synthetic Procedures 
5.4.1  From Synthetic Schemes in Chapter 2 
3-(n-Butylureamethyl)pyridine (60): 3-(Aminomethyl)pyridine (1 ml, 9.25 mmol) was 
dissolved in degassed chloroform (~30 ml) under N2. n-Butylisocyanate (2 ml, 19.54 
mmol) was added and the solution stirred for ~2 days. The solvent was then evaporated 
and the crude product washed with hexanes to give a fine white powder (1.71 g, 89%). 
M.p. 140-144 
oC. 
1H-NMR (300 MHz, CDCl3) δ0.84 (t, 3H), δ1.27 (m, 2H), δ1.39 (m, 
2H), δ3.09 (br q, 2H), δ4.33 (d, 2H), δ4.52 (br t, 1H), δ4.88 (br t, 1H), δ7.17 (dd, 1H), 
δ7.59 (d, 1H), δ8.41 (dd, 1H), δ8.45 (d, 1H). 
13C{
1H}-NMR (75 MHz, CDCl3) δ13.7 
(CH3), δ20.0 (CH2), δ32.3 (CH2), δ40.1 (CH2), δ41.6 (CH2), δ123.6 (CH), δ135.4 (CH), 
δ135.6 (C),  δ148.2 (CH), δ148.5 (CH),  δ158.7 (C).  LR-MS (ESI-) m/z Calcd: 207.2 
Found:  206.3  (M-H)
+.  Anal.  Calcd.  for  “C11H17N3O”:  C=63.7%,  H=8.9%,  N=20.3%  
Found: C=63.6%, H=8.4%, N=19.9%. IR (cm
-1) 3323, 2951, 2928, 1626, 1558, 1251. 
 
[Tetrakis(3-(n-butylureamethyl)pyridine)platinum(II)]  ditetrafluoroborate  (59): 
Pt(EtCN)2Cl2
[70]  (0.1  g,  0.27  mmol)  was  refluxed  with  compound  60  (0.224  g,  1.08 
mmol) and AgBF4 (0.116 g, 0.594 mmol) in acetonitrile (~30 ml) for 24 hrs at 100 
oC in 
darkness.  The  resulting  mixture  was  filtered  through  a  glass  fibre  filter  pad  and  the 
solvent  slowly  evaporated  off  to  leave  a  partly  crystalline  grey  powder  (114.53  mg, 
35%). M.p. decomp. ~256 
oC. 
1H-NMR (300 MHz, DMSO-d6) δ0.86 (t, J1=J27.32, 3H, 
CH3), δ1.28 (m, 4H, 2xCH2), δ2.97 (m, 2H, CH2), δ4.21 (d, J5.5, 2H, CH2), δ6.10 (t, 
J1=J25.5, 1H, NH), δ6.42 (t, J1=J25.5, 1H, NH), δ7.57 (dd, J1=J25.5, 1H, pyridine CH), 
δ7.84 (d, J8.0, 1H, pyridine CH), δ8.94 (d, J5.1, 1H, α-pyridine CH), δ9.06 (s, 1H, α-
pyridine  CH). 
13C{
1H}-NMR  (75  MHz,  DMSO-d6)  δ13.6  (CH3),  δ19.5  (CH2),  δ32.0 
(CH2), δ39.1 (CH2), δ40.3 (CH2), δ126.9 (CH), δ139.5 (CH), δ140.9 (C), δ149.7 (CH),   Chapter 5 – Experimental Methods 
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δ150.6 (CH), δ158.0 (C). LR-MS (ESI+) m/z Calcd: 1197.79 Found: 511.9 (M-2BF4)
2+. 
Anal. Calcd. for “PtC44H68N12O4B2F8”: C=44.1%, H=5.7%, N=14.0% Found: C=44.8%, 
H=5.9%, N=13.9%. IR (cm
-1) 3381, 1661, 1633, 1545, 1434, 1325, 1048. 
N-(Isoquinolin-8-yl)-pyrrole-2-carboxamide  (65):  Pyrrole-2-carboxylic  acid  (1.1  g, 
9.91 mmol) was dissolved in thionyl chloride (~50 ml) and refluxed at 90 
oC for ~3 hrs 
until no further gas evolved from the reaction. The thionyl chloride was removed and the 
crude product re-dissolved in dry DCM (~20 ml) under N2(g). This solution was slowly 
added to a solution of 8-aminoisoquinoline (1 g, 6.94 mmol) and triethylamine (4.14 ml, 
4 eqv.) in dry DCM (~40 ml) and the resulting mixture was then stirred overnight at RT. 
A salt had precipitated which was filtered off. The excess triethylamine was removed by 
washes with 5% NaHCO3(aq) (50 ml) and water (4x50 ml). The DCM solution was dried 
over MgSO4 and the crude product absorbed onto a minimum amount of silica and flash 
columned with ethyl acetate to yield a yellowish sludge. This was slowly columned with 
Hexane:Ethyl acetate (3:7) to yield a pale yellow powder (748.5 mg, 41%). M.p. 184-187 
oC. 
1H-NMR (300 MHz, DMSO-d6) δ6.23 (s, 1H), δ7.01 (s, 1H), δ7.2 (s, 1H), δ7.80 (m, 
4H), δ8.53 (d, 1H), δ9.38 (s, 1H), δ10.18 (s, 1H), δ11.73 (br s, 1H). 
13C{
1H}-NMR (75 
MHz, DMSO-d6) δ109.0 (CH), δ111.9 (CH), δ120.2 (CH), δ122.7 (C), δ123.5 (CH), 
δ123.9 (CH), δ125.6 (CH), δ130.4 (C), δ134.6 (CH), δ135.9 (C), δ142.7 (C), δ148.5 
(CH), δ159.9 (C). LR-MS (ESI-) m/z Calcd: 237.26 Found: 236.2 (M-H)
+. Anal. Calcd. 
for “C14H11N3O”: C=70.9%, H=4.7%, N=17.7% Found: C=70.7%, H=4.7%, N=17.7%. 
IR (cm
-1) 3271, 1668, 1550, 1322, 1277, 1136. 
N-(Pyridin-3-ylmethyl)-pyrrole-2-carboxamide (66): Pyrrole-2-carboxylic acid (1.7 g, 
15.3 mmol) was dissolved in thionyl chloride (~25 ml) and refluxed at 90 
oC for ~3 hrs 
until no further gas evolved from the reaction. The thionyl chloride was removed and the 
crude product re-dissolved in dry DCM (~20 ml) under N2(g). This solution was slowly 
added to a solution of 3-aminomethylpyridine (1.16 g, 10.71 mmol) and triethylamine 
(4.5 ml, 4 eqv.) in dry DCM (~25 ml) and the resulting mixture was then stirred for 3 hrs 
at RT. The triethylamine was removed by washes with 5% NaHCO3(aq) (50 ml) and water 
(4x50 ml). The DCM solution was dried over MgSO4 and the crude product absorbed 
onto a minimum amount of silica and flash columned with ethyl acetate to yield an off-
yellow powder (548 mg, 25%). M.p. 131-134 
oC. 
1H-NMR (300 MHz, DMSO-d6) δ4.50 
(d, 2H), δ6.14 (d, 1H), δ6.86 (s, 1H.), δ6.92 (s, 1H), δ7.40 (dd, 1H), δ7.75 (d, 1H), δ8.51 
(d, 1H), δ8.59 (m, 2H), δ11.50 (br s, 1H). 
13C{
1H}-NMR (75 MHz, DMSO-d6) δ40.4   Chapter 5 – Experimental Methods 
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(CH2), δ108.5 (CH), δ110.0 (CH), δ121.4 (CH), δ123.3 (CH), δ125.8 (C), δ134.9 (CH), 
δ135.3 (C), δ147.9 (CH), δ148.7 (CH), δ160.6 (C). LR-MS (ESI-) m/z Calcd: 201.22 
Found:  200.2  (M-H)
+.  Anal.  Calcd.  for  “C11H11N3O”:  C=65.7%,  H=5.5%,  N=20.9% 
Found: C=65.1%, H=5.5%, N=20.8%. IR (cm
-1) 3317, 1688, 1489, 1312, 1250, 1134. 
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[Tetrakis(N-(isoquinolin-8-yl)-pyrrole-2-carboxamide)platinum(II)] 
ditetrafluoroborate (60): Pt(EtCN)2Cl2
[70] (39.63 mg, 0.11 mmol) was dissolved in dry 
MeNO2 (~10 ml). AgBF4 (45.13 mg, 0.23 mmol) was added under darkness and the 
mixture refluxed for 3 hrs in the dark. The mixture was allowed to cool slightly and 
filtered  through  a  microfibre  filter  while  still  hot.  This  filtrate  was  refluxed  with 
compound 65 (100 mg, 0.42 mmol) for a further 3 hrs. The reaction mixture was again 
filtered  through  a  microfibre  filter  and  allowed  to  cool  before  being  saturated  with 
diethyl ether. This solution was left to stand in the freezer overnight to  yield a pale 
yellow precipitate which was collected by filtration (85 mg, 61%). M.p. decomp. ~228 
oC.
 1H-NMR (300 MHz, DMSO-d6) δ6.32 (m, 1H, pyrrole CH), δ7.17 (m, 2H, β-pyrrole 
CH), δ7.80 (d, J7.3, 1H, isoquin. CH), δ7.88 (d, J8.0, 1H, isoquin. CH), δ7.97 (dd, J17.3/ 
J28.0, 1H, isoquin. CH), δ8.14 (d, J6.5, 1H, isoquin. CH), δ9.13 (d, J6.5, 1H, α-isoquin. 
CH), δ9.83 (s, 1H, α-isoquin. CH), δ10.27 (s, 1H, amide NH), δ11.59 (s, 1H, pyrrole 
NH). 
13C{
1H}-NMR  (75  MHz,  DMSO-d6)  δ109.5  (CH),  δ112.8  (CH),  δ120.3  (CH), 
δ122.7 (C), δ123.3 (CH), δ123.9 (CH), δ124.5 (CH), δ125.2 (C), δ134.2 (CH), δ135.8 
(C),  δ136.2  (C),  δ142.5  (CH),  δ153.4  (CH),  δ159.8  (C).  LR-MS  (ESI+)  m/z  Calcd: 
1317.71  Found:  571.3  (M-2BF4)
2+,  1230.3  (M-BF4)
+.  Anal.  calcd.  for 
“C56H44B2F8N12O4Pt+1MeNO2”:  C=49.7%,  H=3.5%,  N=13.2%  Found:  C=49.8%, 
H=3.3%, N=13.4%. IR (cm
-1) 3285, 1633, 1491, 1397, 1049.   Chapter 5 – Experimental Methods 
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[Tetrakis(N-(pyridin-3-ylmethyl)-pyrrole-2-carboxamide)platinum(II)] 
ditetrafluoroborate (61): Pt(EtCN)2Cl2
[70] (93.47 mg, 0.25 mmol) was dissolved in dry 
MeNO2 (~20 ml). AgBF4 (106.42 mg, 0.55 mmol) was added under darkness and the 
mixture refluxed for 3 hrs in the dark. The mixture was allowed to cool slightly and 
filtered  through  a  microfibre  filter  while  still  hot.  This  filtrate  was  refluxed  with 
compound 66 (200 mg, 0.99 mmol) for a further 3hrs. The reaction mixture was again 
filtered  through  a  microfibre  filter  and  allowed  to  cool  before  being  saturated  with 
diethyl ether. This solution was left to stand in the freezer overnight to yield an off-
yellow precipitate which was collected by filtration, redissolved in the absolute minimum 
amount of MeNO2 and rapidly saturated with diethyl ether again. The precipitate was 
filtered and dried to yield a cream powder (141.6 mg, 48%). M.p. decomp. ~215 
oC.
  1H-
NMR (300 MHz, DMSO-d6) δ4.41 (d, J5.8, 2H), δ6.12 (m, 1H, pyrrole CH), δ6.76 (m, 
1H, β-pyrrole CH), δ6.93 (m, 1H, β-pyrrole CH), δ7.55 (dd, J18.3/ J25.5, 1H, pyridine 
CH), δ7.85 (d, J8.3, 1H, pyridine CH), δ8.55 (t, J1=J25.8, 1H, α-pyridine CH), δ8.91 (d, 
J5.5, 1H, amide NH), δ9.0 (s, 1H, α-pyridine CH), δ11.41 (s, 1H, pyrrole NH). 
13C{
1H}-
NMR  (100  MHz,  DMSO-d6)  δ63.3  (CH2),  δ108.8  (CH),  δ110.5  (CH),  δ122.0  (CH), 
δ125.3 (CH), δ126.9 (C), δ139.6 (CH), δ149.9 (CH), δ160.4 (CH), δ160.9 (CH), δ180.6 
(C).  LR-MS  (ESI+)  m/z  Calcd:  1173.59  Found:  499.5  (M-2BF4)
2+.  Anal.  calcd.  for 
“PtC44H44N12O4B2F8+1MeNO2”:  C=43.8%,  H=3.8%,  N=14.8%  Found:  C=43.6%, 
H=3.9%, N=14.8%. IR (cm
-1) 3256, 1627, 1387, 1042. 
8-(n-butylurea)isoquinoline  (71):
[68]  8-aminoisoquinoline
[71,  72]  (500  mg,  3.47  mmol) 
was dissolved in dry dichloromethane (~20 ml) under N2. n-Butylisocyanate (1.94 ml, 
17.34 mmol) was added and the solution stirred for 5 days. The solution was then filtered 
and  the  product  recovered  by  allowing  slow  n-hexane  diffusion  through  the 
dichloromethane solution. The precipitate was then filtered and dried to leave a fine pale 
yellow powder (458 mg, 58%). 
1H-NMR (300 MHz, DMSO-d6) δ0.93 (t, 3H), δ1.30 (m,   Chapter 5 – Experimental Methods 
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2H), δ1.43 (m, 2H), δ3.18 (q, 2H,), δ6.60 (t, 1H), δ7.53 (d, 1H), δ7.66 (t, 1H), δ7.77 (d, 
1H), δ8.15 (d, 1H), δ8.48 (d, 1H), δ8.87 (s, 1H), δ9.49 (s, 1H). LR-MS (ESI+) m/z 
Calcd: 243.2 Found: 244.2 (M+H)
+, 509.3 (2M+Na)
+, 752.4 (3M+Na)
+, 995.6 (4M+Na)
+. 
Spectra agrees with the literature.
[68] 
N
NH
N
HN
Pt2+
(BF4
 )2
70
O
HN
O
NH
N
N
 
Trans-[bis(8-(n-butylurea)isoquinoline)bispyridineplatinum(II)] ditetrafluoroborate 
(70): Trans-dichlorobis(pyridine)platinum(II)
[86] (106.5 mg, 0.25 mmol) was dissolved in 
nitromethane  (~20  ml)  with  silver  tetrafluoroborate  (107.07  mg,  0.55  mmol).  The 
solution was refluxed in darkness for 2.5 hrs at 111 
oC. The refluxing solution was then 
exposed to light for 0.5 hrs and hot filtered through microfibre paper into a solution of 
compound  71  (114.64  mg,  0.5  mmol)  in  nitromethane  (~20  ml).  The  solution  was 
refluxed for a further 3hrs in the light at 111 
oC. The resulting solution was microfibre 
filtered while hot, reduced to minimum volume, precipitated with diethyl ether and the 
crude  product  collected  by  filtration.  This  was  partially  dissolved  in  acetonitrile  and 
decanted twice, then boiled in diethyl ether/DCM (1:1) overnight and filtered yielding a 
green powder (121 mg, 48 %). M.p. decomp. ~250 
oC. 
1H-NMR (300 MHz, DMSO-d6) 
δ0.95 (t, J17.29/J26.96, 6H, CH3), δ1.40 (m, 4H, CH2), δ1.50 (m, 4H, CH2), δ3.16 (m, 
4H, CH2), δ6.57 (t, J1=J25.49, 2H, NH), δ7.6 (t, J16.6/J27.68, 4H, pyridine CH), δ7.76 (t, 
J18.4/J28.04, 4H, isoquin. CH), δ7.91 (t, J18.04/J27.68, 1H, pyridine CH), δ8.01 (br t, 2H, 
isoquin. CH), δ8.05 (d, J6.75, 2H, isoquin. CH), δ8.79 (d, J6.6, 2H, α-isoquin. CH), 
δ8.88 (s, 2H, NH), δ9.03 (d, J5.13, 4H, α-pyridine CH), δ9.73 (s, 2H, α-isoquin. CH). 
13C{
1H}-NMR  (75  MHz,  DMSO-d6)  δ13.7  (CH3),  δ19.6  (CH2),  δ31.8  (CH2),  δ39.3   Chapter 5 – Experimental Methods 
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(CH2),  δ121.9  (CH),  δ123.5  (CH),  δ124.4  (CH),  δ127.5  (CH),  δ134.7  (CH),  δ136.2 
(CH), δ137.8 (C), δ141.0 (C), δ141.7 (CH), δ151.9 (CH), δ153.8 (CH), δ155.5 (C). LR-
MS (ESI+) m/z Calcd: 1013.5 Found: 420.4 (M-2BF4)
2+, 926.8 (M-BF4)
+. Anal. Calcd. 
for  “C38H44B2F8N8O2Pt+1DCM”:  C=42.6%,  H=4.2%,  N=10.2%  Found:  C=42.7%, 
H=4.1%, N=10.5%. 
5.4.2 From Synthetic Schemes in Chapter 3 
 
2,6-Bis(2-carboxamidobenzimidazolyl)pyridine  (88):  2-Aminobenzimidazole  (1  g, 
7.51 mmol) was dissolved in dry DMA (~50 ml) with DMAP (1 microspatula) and TEA 
(1 ml) and stirred for 15 mins. Meanwhile, 2,6-pyridinedicarbonyldichloride (766.1 mg, 
3.76 mmol) was dissolved in dry DMA  (~50  ml) and slowly  added under N2 to the 
prepared solution and stirred for 3 days. A salt was filtered off and the DMA removed in-
vacuo. The oily residue was triturated with MeOH to precipitate a yellow powder which 
was  filtered,  resuspended  in  MeOH  and  boiled  for  a  few  mins.  The  suspension  was 
cooled slightly, filtered and dried to leave a fine yellow powder (1.21 g, 81%). M.p. 303-
306 
oC. 
1H-NMR (300 MHz, DMSO-d6) δ7.17 (d, J7.89, 4H, benzene CH), δ7.56 (br m, 
4H,  benzene  CH),  δ8.40  (dd,  J17.14/J26.78,  1H,  pyridine  CH),  δ8.50  (d,  J7.53,  2H, 
pyridine CH), δ12.42 (s, 2H, amide NH), δ12.87 (s, 2H, imidazole NH). 
13C-NMR (75 
MHz, DMSO-d6) δ111.8 (CH), δ117.3 (CH), δ121.4 (CH), δ126.4 (CH), δ140.3 (C), 
δ146.2  (C),  δ147.9  (C),  δ162.9  (C).  LR-MS  (ESI+)  m/z  Calcd:  397.4  Found:  398.2 
(M+H)
+. Anal. Calcd. for “C21H15N7O2+H2O”: C=60.72%, H=4.12%, N=23.6%  Found: 
C=60.54%, H=3.89%, N=23.28%. IR (cm
-1) 3342, 3231, 1681, 1628, 1557, 1453, 1417, 
1270. 
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2,6-Bis(benzimidazol-2-yl)isophthalamide (89): 2-Aminobenzimidazole (500 mg, 3.76 
mmol) was dissolved in MeCN (~70 ml) with DMAP (1 microspatula) and TEA (500 µl) 
and heated to 60 
oC to dissolve the amine. Isophthaloyl dichloride (381.2 mg, 1.88 mmol) 
in  MeCN  (~70  ml)  was  slowly  added  under  N2  to  the  prepared  solution  and  stirred 
overnight at 55 
oC. The precipitate was filtered, washed with water (3x30 ml) and diethyl 
ether (2x20 ml) before being dried in-vacuo to leave a pale yellow powder (642 mg, 
86%). M.p. decomp. >340 
oC.
  
1H-NMR (300 MHz, DMSO-d6) δ6.20 (s, 1H, imidazole 
NH), δ6.23 (s, 1H, imidazole NH), δ6.74 (t, J17.32/J26.96, 4H, benzene CH), δ7.07 (t, 
J17.68/J26.57, 4H, benzene CH), δ7.22 (m, 2H, pyridine CH), δ7.80 (t, J17.68/J28.04, 2H, 
pyridine CH), δ8.03 (s, 1H, amide NH), δ8.04 (s, 1H, amide NH), δ8.12 (s, 1H, pyridine 
CH). 
13C-NMR (75 MHz, DMSO-d6) δ112.5 (CH), δ115.9 (CH), δ119.3 (CH), δ124.1 
(CH),  δ128.4  (CH),  δ129.7  (CH),  δ130.8  (C),  δ132.3  (CH),  δ134.8  (C),  δ143.3  (C), 
δ154.4 (C), δ168.3 (C). LR-MS (ESI+) m/z Calcd: 396.4 Found: 397.2 (M+H)
+, 398.3 
(M+2H)
+. HR-MS (ES+) Calcd: 397.1413 (M+H)
+ Found: 397.1406 (M+H)
+. IR (cm
-1) 
3446, 3419, 3082, 1692, 1651, 1461, 1321. 
 
2,6-Bis(2-carboxamido-1-methylbenzimidazolyl)pyridine  (90):  2-Amino-1-
methylbenzimidazole (460 mg, 3.13mmol) was dissolved in dry DMA (~20 ml) with 
TEA  (~600  µl)  and  DMAP  (1  microspatula).  Meanwhile,  2,6-pyridinedicarbonyl 
dichloride (318.81 mg, 1.56 mmol) was dissolved in dry  DMA (~25 ml) and slowly 
added to the amine solution under N2. The resulting solution was stirred at RT for 3 days, 
after which a salt was removed by filtration. The DMA was removed in-vacuo and the 
residue  precipitated  with  methanol  (~70  ml).  The  precipitate  was  filtered  off  and 
recrystallised  twice  from  DMF/MeOH  in  the  freezer  to  leave  fine  off-white  needles   Chapter 5 – Experimental Methods 
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which  were  filtered,  washed  with  MeOH  and  diethyl  ether.  The  crystals  were  then 
suspended in MeOH (100 ml), boiled for 5 mins, cooled slightly and filtered to leave a 
fine white powder (359.6 mg, 54%). M.p. 260-264 
oC. 
1H-NMR (300 MHz, DMSO-d6) 
δ3.74 (s, 6H, imidazole CH3), δ7.28 (m, 4H, benzene CH), δ7.62 (m, 4H, benzene CH), 
δ8.37 (br t, 1H, pyridine CH), δ8.47 (br d, 2H, pyridine CH), δ11.89 (br s, 2H, amide 
NH). 
13C-NMR (75 MHz, DMSO-d6) δ30.3 (CH3), δ110.2 (CH), δ118.6 (CH), δ122.3 
(CH), δ126.2 (CH), δ134.9 (C), δ140.3 (C), δ145.1 (C), δ147.6 (C), δ163.5 (C). LR-MS 
(ESI+)  m/z  Calcd:  425.4  Found:  426.2  (M+H)
+,  448.2  (M+Na)
+.  Anal.  Calcd.  for 
“C23H19N7O2”:  C=64.93%,  H=4.5%,  N=23.03%    Found:  C=64.83%,  H=4.45%, 
N=22.82%. IR (cm
-1) 3232, 1558, 1484, 1379, 1350, 1301, 1258, 1162. 
6-(4-Butylphenylcarbamoyl)-pyridine-2-carboxylic acid  (95): Compound  94
[107] (1.5 
g, 8.28 mmol) was dissolved in thionyl chloride (~80 ml) and refluxed for 2 hrs at 90 
oC. 
The thionyl chloride was removed in-vacuo and the crude material redissolved in dry 
DCM (100 ml). This solution was slowly added to a dry DCM (100 ml) solution of 4-
butylaniline  (1.19  ml,  7.53  mmol),  triethylamine  (1.5  ml)  and  DMAP  (cat.)  under 
nitrogen.  The  resulting  mixture  was  stirred  overnight  at  room  temperature  under 
nitrogen. The solution was washed with a saturated aqueous sodium hydrogencarbonate 
solution (~50 ml), dried over MgSO4, absorbed onto silica and flash columned on silica 
gel eluted with hexanes:ethyl acetate (3:2). This afforded a white powder (2.5 g, 8 mmol) 
which was dissolved in dioxane/25% water (100 ml) with KOH (1 g, 0.018 mol) and 
stirred overnight at room temperature. The solution was reduced to minimum volume, 
taken  up  with  water  and  acidified  with  concentrated  HCl.  This  aqueous  phase  was 
extracted with DCM, dried over MgSO4, precipitated with petroleum ether and filtered to 
leave the title compound as a fine white powder (2.3 g, 97%). M.p. 145-148 
oC. 
1H-NMR 
(300 MHz, DMSO-d6) δ0.90 (t, 3H), δ1.30 (m, 2H), δ1.54 (m, 2H), δ2.58 (t, 2H), δ7.22 
(d, 2H), δ7.70 (d, 2H), δ8.30 (m, 2H), δ8.37 (m, 1H), δ10.78 (s, 1H).
  13C-NMR (100 
MHz, DMSO-d6) δ13.8 (CH3), δ21.7 (CH2), δ33.1 (CH2), δ34.3 (CH2), δ120.7 (CH), 
δ125.8 (CH), δ126.9 (CH), δ128.6 (CH), δ135.6 (C), δ138.4 (C), δ140.2 (CH), δ146.1 
(C), δ149.3 (C), δ161.2 (C), δ164.7 (C). LR-MS (ESI-) m/z Calcd: 298.3 Found: 297.1 
(M-H). HR-MS (ES+)  Calcd: 299.1396 (M+H)
+ Found: 299.1390 (M+H)
+.  IR  (cm
-1) 
3080, 2848, 2541, 1722, 1694, 1428, 1247.   Chapter 5 – Experimental Methods 
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2-(Carboxamidobenzimidazolyl)-6-(4-butylphenylcarbamoyl)pyridine  (91):  2-
Aminobenzimidazole (89.3 mg, 0.67 mmol), EDCI (141.4 mg, 0.74 mmol), compound 
95 (200 mg, 0.67 mmol) and DMAP (cat.) were dissolved in dry pyridine (~50 ml) and 
stirred under nitrogen for 3 days. 
The pyridine was removed in-vacuo and the residue precipitated with DCM/diethyl ether. 
The  precipitate  was  filtered,  washed  with  water  (~100  ml)  followed  by  diethyl  ether 
(~100 ml) and recrystallised by slow evaporation of a methanolic solution of the crude 
compound. This afforded off-white needles (149.6 mg, 54%). M.p. 248-252 
oC. 
1H-NMR 
(300 MHz, DMSO-d6) δ0.92 (br t, 3H, CH3), δ1.34 (m, 2H, CH2), δ1.58 (m, 2H, CH2), 
δ4.07 (m, 2H, CH2), δ7.15 (d, J6.03, 2H, benzene CH), δ7.26 (d, J6.03, 2H, benzene 
CH), δ7.55 (m, 2H, benzene CH), δ7.73 (d, J6.39, 2H, benzene CH), δ8.33 (m, 1H, 
pyridine CH), δ8.45 (m, 2H, pyridine CH), δ11.22 (s, 1H, amide NH), δ12.43 (s, 1H, 
benzimid. amide NH), δ12.52 (s, 1H, imidazole NH). 
13C-NMR (100 MHz, DMSO-d6) 
δ13.8 (CH3), δ21.7 (CH2), δ33.1 (CH2), δ34.3 (CH2), δ121.9 (CH), δ125.7 (CH), δ125.9 
(CH), δ128.5 (CH), δ135.5 (C), δ138.7 (C), δ140.0 (CH), δ146.0 (C), δ147.6 (C), δ149.4 
(C), δ161.5 (C), δ163.0 (C). LR-MS (ESI+) m/z Calcd: 413.5 Found: 414.2 (M+H)
+. 
HR-MS (ES+) Calcd: 414.1930 (M+H)
+ Found: 414.1926 (M+H)
+. IR (cm
-1) 3492, 3356, 
3291, 2927, 1625, 1558, 1454. 
 
N,  N
’-Bis(2-pyridyl)pyridine-2,6-dicarboxamide  (92):  2-Aminopyridine  (706.8  mg, 
7.51  mmol)  was  dissolved  in  dry  DCM  (~25  ml)  with  TEA  (~1  ml)  and  DMAP  (1 
microspatula). Meanwhile, 2,6-pyridinedicarbonyl dichloride (766.1 mg, 3.76 mmol) was 
dissolved in dry DCM (~30 ml) and slowly added to the amine solution under N2. The 
resulting solution was stirred at RT for 3 days and the DCM reduced in-vacuo and the   Chapter 5 – Experimental Methods 
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crude product precipitated with addition of hexanes (~40 ml). The crude product was 
redissolved in the minimum amount of DCM and crystallised by slow evaporation of the 
solvent to leave large white needles of pure title compound (723.2 mg, 60%). 
1H-NMR 
(300 MHz, DMSO-d6) δ7.25 (m, 2H, pyridine CH), δ7.91 (m, 2H, pyridine CH), δ8.31 
(m, 3H, pyridine CH), δ8.41 (d, J8.04, 2H, pyridine CH), δ8.49 (m, 2H, pyridine CH), 
δ11.81  (s,  2H,  amide  NH). 
13C-NMR  (75  MHz,  DMSO-d6)  δ114.8  (2xCH),  δ120.3 
(2xCH), δ125.8 (2xCH), δ138.4 (2xCH), δ139.8 (CH), δ148.0 (2xCH), δ148.9 (2xC), 
δ151.6 (2xC), δ162.7 (2xC). LR-MS (ESI+) m/z Calcd: 319.3 Found: 320.2 (M+H)
+, 
342.1 (M+Na)
+. Agrees with literature.
[108] 
 
2,6-Bis(2-carboxamidobenzimidazolyl)-4-butoxypyridine  (96):  Compound  99  (250 
mg, 1.05 mmol) was refluxed in thionyl chloride (30 ml) for 3 hrs until no further gas 
evolved. The thionyl chloride was removed in-vacuo and the crude residue taken up in 
dry DMA (~40 ml). To this solution was added 2-aminobenzimidazole (278 mg, 2.09 
mmol), triethylamine (0.5 ml) and DMAP (cat.) and the resulting mixture stirred for 3 
days  at  room  temperature  under  argon.  The  solvent  was  reduced  in-vacuo  and 
precipitated with cold methanol. The precipitate was filtered, washed with methanol and 
diethylether and dried to leave the title compound as white powder (415 mg, 84%). M.p. 
320-324 
oC. 
1H-NMR (400 MHz, DMSO-d6) δ0.95 (t, J17.52/J27.04, 3H, CH3), δ1.49 (m, 
2H, CH2), δ1.78 (m, 2H, CH2), δ4.30 (t, J1= J26.52, 2H, CH2), δ7.16 (d, J6.04, 4H, 
benzene CH), δ7.56 (s, 4H, benzene CH), δ7.90 (s, 2H, pyridine CH), δ12.38 (s, 2H, 
amide  NH),  δ12.80  (s,  2H,  imidazole  NH). 
13C-NMR  (100  MHz,  DMSO-d6)  δ13.6 
(CH3), δ18.6 (CH2), δ30.2 (CH2), δ68.6 (CH2), δ111.7 (CH), δ112.1 (4xCH), δ117.2 
(CH),  δ121.4  (4xCH),  δ132.7  (C),  δ140.7  (C),  δ146.1  (2xC),  δ149.9  (2xC),  δ162.7 
(2xC),  δ167.5  (2xC),  δ181.0  (C).  LR-MS  (ESI+)  m/z  Calcd:  469.5  Found:  470.2 
(M+H)
+. HR-MS (ES+) Calcd: 470.1941 (M+H)
+ Found: 470.1936 (M+H)
+. IR (cm
-1) 
3392, 3295, 2956, 1686, 1568, 1451.   Chapter 5 – Experimental Methods 
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2,6-Bis((benzimidazol-2-ylamino)methyl)pyridine  (100):  Compound  102  (507.4  mg, 
3.76  mmol)  and  2-aminobenzimidazole  (1  g,  7.51  mmol)  were  stirred  in 
ethanol/acetonitrile 1:1 (20 ml) overnight at room temperature under argon. The solvent 
was removed in-vacuo and the crude solid thoroughly dried under high vacuum. The 
solid was taken up in absolute ethanol (50 ml) and a mixture of NaBH4 (1.44 g, 38 
mmol) and NaCNBH3 (2.39 g, 38 mmol) was carefully added in portions. The resulting 
solution was left to stir for 48 hrs under argon at room temperature. The solvent was 
removed and the residue taken up in water and basified with aqueous NaHCO3 which 
resulted in a precipitate which was filtered. This precipitate was extracted on the filter 
funnel with hot acetonitrile (150 ml). The solvent was removed and the white sludge 
repeatedly azeotroped with toluene/methanol to precipitate a white powder which was 
filtered and washed with toluene to leave the pure title compound (894.7 mg, 64%). M.p. 
220-224 
oC. 
1H-NMR (300 MHz, DMSO-d6) δ4.61 (d, J5.64, 4H, CH2), δ6.86 (m, 4H, 
benzene CH), δ7.14 (m, 4H, benzene CH), δ7.25 (d, J6.03, 2H, pyridine CH), δ7.69 (t, 
J17.92/J27.17, 1H, pyridine CH), δ10.89 (s, 2H, imdazole NH). 
13C-NMR (100 MHz, 
DMSO-d6) δ47.3 (CH2), δ111.3 (4xCH), δ120.4 (2xCH), δ123.2 (4xCH), δ129.7 (4xC), 
δ138.3  (CH),  δ150.5  (2xC),  δ155.7  (2xC).  LR-MS  (ESI+)  m/z  Calcd:  369.4  Found: 
370.3 (M+H)
+. HR-MS (ES+) Calcd: 370.1780 (M+H)
+ Found: 370.1773 (M+H)
+. IR 
(cm
-1) 3052, 1630, 1567, 1460, 1264. 
2-(2-(2-(4-Amino-3-nitrophenoxy)ethoxy)ethoxy)ethanol  (111):  4-amino-3-
nitrophenol (500 mg, 3.24 mmol), 2-[2-(2-chlorethoxy)-ethoxy]-ethanol (656.4 mg, 3.89 
mmol) and caesium carbonate (1.59 g, 4.87 mmol) were stirred in dry DMF (40 ml) at 80 
oC for 12 hrs under nitrogen. The DMF was removed in-vacuo and the residue extracted 
with  DCM,  absorbed  onto  silica  and  flash  columned  on  silica  gel  eluted  with  ethyl 
acetate to afford the product as a dark orange oil (797.2 mg, 86%). 
1H-NMR (300 MHz, 
DMSO-d6) δ3.42 (m, 8H), δ3.71 (t, 2H), δ4.04 (t, 2H), δ4.56 (t, 1H), δ7.01 (d, 1H), 
δ7.17  (dd,  1H),  δ7.24  (s,  2H),  δ7.39  (d,  1H).
  13C-NMR  (75  MHz,  DMSO-d6)  δ60.2 
(CH2), δ67.8 (CH2), δ68.8 (CH2), δ69.7 (CH2), δ69.9 (CH2), δ72.4 (CH2), δ106.1 (CH),   Chapter 5 – Experimental Methods 
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δ120.7 (CH), δ127.5 (CH). LR-MS (ESI-) m/z Calcd: 286.3 Found: 285.5 (M-H). IR 
(cm
-1) 3220, 3049, 1690, 1544, 1460, 1164. 
4-(2-(2-(2-(Allyloxy)ethoxy)ethoxy)ethoxy)-2-nitrobenzenamine  (112):  Compound 
111 (740 mg, 2.58 mmol), allyl bromide (0.3 ml, 3.36 mmol), sodium hydroxide (144.8 
mg, 3.62 mmol) and TBA
+HSO4
- (15 mg, cat.) were heated in toluene (60 ml) at 80 
oC 
under nitrogen for 1 day. The toluene was removed in-vacuo and the product extracted 
with DCM and flash columned on silica gel eluted with DCM/methanol (2%) to yield the 
product as an orange oil (97 mg, 12%). 
1H-NMR (300 MHz, DMSO-d6) δ3.55 (m, 8H), 
δ3.71 (t, 2H), δ3.92 (d, 2H), δ4.04 (t, 2H), δ5.20 (m, 2H), δ5.90 (m, 1H), δ6.98 (d, 1H), 
δ7.16 (m, 1H), δ7.24 (s, 2H), δ7.38 (d, 1H).
 13C-NMR (100 MHz, CD2Cl2) δ69.1 (CH2), 
δ70.2 (CH2), δ70.3 (CH2), δ71.3 (CH2), δ71.4 (CH2), δ71.5 (CH2), δ72.8 (CH2), δ108.2 
(CH), δ117.1 (CH2), δ120.9 (CH), δ127.7 (CH), δ132.2 (C), δ135.8 (CH), δ140.9 (C), 
δ150.6 (C). IR (cm
-1) 3220, 2964, 1630, 1576, 1454, 1238. 
Carbonyl  diisocyanate  (116):  This  was  prepared  according  to  a  modified  literature 
procedure
[116] as follows; under an inert atmosphere, trichloroisocyanuric acid (3.67 g, 
0.016  mmol)  and  N-chlorocarbonyl  isocyanate  (5  g,  0.05  mol)  were  introduced 
consecutively to a micro-distillation setup with a 2-neck receiving flask at 0 
oC. The 
reaction was warmed with stirring to 50 
oC for 1 hr during which time Cl2 gas was 
liberated which was periodically evacuated with N2 gas. The temperature was gradually 
raised to 90 
oC for 1 hr and then 130 
oC to begin distillation of the product which was 
eventually completed with the aid of a vacuum. This yielded an off-white oil which was 
stored under nitrogen on dry ice and used in the next step as soon as possible without 
purification or analysis. 
Carbonylbis(carbamoylchloride)  (117):  This  was  prepared  according  to  a  modified 
literature  procedure
[115]  as  follows;  crude  carbonyl  diisocyanate  was  taken  up  in  dry 
DCM (40 ml) and cooled to -88 
oC. Dry HCl gas was bubbled through this solution for 2 
hrs and then left to stir for a further 4 hrs at -88 
oC. This resulted in a white precipitate 
which was kept suspended in the DCM under nitrogen on dry ice ready for use in the 
next step without purification or analysis. 
Spirobarbiturate (103): The DCM solution of 117 was slowly allowed to reach -2 
oC 
during which time the  DCM and any  residual  HCl gas were removed  in-vacuo. The 
resulting white precipitate was then dissolved in dry THF (50 ml) at -2 
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Meanwhile barbituric acid (6.07 g, 0.047 mol) was partially dissolved in dry THF (125 
ml) under nitrogen and cooled to -88 
oC. To this slurry was added drop-wise, a solution 
of 
tbutyl-lithium (2.5 M solution in hexanes, 37.6 ml, 0.094 mol) in dry THF (~25 ml). 
This resulted in a slurry which was slowly allowed to reach -2 
oC. The THF solution of 
117 was slowly introduced to the slurry via cannula and the resulting slurry allowed to 
reach room temperature before being stirred overnight. 
The  slurry  was  quenched  with  water  (~70  ml)  which  resulted  in  two  phases  with  a 
precipitate  which  was  filtered  and  washed  with  copious  THF,  water  and  DCM.  The 
precipitate was purified by suspension in DMF and refluxing for a few hours, followed 
by hot filtration of the precipitate. This process was repeated except with a DMF/THF 
solution (75/25 ml) followed by drying in-vacuo to leave a yellow powder (410 mg, 4% 
overall yield). Mp. decomp. >350 
oC. 
1H-NMR (300 MHz, DMSO-d6) δ10.09 (s, 4H). 
13C-NMR (75 MHz, DMSO-d6) δ84.3 (C), δ149.9 (C), δ166.7 (C). LR-MS (ESI+) m/z 
Calcd: 240.1 Found: 241.4 (M+H)
+. IR (cm
-1) 3041, 1685, 1567, 1382. 
5.4.3  From Synthetic Schemes in Chapter 4 
7-Bromoheptan-2-one (127):- To a solution of 1-methylcyclohexanol (6.85 g, 0.06 mol) 
in chloroform (200 ml) was added potassium carbonate (49.75 g, 0.36 mol). The reaction 
mixture was stirred at 0 
oC for 10 min and bromine (47.93 g, 0.3 mol) was then added. 
After  stirring  at  0 
oC  for  5  hrs  the  reaction  was  quenched  with  a  saturated  aqueous 
sodium thiosulfate solution and filtered. The organic layer was separated, washed with 
water, dried over sodium sulfate and concentrated in-vacuo. The concentrate was filtered 
through a short plug of silica, eluted with ethyl acetate which was then reduced in-vacuo 
to leave an off yellow oil. 
1H-NMR (CDCl3, 300 MHz) δ1.42 (m, 2H), δ1.56 (m, 2H), 
δ1.83 (m, 2H), δ2.10 (s, 3H), δ2.42 (t, 2H), δ3.35 (t, 2H). Agrees with literature.
[138] 
2-(5-Bromopentyl)-2-methyl-1,3-dioxolane (128):- Compound 127 (7.5 g, 0.04 mol), 
ethylene glycol (4.35 g, 0.07 mol) and para-toluenesulfonic acid (900 mg, cat.) were 
refluxed  in  benzene  (~200  ml)  with  azeotropic  water  removal  by  a  Dean-Stark  trap 
overnight. The reaction mixture was cooled and neutralised with a 5% aqueous sodium 
hydrogencarbonate  solution  (50  ml).  The  organic  layer  was  separated,  dried  over 
magnesium sulfate, concentrated in-vacuo and flash columned on silica gel, eluted with 
hexanes:ethyl acetate (4:1). This yielded an off yellow oil (9 g, 99%). 
1H-NMR (CDCl3,   Chapter 5 – Experimental Methods 
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300 MHz) δ1.27 (s, 3H), δ1.39 (m, 4H), δ1.60 (m, 2H), δ1.81 (m, 2H), δ3.37 (t, 2H), 
δ3.89 (m, 4H). Agrees with literature.
[139] 
2-(Hept-6-ynyl)-2-methyl-1,3-dioxolane (129a):- Compound 128 (4 g, 0.017 mol) was 
taken up in dry DMF (~15 ml) and cooled to 0 ˚C under argon. To this solution was 
added a slurry of 18 wt. % sodium acetylide in xylene/light mineral oil (6.8 ml). The 
resulting  slurry  was  allowed  to  reach  room  temperature  and  stirred  overnight.  The 
reaction mixture was diluted with diethyl ether and quenched with water. The organic 
layer was then washed with 1 M HCl, brine and water, dried over sodium sulfate and 
concentrated in-vacuo. The crude material was flash columned on silica gel eluted with 
hexanes:ethyl acetate (4:1) to leave a colourless oil (2.82 g, 92%). 
1H-NMR (CDCl3, 300 
MHz) δ1.18 (s, 3H), δ1.29 (m, 4H), δ1.44 (m, 2H), δ1.52 (m, 2H), δ1.84 (t, 1H), δ2.06 
(m, 2H), δ3.80 (m, 4H).
  13C{
1H}-NMR (CDCl3, 75 MHz) δ19.8 (CH2), δ25.1 (CH2), 
δ25.2 (CH2), δ30.0 (CH2), δ30.4 (CH2), δ40.6 (CH2), δ66.1 (2xCH2), δ69.8 (CH), δ86.0 
(C), δ111.5 (C). LR-MS (CI) m/z Calcd: 182.3 Found: 183.2 (M+H)
+. HR-MS (EI+) m/z 
Calcd:  167.1072  (M-CH3)
+  Found:  167.1076  (M-CH3)
+.
  IR  (cm
-1)  3309,  2929,  2865, 
1376, 1252, 1218. 
1,4-Bis(6-(2-methyl-1,3-dioxolan-2-yl)hexyl)-1H-1,2,3-triazole (130):- Compound 128 
(3.8 g, 0.016 mol) and sodium azide (3.12 g, 0.048 mol) were stirred in DMF (15 ml) 
overnight at 60 
oC. The reaction was cooled to room temperature and compound 4 (2.75 
g, 0.015 mol) added in DMF (5 ml). Copper sulfate pentahydrate (400 mg, 10 mol %) 
and sodium ascorbate (634 mg, 20 mol %) were dissolved in water (5 ml) and added to 
the reaction and the resulting mixture stirred overnight at room temperature. Water was 
added and the mixture extracted with ethyl acetate. The organic layer was washed with 
5%  aqueous  sodium  hydrogencarbonate  and  brine,  dried  over  magnesium  sulfate, 
concentrated and columned on silica gel eluted with 2% methanol/DCM. This yielded a 
colourless oil (2.94 g, 50%). 
1H-NMR (CDCl3, 300 MHz) δ1.17 (s, 6H), δ1.30 (m, 8H), 
δ1.56 (m, 6H), δ1.78 (m, 2H), δ2.58 (t, 2H), δ3.78 (m, 8H), δ4.17 (t, 2H), δ7.19 (s, 1H).
 
13C{
1H}-NMR  (CDCl3,  100  MHz)  δ22.7  (CH2),  δ22.9  (2xCH3),  δ23.0  (CH2),  δ24.8 
(CH2), δ25.9 (CH2), δ28.6 (CH2), δ28.7 (CH2), δ29.5 (CH2), δ38.1 (CH2), δ38.3 (CH2), 
δ49.4 (CH2), δ63.8 (4xCH2), δ109.1 (C), δ109.3 (C), δ119.7 (CH), δ147.3 (C). LR-MS 
(ESI+)  m/z  Calcd:  381.5  Found:  382.4  (M+H)
+,  404.4  (M+Na)
+.  HR-MS  (ES+)  m/z 
Calcd:  382.2706  (M+H)
+,  404.2525  (M+Na)
+  Found:  382.2694  (M+H)
+,  404.2515 
(M+Na)
+. IR (cm
-1) 3398, 2936, 2862, 1709, 1360.   Chapter 5 – Experimental Methods 
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1,4-Bis(6,6-di(pyrrol-2-yl)heptyl)-1H-1,2,3-triazole  (131):-  Compound  130  (1.43  g, 
3.74 mmol) was stirred in 10% water/acetone (50 ml) with para-toluenesulfonic acid 
(700 mg, ~1 eqv.) for 20hrs at room temperature. The reaction mixture was concentrated, 
taken up with a little 5% aqueous sodium hydrogencarbonate solution, extracted with 
DCM,  dried  over  sodium  sulfate  and  concentrated  to  leave  an  off-yellow  oil  in 
quantitative yield which was used in the next step without further purification or analysis.  
The oil (1 g, 3.4 mmol) was taken up in pyrrole (9.46 ml, 0.14 mol) and TFA 
(141 µl, 1.67 mmol) was added with stirring. The resulting mixture was then stirred at 60 
oC for 0.5 hrs. The reaction was quenched with 0.1 M NaOH and the solution extracted 
with DCM and dried over sodium sulfate. The crude material was gradient columned on 
silica  gel,  starting  with  hexanes:ethyl  acetate  (4:1)  to  remove  pyrrole  and  two  by-
products and increasing to hexanes:ethyl acetate (1:1) to remove the product as an off-
white foam (812 mg, 45%). 
1H-NMR (CDCl3, 300 MHz) δ1.22 (m, 8H), δ1.55 (s, 6H), 
δ1.62 (m, 2H), δ1.82 (m, 2H), δ1.92 (m, 4H), δ2.64 (t, 2H), δ4.22 (t, 2H), δ6.04 (s, 4H), 
δ6.11 (s, 4H), δ6.57 (s, 4H), δ7.17 (s, 1H), δ7.74 (s, 2H), δ7.78 (s, 2H). 
13C{
1H}-NMR 
(CD2Cl2, 75 MHz) δ24.2 (CH2), δ24.5 (CH2), δ25.8 (CH2), δ26.2 (CH3), δ27.2 (CH2), 
δ29.7 (CH2), δ29.9 (CH2), δ30.6 (CH2), 39.3 (C), 41.3 (CH2), 50.3 (CH2), 104.7 (CH), 
108.0 (CH), 117.1 (CH), 120.9 (CH), 138.4 (C), 138.6 (C), 148.4 (C). LR-MS (ESI+) 
m/z Calcd: 525.7 Found: 548.6 (M+Na)
+. HR-MS (ES+) m/z Calcd: 548.3478 (M+Na)
+ 
Found: 548.3466 (M+Na)
+. IR (cm
-1) 3304, 2938, 1648, 1554, 1241. 
NH
NH HN
HN
N
N
N
H
 
Clicked-calix[4]pyrrole (125):- Compound 131 (808 mg, 1.54 mmol) was dissolved in 
acetone (150 ml) under argon and BF3.OEt2 (289 µl, 1.5 eqv.) was added. The resulting 
solution was stirred at room temperature for 3 hrs and quenched with 0.1 M NaOH. The 
solution  was  extracted  with  DCM  exhaustively,  dried  over  sodium  sulfate  and  flash 
columned on silica gel eluted with hexanes:ethyl acetate (1:1) to leave a pink oil. This oil 
was triturated with methanol which produced fine white crystals which were collected   Chapter 5 – Experimental Methods 
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and washed with ice-cold methanol to yield the pure title compound (41 mg, 5%). M.p. 
decomp. ~222 
oC. 
1H-NMR (CD3CN, 300 MHz) δ1.05 (m, 5H, CH2), δ1.30 (m, 5H, 
CH2), δ1.36 (s, 6H, 2xCH3), δ1.45 (s, 12H, 4xCH3), δ1.57 (m, 3H, CH2), δ1.76 (m, 3H, 
CH2), δ2.61 (t, J15.28/J24.89, 2H, CH2), δ4.26 (t, J14.53/J24.50, 2H, CH2), δ5.83 (s, 8H, 
β-pyrrole CH), δ7.53 (s, 1H, triazole CH), δ7.95 (s, 4H, pyrrole NH). 
13C{
1H}-NMR 
(CD3CN, 75 MHz) δ24.4 (CH2), δ24.7 (CH2), δ26.1 (CH2), δ26.2 (CH2), δ27.0 (CH2), 
δ28.2 (2xCH3), δ28.8 (CH2), δ30.2 (4xCH3), 30.9 (CH2), 31.6 (CH2), 35.6 (CH2), 41.4 
(2xC), 41.5 (2xC), 50.7 (CH2), 103.9 (4xCH), 105.1 (4xCH), 122.5 (CH), 138.3 (2xC), 
138.4  (2xC),  138.7  (2xC),  138.8  (2xC),  149.1  (C).  LR-MS  (ESI+)  m/z  Calcd:  605.9 
Found:  606.6  (M+H)
+,  628.6  (M+Na)
+.
  HR-MS  (ES+)  m/z  Calcd:  606.4284  (M+H)
+ 
Found: 606.4271 (M+H)
+. IR (cm
-1) 3294, 2935, 1708, 1363. 
1,8-Bis(methoxycarbonyl)triptycene (145): 1,8-Bis(methoxycarbonyl)anthracene (500 
mg,  1.7  mmol)  was  dissolved  in  DCE  (50  mL)  and  benzenediazonium-2-carboxylate 
hydrochloride
[151] (1.4 g, 7.5 mmol) was added. 1,2-Epoxypropane (12 mL) was added to 
the reaction vessel and the resulting solution allowed to reflux overnight. Solvents were 
removed from the brown solution under reduced pressure. The resulting brown oil was 
purified by column chromatography (Silica gel, 100% DCM, Rf: 0.53), to give white 
powder of pure title compound (0.52g, 82%). 
1H-NMR (CDCl3, 300 MHz) δ7.93 (s, 1H), 
δ7.60 (m, 4H), δ7.39 (m, 1H), 7.03 (m, 4H), δ5.50 (s, 1H), δ4.02 (s, 6H). Spectrum 
agrees with literature.
[152] 
1-Methyl-2-hydrogen-3-diazoniumphthalate  hydrochloride  (147):  (14.14  g,  0.063 
mol)  was  dissolved  in  a  minimum  quantity  of  methanol  followed  by  addition  of 
palladium/carbon 10 wt. % (1 g, cat.). The reaction vessel was evacuated and back-filled 
with hydrogen  gas. The reaction mixture was stirred vigorously  at room temperature 
overnight. The Pd/C was removed by filtration and the methanol removed under reduced 
pressure, leaving an off-white oil. This oil was taken up in ethanol and acidified with 
concentrated HCl. Isoamyl nitrite was added slowly at 0 
oC and stirred for 15 min. Ether 
was  added  and  reaction  stirred  for  a  further  15  min.  The  resulting  precipitate  was 
collected by filtration and dried on a high vacuum line (12.55 g, 82%). 
1H-NMR (300 
MHz, MeOD) δ7.40 (d J8.28 1H), δ6.87 (d J7.92 1H) δ6.65 (dt J8.29, 7.90 1H), δ2.38 (s 
3H). 
13C-NMR (100 MHz, MeOD) δ53.6 (CH3), δ118.1 (C), δ118.6 (C), δ121.7 (CH), 
δ122.4 (CH), δ135.6 (CH), δ135.9 (CH), 161.3 (C), 165.9 (C). IR (cm
-1) 3053, 2279, 
1745, 1716, 1290, 1101.   Chapter 5 – Experimental Methods 
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Syn- and anti-tris(methoxycarbonyl)triptycene (133): Compound 141 (2 g, 6.8 mmol) 
was  dissolved  in  DCE  (50  mL)  and  compound  147  (7.3  g,    0.03  mol)  added.  1,2-
epoxypropane  (45  mL)  was  added  to  the  reaction  vessel  and  the  resulting  mixture 
allowed  to  reflux  overnight.  Solvents  were  removed  from  the  brown  solution  under 
reduced pressure. The resulting brown oil was purified and the isomers separated by 
column chromatography (silica gel, ethyl acetate : hexane, 1:4 (v/v), anti-isomer Rf: 0.19, 
syn-isomer  Rf:  0.13).  The  fractions  for  each  isomer  were  each  recrystallised  from 
DCM:ethyl acetate, 1:1 (v/v) to give colourless crystals. Yields: Anti-127 (0.084 g, 3%), 
Syn-127 (0.35 g, 12%). Anti-127: 
1H-NMR (300 MHz, DMSO-d6) δ7.60 (m, 6H), δ7.18 
(m, 3H), δ6.84 (s, 1H), δ5.75 (s, 1H), δ3.97 (s, 6H), δ3.31 (s, 3H). Syn-127: 
1H-NMR 
(300 MHz, DMSO-d6) δ8.12 (s, 1H), δ7.67 (m, 3H), δ7.40 (m, 3H), δ7.14 (m, 3H), δ5.94 
(s, 1H), δ3.94 (s, 9H). LR-MS (ESI+) m/z. Calcd: 428. Found: 451.2 (M + Na
+), 879.4 
(2M + Na
+). Spectra agrees with literature.
[149] 
1,8,13-tris(methanol)triptycene  (134):  1,8,13-tris(methoxycarbonyl)triptycene  (100 
mg, 0.230 mmol) was dissolved in dry THF (10 mL) and slowly injected into a mixture 
of lithium aluminium hydride (26.57 mg, 0.7 mmol) suspended in dry THF under an inert 
atmosphere. The mixture was stirred at room temperature overnight. The reaction was 
quenched by addition of methanol until no more effervescence was observed. A solid 
was filtered from the reaction mixture, and the solvents removed under reduced pressure, 
affording  a  white  solid.  The  solid  was  washed  in  methanol  before  being  boiled  in 
acetonitrile and filtered to give pure title compound (35.6 mg, 45%). M.p. decomp. >300 
oC. 
1H-NMR (400 MHz, DMSO-d6) δ7.33 (d, J6.52, 3H), δ6.95 (m, 6H), δ6.57 (s, 1H), 
δ5.61 (s, 1H), δ5.20 (t, 3H), δ4.80 (d, J4.52, 6H). 
13C-NMR (100 MHz, DMSO-d6) 146.2 
(C), 142.9 (C), 136.5 (C), 124.4 (CH), 124.3 (CH), 122.5 (CH), 61.2 (CH2), 53.0 (CH), 
48.6 (CH). LR-MS (ESI+) m/z. Calcd:  344.4. Found: 367.2 (M + Na)
+. IR (cm
-1) 3236, 
2951, 1732, 1432, 1238. 
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Appendix 1 – X-Ray Crystal Structure Data 
 
The crystal structures reported in Chapters 2, 3 and 4 were solved by the EPSRC National 
Crystallography Service based at the University of Southampton by Dr Mark E. Light. The 
refinement of the structures and the fractional coordinates are reported for the sake of 
completeness and so that the structures can be rendered from this text if necessary. 
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Structures from Chapter 2 
Hydrogen sulfate complex of receptor 59: 
Table 1. Crystal data and structure refinement details. 
 
Identification code   2006sot0749     
Empirical formula   C44H70N12O12PtS2 
  C44H68N12O4Pt
2+ . 2(HSO4)
- 
Formula weight   1218.33 
Temperature   120(2) K 
Wavelength   0.71069 Å 
Crystal system   Monoclinic 
Space group   P21/c  
Unit cell dimensions  a = 16.685(4) Å   
  b = 8.9880(14) Å  β = 92.453(7)° 
  c = 17.319(3) Å   
Volume  2594.9(9) Å
3 
Z  2 
Density (calculated)  1.559 Mg / m
3 
Absorption coefficient  2.855 mm
−1 
F(000)  1248 
Crystal  Slab; Colourless 
Crystal size  0.3 × 0.1 × 0.04 mm
3 
θ range for data collection  3.27 − 25.88° 
Index ranges  −20 ≤ h ≤ 20, −10 ≤ k ≤ 10, −21 ≤ l ≤ 21 
Reflections collected  26222 
Independent reflections  4914 [Rint = 0.1792] 
Completeness to θ = 25.88°  97.8 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.8944 and 0.4713 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  4914 / 172 / 338 
Goodness-of-fit on F
2  0.999 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0739, wR2 = 0.1395 
R indices (all data)  R1 = 0.1927, wR2 = 0.1769 
Largest diff. peak and hole  1.113 and −1.845 e Å
−3 
 
 
Diffractometer:  Nonius  KappaCCD  area  detector  (φ  scans  and  ω  scans  to  fill  asymmetric  unit  ).  Cell  determination:  DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular  Crystallography,  part  A,  pp.  307−326;  C.  W.  Carter,  Jr.  &  R.  M.  Sweet,  Eds.,  Academic  Press).  Absorption 
correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption correction - V2.10 Structure solution: 
SHELXS97  (G.  M.  Sheldrick,  Acta  Cryst.  (1990)  A46  467−473).  Structure  refinement:  SHELXL97  (G.  M.  Sheldrick  (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model. 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3]  and  site  occupancy  factors.  Ueq  is  defined  as  one  third  of  the  trace  of  the 
orthogonalized U
ij tensor. 
 
Atom   x  y  z  Ueq  S.o.f. 
 
Pt1  5000  0  5000  51(1)  1 
C1A  8260(30)  2920(30)  9600(30)  198(14)  0.50 
C2A  8799(17)  1750(40)  9240(20)  149(8)  0.50 
C3A  8351(19)  290(30)  9054(17)  111(8)  0.50 
C4A  7700(20)  490(40)  8400(9)  116(10)  0.50 
C1B  8760(20)  730(50)  9770(30)  198(14)  0.50 
C2B  8668(16)  2020(40)  9180(20)  149(8)  0.50 
C3B  7794(17)  2230(30)  8887(16)  111(8)  0.50 
C4B  7506(19)  940(40)  8356(11)  116(10)  0.50 
C5  7945(7)  −196(16)  7134(8)  65(3)  1 
C6  8171(7)  −873(15)  5790(7)  69(4)  1 
C7  7496(7)  −996(13)  5179(6)  55(3)  1 
C8  7646(7)  −1582(12)  4458(6)  60(3)  1 
C9  7014(7)  −1743(13)  3900(7)  70(4)  1 
C10  6273(6)  −1279(12)  4070(6)  55(3)  1 
C11  6720(7)  −588(12)  5303(7)  55(3)  1 
C12  4273(6)  −2574(12)  4183(6)  50(3)  1 
C13  4468(7)  −2966(13)  5495(7)  58(3)  1 
C14  4122(7)  −4361(14)  5432(8)  62(3)  1 
C15  3824(7)  −4821(13)  4720(8)  63(3)  1 
C16  3908(7)  −3935(12)  4073(7)  57(3)  1 
C17  3633(7)  −4387(14)  3260(7)  72(4)  1 
C18  2174(8)  −4695(13)  3281(9)  80(4)  1 
C19  740(7)  −5258(18)  3157(12)  133(7)  1 
C20  270(11)  −5940(30)  2463(14)  228(13)  1 
C21  450(15)  −5340(30)  1667(16)  214(13)  1 
C22  128(13)  −6500(30)  1086(17)  225(13)  1 
N1  7898(6)  938(12)  7647(6)  82(3)  1 
N2  8024(5)  192(9)  6384(5)  52(2)  1 
N3  6118(5)  −714(10)  4773(5)  53(2)  1 
N4  4555(5)  −2081(10)  4875(5)  53(2)  1 
N5  2915(6)  −5329(9)  3223(6)  67(3)  1 
N6  1560(6)  −5685(13)  3179(9)  117(5)  1 
O1  7923(5)  −1538(9)  7335(4)  73(2)  1 
O2  2084(6)  −3381(9)  3421(6)  101(3)  1 
O3  5601(4)  8636(8)  8033(4)  66(2)  1 
O4  4878(5)  9314(11)  6894(4)  84(3)  1 
O5  6016(4)  7794(8)  6835(4)  64(2)  1 
O6  6158(5)  10237(7)  7172(6)  77(2)  1 
S1  5583(2)  8955(4)  7200(2)  71(1)  1 
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Bromide complex of receptor 70: 
Table 1. Crystal data and structure refinement. 
 
 
Identification code     2007sot1536     
Empirical formula     C38H44Br2N8O2Pt 
Formula weight     999.72 
Temperature       120(2) K 
Wavelength       0.71073 Å 
Crystal system     Monoclinic 
Space group       P21/n  
Unit cell dimensions    a = 14.0597(5) Å  α = 90° 
        b = 9.3584(2) Å  β = 95.3300(10)° 
        c = 14.9751(4) Å  γ  = 90° 
Volume      1961.85(10) Å
3 
Z        2 
Density (calculated)    1.692 Mg / m
3 
Absorption coefficient  5.657 mm
− − − −1 
F(000)       984 
Crystal Blade;      Colourless 
Crystal size      0.16 × 0.05 × 0.01 mm
3 
θ range for data collection  3.02 − 27.48° 
Index ranges      −18 ≤ h ≤ 18, −12 ≤ k ≤ 12, −19 ≤ l ≤ 19 
Reflections collected    20717 
Independent reflections  4480 [Rint = 0.0427] 
Completeness to θ = 27.48°  99.8 %  
Absorption correction   Semi−empirical from equivalents 
Max. and min. transmission  0.9456 and 0.4647 
Refinement method    Full-matrix least-squares on F
2 
Data / restraints / parameters  4480 / 0 / 233 
Goodness-of-fit on F
2   1.115 
Final R indices [F
2 > 2σ(F
2)] R1 = 0.0318, wR2 = 0.0620 
R indices (all data)    R1 = 0.0435, wR2 = 0.0678 
Largest diff. peak and hole  1.770 and −0.798 e Å
− − − −3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit sphere). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular  Crystallography,  part  A,  pp.  307−326;  C.  W.  Carter,  Jr.  &  R.  M.  Sweet,  Eds.,  Academic  Press).  Absorption 
correction: SORTAV (R. H. Blessing, Acta Cryst. A51 (1995) 33−37; R. H. Blessing, J. Appl. Cryst. 30 (1997) 421−426). Structure 
solution: SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3]  and  site  occupancy  factors.  Ueq  is  defined  as  one  third  of  the  trace  of  the 
orthogonalized U
ij tensor. 
 
Atom   x  y  z  Ueq  S.o.f. 
 
Pt1  5000  0  0  17(1)  1 
O1  2492(2)  4345(3)  3183(2)  31(1)  1 
N1  5557(2)  1901(4)  −319(2)  23(1)  1 
N2  3709(2)  961(3)  −65(2)  19(1)  1 
N3  2789(3)  2382(4)  2337(2)  25(1)  1 
N4  3714(3)  2852(4)  3638(2)  35(1)  1 
C1  5864(3)  2829(5)  325(3)  35(1)  1 
C2  6220(4)  4149(6)  110(4)  56(2)  1 
C3  6254(5)  4507(6)  −769(5)  62(2)  1 
C4  5939(4)  3556(5)  −1432(4)  47(1)  1 
C5  5593(3)  2256(5)  −1186(3)  30(1)  1 
C6  3194(3)  1260(4)  −875(3)  23(1)  1 
C7  2390(3)  2061(4)  −910(3)  23(1)  1 
C8  2043(3)  2585(4)  −114(3)  20(1)  1 
C9  1231(3)  3470(4)  −115(3)  26(1)  1 
C10  956(3)  3953(5)  686(3)  27(1)  1 
C11  1444(3)  3588(4)  1508(3)  24(1)  1 
C12  2245(3)  2736(4)  1542(3)  19(1)  1 
C13  2550(3)  2212(4)  715(3)  17(1)  1 
C14  3396(3)  1408(4)  693(3)  17(1)  1 
C15  2969(3)  3280(4)  3068(3)  24(1)  1 
C16  4001(3)  3634(5)  4467(3)  33(1)  1 
C17  3537(4)  3076(6)  5263(3)  37(1)  1 
C18  3959(4)  3733(6)  6145(3)  42(1)  1 
C19  3464(5)  3211(7)  6951(4)  60(2)  1 
Br21  4660(1)  −991(1)  −2469(1)  27(1)  1 
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Sulfate complex of receptor 70 from nitromethane: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2008sot0774 (mgf101SO4)     
Empirical formula   C120H150B2F8N30O26Pt3S2 
3(C38H44N8O2Pt)
2+.6(CH3NO2).2(O4S)
2-
.2(BF4)
- 
Formula weight   3251.71 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Triclinic 
Space group   P−1  
Unit cell dimensions  a = 12.6995(4) Å  α = 76.749(2)° 
  b = 13.8948(4) Å  β = 89.381(2)° 
  c = 20.3426(5) Å  γ  = 73.750(2)° 
Volume  3348.97(16) Å
3 
Z  1  
Density (calculated)  1.612 Mg / m
3 
Absorption coefficient  3.249 mm
− − − −1 
F(000)  1636 
Crystal  Block; Yellow 
Crystal size  0.2 × 0.2 × 0.1 mm
3 
θ range for data collection  3.02 − 25.03° 
Index ranges  −15 ≤ h ≤ 15, −16 ≤ k ≤ 16, −24 ≤ l ≤ 24 
Reflections collected  49439 
Independent reflections  11804 [Rint = 0.0820] 
Completeness to θ = 25.03°  99.8 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.7371 and 0.5527 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  11804 / 506 / 882 
Goodness-of-fit on F
2  1.031 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0439, wR2 = 0.0929 
R indices (all data)  R1 = 0.0747, wR2 = 0.1050 
Largest diff. peak and hole  2.312 and −0.977 e Å
−3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: 
DirAx (Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. 
Hooft,  Nonius  B.V.,  1998).  Data  reduction  and  cell  refinement:  Denzo  (Z.  Otwinowski  &  W.  Minor,  Methods  in 
Enzymology (1997) Vol. 276: Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., 
Academic Press). Absorption correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption 
correction  -  V2.10  Structure  solution:  SHELXS97  (G.  M.  Sheldrick,  Acta  Cryst.  (1990)  A46  467−473).  Structure 
refinement: SHELXL97 (G. M. Sheldrick (1997), University of Göttingen, Germany). Graphics: Cameron - A Molecular 
Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, Chemical Crystallography Laboratory, University of Oxford, 
1993). 
 
Special details:   All hydrogen atoms were identified in the difference map and then  placed in idealised positions and 
refined using a riding model. 
 
 
 
 
 
   Appendix  
 
 
 
Table 2. Atomic coordinates [× 104], equivalent isotropic displacement parameters 
[Å2 × 103] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom   x  y  z  Ueq  S.o.f.  
 
Pt1  1455(1)  1823(1)  3459(1)  24(1)  1 
O1  −4208(3)  3884(3)  1500(2)  38(1)  1 
O2  1722(3)  7374(3)  2891(2)  48(1)  1 
N1  350(3)  1986(3)  4172(2)  29(1)  1 
N2  2623(3)  1626(3)  2772(2)  26(1)  1 
N3  496(3)  1211(3)  2980(2)  24(1)  1 
N4  −2467(4)  3215(3)  2010(2)  35(1)  1 
N5  −3404(4)  4905(3)  1924(2)  33(1)  1 
N6  2305(3)  2533(3)  3916(2)  24(1)  1 
N7  1579(4)  5724(3)  3133(2)  32(1)  1 
N8  740(4)  6883(3)  2168(2)  44(1)  1 
C1  −518(5)  2846(5)  4092(3)  42(2)  1 
C2  −1255(6)  2956(6)  4580(3)  59(2)  1 
C3  −1126(6)  2188(6)  5159(4)  72(2)  1 
C4  −233(7)  1317(6)  5253(4)  74(2)  1 
C5  484(5)  1239(4)  4738(3)  45(2)  1 
C6  3368(4)  706(4)  2845(3)  35(2)  1 
C7  4179(5)  543(4)  2397(3)  39(2)  1 
C8  4228(5)  1330(4)  1865(3)  38(2)  1 
C9  3473(5)  2276(5)  1799(3)  52(2)  1 
C10  2669(5)  2400(4)  2261(3)  38(2)  1 
C11  746(4)  171(4)  3024(3)  29(1)  1 
C12  48(4)  −226(4)  2764(3)  31(1)  1 
C13  −977(4)  407(4)  2430(3)  30(1)  1 
C14  −1756(5)  14(4)  2186(3)  42(2)  1 
C15  −2723(5)  668(4)  1884(3)  45(2)  1 
C16  −2971(5)  1740(4)  1820(3)  36(2)  1 
C17  −2235(4)  2164(4)  2056(3)  30(1)  1 
C18  −1209(4)  1491(4)  2370(2)  23(1)  1 
C19  −432(4)  1829(4)  2669(2)  25(1)  1 
C20  −3426(4)  3998(4)  1790(3)  29(1)  1 
C21  −4246(4)  5874(4)  1631(3)  33(1)  1 
C22  −4153(4)  6250(4)  874(3)  33(1)  1 
C23  −4983(5)  7249(4)  558(2)  32(1)  1 
C24  −4884(5)  7562(4)  −201(3)  40(2)  1 
C25  3047(4)  2054(4)  4452(3)  36(2)  1 
C26  3522(5)  2595(4)  4769(3)  37(2)  1 
C27  3289(4)  3680(4)  4554(3)  33(2)  1 
C28  3759(4)  4281(4)  4868(3)  35(2)  1 
C29  3492(5)  5319(5)  4612(3)  42(2)  1 
C30  2764(4)  5819(4)  4039(3)  37(2)  1 
C31  2281(4)  5276(4)  3715(3)  30(1)  1 
C32  2526(4)  4176(4)  3976(2)  28(1)  1   Appendix  
 
 
 
C33  2070(4)  3545(4)  3700(2)  26(1)  1 
C34  1373(5)  6713(4)  2740(3)  38(2)  1 
C35  498(5)  7836(4)  1647(3)  40(2)  1 
C36  983(5)  7694(4)  988(3)  37(2)  1 
C37  741(5)  8695(4)  440(3)  45(2)  1 
C38  1326(6)  8559(5)  −204(3)  61(2)  1 
Pt2  10000  5000  0  22(1)  1 
O3  6131(3)  8715(3)  1928(2)  46(1)  1 
N9  11403(3)  5216(3)  299(2)  23(1)  1 
N10  9218(3)  6523(3)  −158(2)  26(1)  1 
N11  7425(4)  7705(3)  1379(2)  34(1)  1 
C39  11733(4)  4950(4)  957(3)  29(1)  1 
C40  12716(5)  5014(4)  1183(3)  35(2)  1 
C41  13393(5)  5385(4)  720(3)  40(2)  1 
C42  13036(4)  5716(4)  37(3)  35(2)  1 
C43  12047(4)  5604(4)  −150(2)  25(1)  1 
C44  9232(4)  7163(4)  −772(3)  34(2)  1 
C45  8617(5)  8172(4)  −923(3)  40(2)  1 
C46  7928(4)  8580(4)  −443(3)  32(1)  1 
C47  7222(5)  9593(4)  −594(3)  46(2)  1 
C48  6548(5)  9904(4)  −118(3)  50(2)  1 
C49  6584(5)  9288(4)  537(3)  49(2)  1 
C50  7311(4)  8325(4)  727(3)  33(1)  1 
C51  7965(4)  7923(4)  213(3)  25(1)  1 
C52  8633(4)  6885(4)  311(3)  27(1)  1 
C53  6913(5)  7934(4)  1942(3)  37(2)  1 
N12A  7338(4)  7229(4)  2518(2)  52(2)  0.399(8) 
C54A  6953(12)  7282(15)  3235(10)  59(2)  0.399(8) 
C55A  7723(11)  7799(14)  3499(10)  87(4)  0.399(8) 
C56A  8891(12)  7222(16)  3612(8)  84(4)  0.399(8) 
C57A  9260(20)  6460(20)  4240(11)  146(6)  0.399(8) 
N12B  7338(4)  7229(4)  2518(2)  52(2)  0.601(8) 
C54B  7003(10)  7420(12)  3156(7)  59(2)  0.601(8) 
C55B  7983(11)  7162(10)  3663(7)  87(4)  0.601(8) 
C56B  8701(10)  6117(10)  3860(6)  84(4)  0.601(8) 
C57B  9595(14)  5957(10)  4338(6)  146(6)  0.601(8) 
O8  3249(5)  7905(4)  1665(3)  79(2)  1 
O9  2686(4)  9101(4)  2206(3)  71(2)  1 
N13  3260(5)  8248(5)  2171(3)  57(2)  1 
C58  4035(6)  7618(6)  2738(3)  66(2)  1 
O10  4281(5)  4836(5)  2809(3)  117(3)  1 
O11  4476(6)  3166(6)  2994(4)  129(3)  1 
N14  4748(7)  3953(8)  3055(4)  106(3)  1 
C59  5765(7)  3780(9)  3484(4)  114(4)  1 
O12  7596(6)  1234(7)  3750(3)  127(3)  1 
O13  7757(8)  −369(7)  4048(4)  174(4)  1 
N15  7211(7)  550(8)  3836(4)  113(3)  1 
C60  6054(9)  723(8)  3733(5)  114(4)  1 
F1  7189(4)  1189(5)  5969(3)  143(2)  1 
F2  5456(3)  1276(4)  5939(2)  94(2)  1   Appendix  
 
 
 
F3  6160(3)  2212(3)  5084(2)  78(1)  1 
F4  6609(8)  542(5)  5275(3)  188(3)  1 
B1  6336(6)  1336(6)  5556(4)  45(2)  1 
S1  9432(1)  4787(1)  2147(1)  27(1)  1 
O4  8706(3)  4470(4)  2669(2)  56(1)  1 
O5  9339(3)  4315(3)  1584(2)  44(1)  1 
O6  9089(3)  5919(3)  1910(2)  47(1)  1 
O7  10581(3)  4468(3)  2418(2)  35(1)  1 
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Sulfate complex of 70 from DMSO: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2008sot0775 (mgf101SO4(ii))     
Empirical formula   C38H48N8O8PtS 
Formula weight   971.99 
Temperature   120(2) K 
Wavelength   0.71069 Å 
Crystal system   Triclinic 
Space group   P−1  
Unit cell dimensions  a = 12.0709(11) Å  α = 69.502(6)° 
  b = 12.2392(13) Å  β = 72.956(6)° 
  c = 15.3701(15) Å  γ  = 76.034(7)° 
Volume  2009.0(3) Å
3 
Z  2 
Density (calculated)  1.607 Mg / m
3 
Absorption coefficient  3.605 mm
− − − −1 
F(000)  980 
Crystal  Lath; Pale Green 
Crystal size  0.12 × 0.07 × 0.01 mm
3 
θ range for data collection  2.92 − 25.02° 
Index ranges  −14 ≤ h ≤ 14, −14 ≤ k ≤ 12, −18 ≤ l ≤ 17 
Reflections collected  17653 
Independent reflections  6960 [Rint = 0.0811] 
Completeness to θ = 25.02°  97.9 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9648 and 0.6615 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  6960 / 6 / 522 
Goodness-of-fit on F
2  1.199 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0934, wR2 = 0.1732 
R indices (all data)  R1 = 0.1572, wR2 = 0.2002 
Largest diff. peak and hole  2.042 and −0.991 e Å
− − − −3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: 
DirAx (Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. 
Hooft,  Nonius  B.V.,  1998).  Data  reduction  and  cell  refinement:  Denzo  (Z.  Otwinowski  &  W.  Minor,  Methods  in 
Enzymology (1997) Vol. 276: Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., 
Academic Press). Absorption correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption 
correction  -  V2.10  Structure  solution:  SHELXS97  (G.  M.  Sheldrick,  Acta  Cryst.  (1990)  A46  467−473).  Structure 
refinement: SHELXL97 (G. M. Sheldrick (1997), University of Göttingen, Germany). Graphics: Cameron - A Molecular 
Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, Chemical Crystallography Laboratory, University of Oxford, 
1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model. Except those of 
the water that were included in restrained positions. 
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Table 2. Atomic coordinates [× 104], equivalent isotropic displacement parameters 
[Å2 × 103] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom   x  y  z  Ueq  S.o.f.  
 
Pt1  0  0  0  28(1)  1 
O1  3797(12)  −893(12)  3553(9)  50(3)  1 
N1  −1431(10)  −532(11)  1025(9)  26(3)  1 
N2  216(12)  882(12)  825(10)  36(3)  1 
N3  2945(11)  −474(13)  2294(10)  36(3)  1 
N4  4046(13)  −2250(13)  2813(10)  42(4)  1 
C1  −2516(12)  −42(15)  939(12)  31(4)  1 
C2  −3485(16)  −302(14)  1636(12)  36(4)  1 
C3  −3337(15)  −1188(15)  2492(13)  37(4)  1 
C4  −2226(16)  −1708(18)  2581(13)  50(5)  1 
C5  −1259(16)  −1371(17)  1832(12)  42(5)  1 
C6  −476(15)  1941(15)  862(12)  37(4)  1 
C7  −311(14)  2562(14)  1368(14)  38(4)  1 
C8  611(17)  2190(15)  1850(12)  38(4)  1 
C9  855(17)  2855(18)  2352(13)  45(5)  1 
C10  1747(18)  2426(17)  2770(14)  48(5)  1 
C11  2477(17)  1334(19)  2754(14)  51(5)  1 
C12  2277(15)  630(15)  2321(12)  37(4)  1 
C13  1338(15)  1067(15)  1817(11)  35(4)  1 
C14  1074(13)  442(14)  1304(11)  27(4)  1 
C15  3615(15)  −1198(17)  2932(12)  36(4)  1 
C16  4588(16)  −3222(16)  3501(12)  42(5)  1 
C17  5597(16)  −3987(16)  3046(13)  41(5)  1 
C18  6139(17)  −5058(17)  3709(13)  46(5)  1 
Pt2  5000  5000  0  29(1)  1 
O2  1913(10)  4202(12)  5296(9)  47(3)  1 
N5  3945(12)  4082(12)  −139(10)  33(3)  1 
N6  5178(11)  3819(11)  1275(9)  27(3)  1 
N7  2883(12)  4409(13)  3729(10)  38(4)  1 
N8  1619(13)  5944(14)  4158(10)  45(4)  1 
C19  7200(17)  −5750(20)  3218(18)  68(7)  1 
C20  4339(15)  3045(15)  −306(11)  33(4)  1 
C21  3658(15)  2412(17)  −473(12)  38(4)  1 
C22  2475(17)  2865(17)  −435(12)  42(5)  1 
C23  2027(16)  3906(17)  −213(12)  41(5)  1 
C24  2790(14)  4493(14)  −73(11)  30(4)  1 
C25  6124(15)  2908(14)  1343(12)  36(4)  1 
C26  6259(17)  2155(17)  2211(14)  37(5)  1 
C27  5476(15)  2243(16)  3054(12)  36(4)  1 
C28  5625(16)  1461(15)  3943(12)  35(4)  1 
C29  4824(16)  1632(17)  4736(12)  40(4)  1 
C30  3884(15)  2587(15)  4711(12)  38(4)  1 
C31  3746(14)  3390(15)  3834(12)  34(4)  1   Appendix  
 
 
 
C32  4542(13)  3183(15)  2982(11)  28(4)  1 
C33  4404(14)  3919(14)  2076(12)  32(4)  1 
C34  2081(15)  4840(17)  4451(13)  39(4)  1 
C35  710(20)  6552(19)  4777(14)  60(6)  1 
C36  390(20)  7840(20)  4226(15)  67(7)  1 
C37  −660(20)  8480(20)  4787(16)  69(7)  1 
C38  −970(20)  9750(20)  4190(20)  78(8)  1 
S1  2361(4)  7172(4)  1478(3)  30(1)  1 
O3  2202(11)  6764(11)  741(8)  46(3)  1 
O4  3143(11)  6281(11)  2042(8)  43(3)  1 
O5  1223(11)  7410(12)  2107(9)  44(4)  1 
O6  2903(11)  8253(10)  1027(8)  39(3)  1 
O7  268(13)  4398(14)  7014(9)  58(4)  1 
O8  70(13)  5945(15)  1070(10)  60(4)  1 
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Structures from Chapter 3 
DMSO solvate of compound 88: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2007sot0175 (mgf134(xiii))     
Empirical formula   C23H21N7O3S 
Formula weight   475.53 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Monoclinic 
Space group   P21/n  
Unit cell dimensions  a = 19.3932(4) Å   
  b = 5.87740(10) Å β  = 102.8420(10)° 
  c = 19.4872(4) Å   
Volume  2165.62(7) Å
3 
Z  4 
Density (calculated)  1.458 Mg / m
3 
Absorption coefficient  0.193 mm
−1 
F(000)  992 
Crystal  Slab; Pale Yellow 
Crystal size  0.35 × 0.2 × 0.04 mm
3 
θ range for data collection  3.16 − 27.48° 
Index ranges  −25 ≤ h ≤ 25, −7 ≤ k ≤ 7, −25 ≤ l ≤ 22 
Reflections collected  29058 
Independent reflections  4975 [Rint = 0.0594] 
Completeness to θ = 27.48°  99.8 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9923 and 0.9256 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  4975 / 0 / 326 
Goodness-of-fit on F
2  1.082 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0505, wR2 = 0.1252 
R indices (all data)  R1 = 0.0681, wR2 = 0.1377 
Extinction coefficient  0.030(2) 
Largest diff. peak and hole  0.490 and −0.612 e Å
−3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption correction - V2.10 Structure solution: 
SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model, those of the NH were freely 
refined. 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized U
ij tensor. 
 
Atom   x  y  z  Ueq  S.o.f. 
 
C1  7816(1)  694(3)  4222(1)  21(1)  1 
C2  8451(1)  1610(3)  4121(1)  25(1)  1 
C3  9063(1)  337(4)  4340(1)  28(1)  1 
C4  9050(1)  −1780(4)  4668(1)  29(1)  1 
C5  8430(1)  −2704(3)  4788(1)  26(1)  1 
C6  7816(1)  −1438(3)  4548(1)  23(1)  1 
C7  6741(1)  −23(3)  4230(1)  22(1)  1 
C8  5595(1)  −1466(3)  4335(1)  24(1)  1 
C9  4814(1)  −1028(3)  4129(1)  22(1)  1 
C10  4356(1)  −2452(3)  4389(1)  26(1)  1 
C11  3641(1)  −1977(3)  4214(1)  27(1)  1 
C12  3403(1)  −142(3)  3775(1)  25(1)  1 
C13  3900(1)  1154(3)  3533(1)  20(1)  1 
C14  3658(1)  3156(3)  3058(1)  20(1)  1 
C15  4095(1)  6148(3)  2402(1)  19(1)  1 
C16  3606(1)  9087(3)  1783(1)  20(1)  1 
C17  3184(1)  10842(3)  1445(1)  23(1)  1 
C18  3502(1)  12416(3)  1088(1)  25(1)  1 
C19  4216(1)  12223(3)  1063(1)  25(1)  1 
C20  4634(1)  10471(3)  1400(1)  24(1)  1 
C21  4325(1)  8893(3)  1777(1)  20(1)  1 
C22  6639(1)  2200(4)  2273(1)  30(1)  1 
C23  6406(1)  6259(4)  2805(1)  33(1)  1 
N1  7113(1)  −1846(3)  4554(1)  24(1)  1 
N2  7129(1)  1571(3)  4031(1)  23(1)  1 
N3  6008(1)  84(3)  4096(1)  24(1)  1 
N4  4593(1)  751(3)  3709(1)  21(1)  1 
N5  4180(1)  4234(3)  2828(1)  21(1)  1 
N6  4625(1)  7033(3)  2175(1)  22(1)  1 
N7  3468(1)  7273(3)  2190(1)  20(1)  1 
O1  5835(1)  −3101(2)  4707(1)  32(1)  1 
O2  3031(1)  3732(2)  2904(1)  25(1)  1 
O3  5577(1)  2817(2)  2896(1)  28(1)  1 
S1  5904(1)  3961(1)  2352(1)  21(1)  1 
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DMF/H2O solvate of compound 90: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2007sot0568     
Empirical formula   C49H49.67N15O7.34 
Formula weight   966.06 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Triclinic 
Space group   P−1  
Unit cell dimensions  a = 10.5481(3) Å  α = 87.777(2)° 
  b = 13.6951(4) Å  β = 80.974(2)° 
  c = 16.4507(6) Å  γ  = 77.225(2)° 
Volume  2288.88(13) Å
3 
Z  2 
Density (calculated)  1.402 Mg / m
3 
Absorption coefficient  0.098 mm
−1 
F(000)  1015 
Crystal  Shard; Colourless 
Crystal size  0.3 × 0.2 × 0.2 mm
3 
θ range for data collection  2.91 − 27.48° 
Index ranges  −13 ≤ h ≤ 13, −17 ≤ k ≤ 17, −21 ≤ l ≤ 21 
Reflections collected  50681 
Independent reflections  10471 [Rint = 0.0708] 
Completeness to θ = 27.48°  99.7 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9806 and 0.9611 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  10471 / 36 / 662 
Goodness-of-fit on F
2  1.064 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0970, wR2 = 0.2437 
R indices (all data)  R1 = 0.1353, wR2 = 0.2727 
Extinction coefficient  0.0753(19) 
Largest diff. peak and hole  1.865 and −1.038 e Å
− − − −3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption correction - V2.10 Structure solution: 
SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model, except those of the waters 
which were refined under contraints. 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized U
ij tensor. 
 
Atom   x  y  z  Ueq  S.o.f. 
 
O1  4568(1)  705(1)  1606(1)  30(1)  1 
O2  7420(1)  2719(1)  2136(1)  32(1)  1 
N1  2461(1)  −140(1)  −45(1)  25(1)  1 
N2  3195(1)  −566(1)  1132(1)  24(1)  1 
N3  3741(1)  883(1)  373(1)  24(1)  1 
N4  5678(1)  2317(1)  1218(1)  23(1)  1 
N5  7272(1)  4297(1)  1540(1)  26(1)  1 
N6  8599(1)  4043(1)  2652(1)  30(1)  1 
N7  8161(1)  5528(1)  2068(1)  27(1)  1 
C1  2434(1)  −1237(1)  1000(1)  25(1)  1 
C2  2099(1)  −2033(1)  1469(1)  28(1)  1 
C3  1284(1)  −2552(1)  1163(1)  31(1)  1 
C4  831(1)  −2288(1)  415(1)  32(1)  1 
C5  1163(1)  −1492(1)  −61(1)  31(1)  1 
C6  1960(1)  −965(1)  251(1)  25(1)  1 
C7  2273(1)  377(1)  −827(1)  31(1)  1 
C8  3199(1)  101(1)  499(1)  23(1)  1 
C9  4396(1)  1139(1)  939(1)  24(1)  1 
C10  4936(1)  2064(1)  705(1)  23(1)  1 
C11  4660(1)  2614(1)  −5(1)  25(1)  1 
C12  5126(1)  3480(1)  −159(1)  29(1)  1 
C13  5864(1)  3759(1)  374(1)  27(1)  1 
C14  6148(1)  3148(1)  1047(1)  23(1)  1 
C15  7017(1)  3370(1)  1630(1)  26(1)  1 
C16  7971(1)  4575(1)  2059(1)  26(1)  1 
C17  7654(1)  6342(1)  1529(1)  34(1)  1 
C18  8914(1)  5607(1)  2674(1)  30(1)  1 
C19  9332(1)  6417(1)  2934(1)  38(1)  1 
C20  10095(2)  6240(1)  3562(1)  46(1)  1 
C21  10416(2)  5288(2)  3916(1)  49(1)  1 
C22  9985(1)  4478(1)  3663(1)  41(1)  1 
C23  9215(1)  4662(1)  3032(1)  31(1)  1 
O3  4427(1)  6450(1)  2298(1)  30(1)  1 
O4  6292(1)  8865(1)  3367(1)  31(1)  1 
N8  3324(1)  3764(1)  2518(1)  23(1)  1 
N9  3155(1)  5177(1)  1819(1)  25(1)  1 
N10  4430(1)  4915(1)  2949(1)  23(1)  1 
N11  5718(1)  7002(1)  3442(1)  22(1)  1 
N12  6530(1)  8720(1)  4745(1)  24(1)  1 
N13  6645(1)  10401(1)  4216(1)  23(1)  1 
N14  6737(1)  10058(1)  5530(1)  24(1)  1 
C24  2416(1)  4609(1)  1482(1)  24(1)  1 
C25  1670(1)  4792(1)  843(1)  29(1)  1 
C26  1029(1)  4049(1)  690(1)  32(1)  1   Appendix  
 
 
 
C27  1135(1)  3154(1)  1146(1)  31(1)  1 
C28  1887(1)  2972(1)  1775(1)  27(1)  1 
C29  2528(1)  3716(1)  1929(1)  24(1)  1 
C30  3727(1)  2969(1)  3094(1)  30(1)  1 
C31  3697(1)  4655(1)  2449(1)  22(1)  1 
C32  4749(1)  5823(1)  2838(1)  23(1)  1 
C33  5519(1)  6067(1)  3475(1)  21(1)  1 
C34  5914(1)  5377(1)  4078(1)  24(1)  1 
C35  6525(1)  5674(1)  4685(1)  25(1)  1 
C36  6685(1)  6654(1)  4678(1)  24(1)  1 
C37  6269(1)  7291(1)  4048(1)  21(1)  1 
C38  6371(1)  8376(1)  4016(1)  23(1)  1 
C39  6617(1)  9671(1)  4796(1)  22(1)  1 
C40  6837(1)  11252(1)  4568(1)  23(1)  1 
C41  7004(1)  12169(1)  4229(1)  27(1)  1 
C42  7268(1)  12845(1)  4752(1)  30(1)  1 
C43  7334(1)  12628(1)  5583(1)  29(1)  1 
C44  7138(1)  11717(1)  5927(1)  28(1)  1 
C45  6903(1)  11034(1)  5403(1)  23(1)  1 
C46  6658(1)  9530(1)  6314(1)  30(1)  1 
O5  6490(1)  925(1)  2591(1)  38(1)  1 
O6  4872(1)  8468(1)  2148(1)  38(1)  1 
O8  894(3)  2337(2)  4643(2)  38(1)  0.33 
O7  36(2)  2053(1)  3269(1)  86(1)  1 
N15  −150(2)  462(2)  3072(1)  105(1)  1 
C48  −342(3)  −517(2)  3235(2)  164(1)  1 
C49  −42(2)  1157(3)  3524(2)  112(1)  1 
C47  −82(3)  704(3)  2179(2)  110(1)  1 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Appendix  
 
 
 
Water solvate of compound 91: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2007sot0569 (mgf170)     
Empirical formula   C24H25N5O3 
Formula weight   431.49 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Monoclinic 
Space group   P21/c  
Unit cell dimensions  a = 16.9981(5) Å   
  b = 6.2221(2) Å  β = 103.902(2)° 
  c = 20.6979(6) Å   
Volume  2124.97(11) Å
3 
Z  4 
Density (calculated)  1.349 Mg / m
3 
Absorption coefficient  0.092 mm
−1 
F(000)  912 
Crystal  Needle; Colourless 
Crystal size  0.32 × 0.02 × 0.02 mm
3 
θ range for data collection  3.43 − 27.48° 
Index ranges  −22 ≤ h ≤ 22, −8 ≤ k ≤ 7, −24 ≤ l ≤ 26 
Reflections collected  21026 
Independent reflections  4844 [Rint = 0.0780] 
Completeness to θ = 27.48°  99.5 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9982 and 0.9613 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  4844 / 3 / 299 
Goodness-of-fit on F
2  1.123 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0874, wR2 = 0.1437 
R indices (all data)  R1 = 0.1447, wR2 = 0.1671 
Extinction coefficient  0.0015(4) 
Largest diff. peak and hole  0.355 and −0.309 e Å
−3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption correction - V2.10 Structure solution: 
SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
Special details:  All hydrogen atoms were located in the difference map and then refined using a riding model, except those of the water 
which were freely refined. 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized U
ij tensor. 
 
Atom   x  y  z  Ueq  S.o.f. 
 
C1  −740(2)  6291(7)  1533(2)  47(1)  1 
C2  −375(2)  4066(7)  1570(2)  35(1)  1 
C3  202(2)  3809(6)  1112(2)  29(1)  1 
C4  614(2)  1606(6)  1186(2)  31(1)  1 
C5  1250(2)  1370(6)  787(2)  26(1)  1 
C6  1914(2)  2744(6)  906(2)  27(1)  1 
C7  2518(2)  2577(6)  562(2)  26(1)  1 
C8  2461(2)  993(6)  75(2)  22(1)  1 
C9  1803(2)  −405(6)  −51(2)  29(1)  1 
C10  1208(2)  −204(6)  308(2)  32(1)  1 
C11  3700(2)  1974(6)  −289(2)  20(1)  1 
C12  4312(2)  1136(6)  −649(2)  20(1)  1 
C13  5021(2)  2301(6)  −604(2)  21(1)  1 
C14  5593(2)  1506(6)  −915(2)  22(1)  1 
C15  5433(2)  −387(6)  −1278(2)  22(1)  1 
C16  4702(2)  −1416(5)  −1304(1)  19(1)  1 
C17  4494(2)  −3437(5)  −1699(2)  19(1)  1 
C18  3456(2)  −6238(5)  −1935(1)  19(1)  1 
C19  3275(2)  −9182(5)  −2532(2)  20(1)  1 
C20  3306(2)  −10962(6)  −2933(2)  23(1)  1 
C21  2665(2)  −12398(6)  −3030(2)  25(1)  1 
C22  2017(2)  −12069(6)  −2728(2)  28(1)  1 
C23  1991(2)  −10307(6)  −2325(2)  25(1)  1 
C24  2627(2)  −8844(6)  −2231(2)  22(1)  1 
N1  3064(2)  675(5)  −289(1)  21(1)  1 
N2  4151(2)  −699(4)  −990(1)  19(1)  1 
N3  3804(2)  −4388(4)  −1626(1)  19(1)  1 
N4  3798(2)  −7476(4)  −2333(1)  20(1)  1 
N5  2759(2)  −6951(5)  −1855(1)  21(1)  1 
O1  3817(1)  3733(4)  −13(1)  27(1)  1 
O2  4919(1)  −4145(4)  −2058(1)  23(1)  1 
O3  2578(2)  −3774(4)  −875(1)  29(1)  1 
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Barbital complex of receptor 88: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2007sot0234 (mgf134xiv)     
Empirical formula   C33H39N9O7S2 
Formula weight   737.85 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Triclinic 
Space group   P−1  
Unit cell dimensions  a = 9.9882(4) Å  α = 64.158(2)° 
  b = 14.1537(5) Å  β = 86.751(3)° 
  c = 14.7208(8) Å  γ  = 70.732(3)° 
Volume  1758.73(13) Å
3 
Z  2 
Density (calculated)  1.393 Mg / m
3 
Absorption coefficient  0.213 mm
−1 
F(000)  776 
Crystal  Block; Colourless 
Crystal size  0.4 × 0.12 × 0.07 mm
3 
θ range for data collection  3.08 − 27.48° 
Index ranges  −12 ≤ h ≤ 12, −18 ≤ k ≤ 17, −16 ≤ l ≤ 19 
Reflections collected  20558 
Independent reflections  7607 [Rint = 0.0609] 
Completeness to θ = 27.48°  94.4 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9853 and 0.9297 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  7607 / 0 / 499 
Goodness-of-fit on F
2  1.023 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0561, wR2 = 0.1274 
R indices (all data)  R1 = 0.0976, wR2 = 0.1467 
Largest diff. peak and hole  0.898 and −0.489 e Å
−3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption correction - V2.10 Structure solution: 
SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model, except those of the NH which 
were freely refined. 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized U
ij tensor. 
 
Atom   x  y  z  Ueq  S.o.f. 
 
O1  3534(1)  1411(1)  989(1)  29(1)  1 
O2  10602(1)  −2299(1)  2144(1)  26(1)  1 
N1  2580(1)  2800(1)  −973(1)  22(1)  1 
N2  4222(1)  2612(1)  −2041(1)  22(1)  1 
N3  4937(1)  1428(1)  −292(1)  21(1)  1 
N4  7117(1)  −302(1)  1125(1)  19(1)  1 
N5  9647(1)  −1250(1)  491(1)  21(1)  1 
N6  10896(1)  −1200(1)  −931(1)  21(1)  1 
N7  11984(1)  −2562(1)  579(1)  25(1)  1 
C1  1910(1)  3552(1)  −1937(1)  22(1)  1 
C2  518(1)  4280(1)  −2279(1)  25(1)  1 
C3  204(1)  4905(1)  −3319(1)  27(1)  1 
C4  1228(1)  4801(1)  −3993(1)  28(1)  1 
C5  2608(1)  4055(1)  −3646(1)  26(1)  1 
C6  2943(1)  3425(1)  −2598(1)  22(1)  1 
C7  3935(1)  2271(1)  −1083(1)  20(1)  1 
C8  4684(1)  1036(1)  706(1)  21(1)  1 
C9  5890(1)  118(1)  1458(1)  20(1)  1 
C10  5676(1)  −261(1)  2484(1)  25(1)  1 
C11  6763(1)  −1112(1)  3201(1)  28(1)  1 
C12  8047(1)  −1545(1)  2871(1)  25(1)  1 
C13  8181(1)  −1116(1)  1839(1)  20(1)  1 
C14  9596(1)  −1607(1)  1511(1)  22(1)  1 
C15  10828(1)  −1660(1)  55(1)  20(1)  1 
C16  12194(1)  −1857(1)  −1072(1)  21(1)  1 
C17  12831(1)  −1764(1)  −1963(1)  26(1)  1 
C18  14158(1)  −2547(1)  −1870(1)  28(1)  1 
C19  14832(1)  −3411(1)  −931(1)  29(1)  1 
C20  14206(1)  −3516(1)  −39(1)  29(1)  1 
C21  12885(1)  −2721(1)  −135(1)  23(1)  1 
O3  7505(1)  638(1)  −1245(1)  24(1)  1 
O4  9820(1)  −316(1)  −3600(1)  36(1)  1 
O5  5548(1)  2771(1)  −4501(1)  36(1)  1 
N8  8727(1)  237(1)  −2452(1)  24(1)  1 
N9  6535(1)  1689(1)  −2882(1)  22(1)  1 
C22  7592(1)  850(1)  −2146(1)  20(1)  1 
C23  8872(1)  376(1)  −3432(1)  24(1)  1 
C24  7896(1)  1439(1)  −4274(1)  23(1)  1 
C25  6557(1)  2010(1)  −3907(1)  25(1)  1 
C26  7500(1)  1213(1)  −5136(1)  29(1)  1 
C27  6603(1)  454(1)  −4824(1)  44(1)  1 
C28  8716(1)  2293(1)  −4653(1)  26(1)  1   Appendix  
 
 
 
C29  10081(1)  1959(1)  −5132(1)  34(1)  1 
S1A  3815(1)  4548(1)  3138(1)  27(1)  0.8807(2) 
O6A  2982(1)  5179(1)  2111(1)  29(1)  0.8807(2) 
C30A  3386(1)  5502(1)  3673(1)  33(1)  0.8807(2) 
C31A  5617(1)  4490(1)  2911(1)  33(1)  0.8807(2) 
S1B  3843(1)  5308(1)  2578(1)  27(1)  0.1193(2) 
O6B  3084(2)  4566(2)  2509(2)  29(1)  0.1193(2) 
C30B  3816(3)  5542(2)  3735(2)  33(1)  0.1193(2) 
C31B  5573(3)  4492(2)  3081(2)  33(1)  0.1193(2) 
S2  323(1)  2970(1)  1285(1)  31(1)  1 
O7  493(1)  3359(1)  171(1)  35(1)  1 
C32  −1254(1)  4017(1)  1335(1)  43(1)  1 
C33  1594(1)  3314(1)  1778(1)  54(1)  1 
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Barbital complex of receptor 96: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2008sot0641 (mgf250BARB)     
Empirical formula   C35H41N9O7S 
Formula weight   731.83 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Monoclinic 
Space group   P21/c  
Unit cell dimensions  a = 9.9352(2) Å   
  b = 13.9203(2) Å  β = 91.5240(10)° 
  c = 25.7967(4) Å   
Volume  3566.45(10) Å
3 
Z  4 
Density (calculated)  1.363 Mg / m
3 
Absorption coefficient  0.153 mm
− − − −1 
F(000)  1544 
Crystal  Rod; Colourless 
Crystal size  0.3 × 0.04 × 0.03 mm
3 
θ range for data collection  2.93 − 25.03° 
Index ranges  −9 ≤ h ≤ 11, −16 ≤ k ≤ 16, −30 ≤ l ≤ 30 
Reflections collected  34448 
Independent reflections  6287 [Rint = 0.0685] 
Completeness to θ = 25.03°  99.7 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9954 and 0.9555 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  6287 / 0 / 498 
Goodness-of-fit on F
2  1.072 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0680, wR2 = 0.1210 
R indices (all data)  R1 = 0.0975, wR2 = 0.1366 
Largest diff. peak and hole  0.334 and −0.320 e Å
−3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: 
DirAx (Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. 
Hooft, Nonius B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in 
Enzymology (1997) Vol. 276: Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., 
Academic Press). Absorption correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption 
correction - V2.10 Structure solution: SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure 
refinement: SHELXL97 (G. M. Sheldrick (1997), University of Göttingen, Germany). Graphics: Cameron - A Molecular 
Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, Chemical Crystallography Laboratory, University of Oxford, 
1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model, except for the 
NH’s which were freely refined. 
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Table 2. Atomic coordinates [× 104], equivalent isotropic displacement parameters 
[Å2 × 103] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom   x  y  z  Ueq  S.o.f.  
 
O1  7850(2)  9564(2)  5804(1)  22(1)  1 
O2  4891(2)  9681(2)  3305(1)  28(1)  1 
O3  4033(2)  7764(2)  4876(1)  23(1)  1 
N1  9899(3)  10754(2)  5994(1)  19(1)  1 
N2  10356(3)  11739(2)  5336(1)  20(1)  1 
N3  8660(3)  10565(2)  5186(1)  18(1)  1 
N4  6801(3)  9872(2)  4485(1)  17(1)  1 
N5  6811(3)  10525(2)  3482(1)  19(1)  1 
N6  8169(3)  11237(2)  2845(1)  22(1)  1 
N7  6089(3)  10774(2)  2594(1)  20(1)  1 
C1  11157(3)  11984(2)  5770(1)  20(1)  1 
C2  12071(3)  12741(3)  5830(1)  25(1)  1 
C3  12679(4)  12851(3)  6316(1)  30(1)  1 
C4  12418(3)  12224(3)  6726(1)  27(1)  1 
C5  11517(3)  11470(2)  6670(1)  22(1)  1 
C6  10889(3)  11377(2)  6183(1)  19(1)  1 
C7  9626(3)  11016(2)  5496(1)  18(1)  1 
C8  7813(3)  9870(2)  5355(1)  18(1)  1 
C9  6802(3)  9500(2)  4962(1)  17(1)  1 
C10  5919(3)  8789(2)  5129(1)  17(1)  1 
C11  4964(3)  8442(2)  4774(1)  20(1)  1 
C12  4937(3)  8819(2)  4273(1)  19(1)  1 
C13  5858(3)  9518(2)  4151(1)  17(1)  1 
C14  5796(3)  9911(2)  3610(1)  21(1)  1 
C15  7021(3)  10842(2)  2983(1)  18(1)  1 
C16  7971(3)  11451(2)  2318(1)  21(1)  1 
C17  8814(4)  11890(3)  1968(1)  28(1)  1 
C18  8310(4)  12031(2)  1466(1)  28(1)  1 
C19  7015(4)  11748(2)  1314(1)  24(1)  1 
C20  6176(4)  11308(2)  1659(1)  23(1)  1 
C21  6672(3)  11174(2)  2159(1)  19(1)  1 
C22  3927(4)  7449(2)  5410(1)  23(1)  1 
C23  2754(3)  6755(2)  5424(1)  26(1)  1 
C24  3028(4)  5762(3)  5203(1)  31(1)  1 
C25  3965(4)  5154(3)  5550(2)  39(1)  1 
O4  9080(2)  11380(2)  4132(1)  23(1)  1 
O5  12631(2)  13279(2)  4532(1)  27(1)  1 
O6  10520(3)  13304(2)  2857(1)  33(1)  1 
N8  10762(3)  12422(2)  4340(1)  19(1)  1 
N9  9901(3)  12295(2)  3490(1)  21(1)  1 
C26  11774(3)  13043(2)  4210(1)  21(1)  1 
C27  9874(3)  11999(2)  3997(1)  20(1)  1 
C28  10671(3)  13029(2)  3304(1)  22(1)  1 
C29  10101(4)  14763(3)  4016(1)  31(1)  1   Appendix  
 
 
 
C30  11399(4)  14557(2)  3732(1)  26(1)  1 
C31  11729(3)  13476(2)  3668(1)  22(1)  1 
C32  13116(3)  13366(2)  3422(1)  25(1)  1 
C33  13512(4)  12324(3)  3312(2)  34(1)  1 
S1  2401(1)  9814(1)  2208(1)  33(1)  1 
O7  3488(3)  10566(2)  2245(1)  37(1)  1 
C34  1648(4)  9773(4)  2828(2)  48(1)  1 
C35  3251(5)  8685(3)  2247(2)  54(1)  1 
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DMSO solvate of reaction intermediate for compound 106: 
Table 1. Crystal data and structure refinement. 
   
Identification code   2007sot1162     
Empirical formula   C25H25N9O8S2 
Formula weight   643.66 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Monoclinic 
Space group   P21/n  
Unit cell dimensions  a = 15.6119(5) Å  α = 90° 
  b = 8.1998(2) Å  β = 99.7100(10)° 
  c = 22.5696(7) Å  γ  = 90° 
Volume  2847.84(14) Å
3 
Z  4 
Density (calculated)  1.501 Mg / m
3 
Absorption coefficient  0.253 mm
− − − −1 
F(000)  1336 
Crystal  Needle; Yellow 
Crystal size  0.35 × 0.03 × 0.02 mm
3 
θ range for data collection  2.95 − 27.48° 
Index ranges  −20 ≤ h ≤ 20, −10 ≤ k ≤ 10, −29 ≤ l ≤ 29 
Reflections collected  27933 
Independent reflections  6508 [Rint = 0.0747] 
Completeness to θ = 27.48°  99.5 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9950 and 0.9166 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  6508 / 0 / 401 
Goodness-of-fit on F
2  1.119 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0935, wR2 = 0.1641 
R indices (all data)  R1 = 0.1375, wR2 = 0.1859 
Largest diff. peak and hole  0.907 and −0.487 e Å
− − − −3 
   
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit sphere). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: SORTAV (R. H. Blessing, Acta Cryst. A51 (1995) 33−37; R. H. Blessing, J. Appl. Cryst. 30 (1997) 421−426). Structure 
solution: SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
Special details: All hydrogen atoms were placed in idealised positions and refined using a riding model. 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized U
ij tensor. 
Atom   x  y  z  Ueq  S.o.f. 
 
O1  7086(2)  7794(4)  3299(1)  28(1)  1 
O2  3145(2)  5826(4)  4229(1)  23(1)  1 
O3  9506(2)  9733(5)  3438(2)  40(1)  1 
O4  10601(2)  11350(5)  3698(2)  46(1)  1 
O5  1713(2)  4437(5)  5581(2)  38(1)  1 
O6  1112(3)  4754(6)  6373(2)  56(1)  1 
N1  5249(2)  6880(4)  3971(2)  18(1)  1 
N2  6783(2)  8465(4)  4224(2)  21(1)  1 
N3  4347(2)  6674(4)  4876(2)  20(1)  1 
N4  7616(2)  10313(5)  4900(2)  25(1)  1 
N5  8164(2)  9562(5)  4080(2)  23(1)  1 
N6  4320(2)  7632(5)  5859(2)  24(1)  1 
N7  3211(2)  6041(5)  5440(2)  24(1)  1 
N8  9910(3)  10751(6)  3781(2)  31(1)  1 
N9  1708(3)  5031(6)  6082(2)  36(1)  1 
C1  5721(3)  6961(5)  3527(2)  21(1)  1 
C2  5428(3)  6425(6)  2952(2)  27(1)  1 
C3  4590(3)  5819(6)  2813(2)  31(1)  1 
C4  4081(3)  5740(6)  3260(2)  23(1)  1 
C5  4451(3)  6255(5)  3833(2)  17(1)  1 
C6  3911(3)  6213(5)  4328(2)  19(1)  1 
C7  3968(3)  6798(5)  5382(2)  21(1)  1 
C8  3056(3)  6440(6)  6006(2)  25(1)  1 
C9  2404(3)  6073(6)  6336(2)  30(1)  1 
C10  2457(3)  6720(6)  6913(2)  32(1)  1 
C11  3140(3)  7684(7)  7157(2)  37(1)  1 
C12  3802(3)  8080(7)  6847(2)  35(1)  1 
C13  3751(3)  7434(6)  6264(2)  27(1)  1 
C14  6603(3)  7754(5)  3673(2)  21(1)  1 
C15  7508(3)  9444(5)  4408(2)  22(1)  1 
C16  8405(3)  11083(6)  4904(2)  23(1)  1 
C17  8847(3)  12175(6)  5316(2)  26(1)  1 
C18  9643(3)  12786(6)  5217(2)  30(1)  1 
C19  9995(3)  12324(6)  4717(2)  30(1)  1 
C20  9550(3)  11239(6)  4301(2)  26(1)  1 
C21  8754(3)  10623(5)  4391(2)  22(1)  1 
S101  1325(1)  7185(1)  922(1)  21(1)  1 
O101  1095(2)  7523(4)  252(1)  23(1)  1 
C101  2481(3)  7138(6)  1089(2)  30(1)  1 
C102  1144(3)  5059(6)  997(2)  31(1)  1 
S201  1280(1)  6410(2)  2635(1)  35(1)  1 
O201  1964(3)  5245(6)  2506(2)  55(1)  1 
C201  1819(3)  7909(7)  3132(2)  34(1)  1 
C202  717(4)  5413(8)  3154(3)  49(2)  1 
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HCl complex of compound 91: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2007sot0800 (mgf170(ii))     
Empirical formula   C25H28ClN5O3 
Formula weight   481.97 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Monoclinic 
Space group   P21/n  
Unit cell dimensions  a = 7.6178(2) Å   
  b = 18.3484(6) Å  β = 90.894(2)° 
  c = 16.8855(5) Å   
Volume  2359.87(12) Å
3 
Z  4 
Density (calculated)  1.357 Mg / m
3 
Absorption coefficient  0.200 mm
−1 
F(000)  1016 
Crystal  Fragment; Colourless 
Crystal size  0.15 × 0.1 × 0.07 mm
3 
θ range for data collection  2.92 − 27.48° 
Index ranges  −9 ≤ h ≤ 9, −23 ≤ k ≤ 23, −21 ≤ l ≤ 21 
Reflections collected  33754 
Independent reflections  5391 [Rint = 0.0946] 
Completeness to θ = 27.48°  99.8 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9862 and 0.9607 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  5391 / 0 / 309 
Goodness-of-fit on F
2  1.012 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0564, wR2 = 0.1283 
R indices (all data)  R1 = 0.0933, wR2 = 0.1455 
Largest diff. peak and hole  0.775 and −0.391 e Å
−3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption correction - V2.10 Structure solution: 
SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model. 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized U
ij tensor. 
 
Atom   x  y  z  Ueq  S.o.f. 
 
O1  767(3)  1496(1)  7348(1)  33(1)  1 
O2  732(2)  5186(1)  6239(1)  30(1)  1 
N1  1429(3)  1836(1)  6088(1)  23(1)  1 
N2  941(3)  3270(1)  6509(1)  22(1)  1 
N3  1929(3)  4294(1)  5480(1)  24(1)  1 
N4  3354(3)  4471(1)  4267(1)  22(1)  1 
N5  2561(3)  5465(1)  4886(1)  23(1)  1 
C1  3838(4)  −1585(1)  2469(2)  34(1)  1 
C2  3659(3)  −1634(1)  3368(1)  25(1)  1 
C3  3059(3)  −913(1)  3723(1)  23(1)  1 
C4  3036(3)  −915(1)  4624(1)  23(1)  1 
C5  2566(3)  −195(1)  5002(1)  22(1)  1 
C6  1953(3)  403(1)  4568(1)  22(1)  1 
C7  1577(3)  1062(1)  4934(1)  22(1)  1 
C8  1788(3)  1140(1)  5750(1)  22(1)  1 
C9  2372(3)  546(1)  6199(1)  24(1)  1 
C10  2751(3)  −107(1)  5821(1)  24(1)  1 
C11  940(3)  1966(1)  6835(1)  23(1)  1 
C12  535(3)  2752(1)  7033(1)  22(1)  1 
C13  −247(3)  2899(1)  7759(1)  25(1)  1 
C14  −634(3)  3614(1)  7948(1)  26(1)  1 
C15  −223(3)  4159(1)  7413(1)  25(1)  1 
C16  571(3)  3959(1)  6712(1)  21(1)  1 
C17  1066(3)  4543(1)  6138(1)  23(1)  1 
C18  2572(3)  4734(1)  4905(1)  22(1)  1 
C19  3888(3)  5054(1)  3795(1)  22(1)  1 
C20  4747(3)  5075(1)  3073(1)  24(1)  1 
C21  5096(3)  5763(1)  2776(1)  27(1)  1 
C22  4622(3)  6400(1)  3187(2)  27(1)  1 
C23  3768(3)  6373(1)  3901(2)  26(1)  1 
C24  3395(3)  5687(1)  4193(1)  23(1)  1 
O3  8824(3)  3246(1)  4592(1)  40(1)  1 
C25  7836(4)  2804(2)  4069(2)  41(1)  1 
Cl1  2871(1)  2850(1)  4570(1)  26(1)  1 
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Structures from Chapter 4 
Methanol complex of compound 125: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2008sot1075     
Empirical formula   C40H59N7O2 
Formula weight   669.94 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Orthorhombic 
Space group   Pbca  
Unit cell dimensions  a = 10.2826(2) Å  α = 90° 
  b = 20.5801(6) Å  β = 90° 
   c  35.6410(10) Å  γ  = 90° 
Volume  7542.2(3) Å
3 
Z  8 
Density (calculated)  1.180 Mg / m
3 
Absorption coefficient  0.074 mm
−1 
F(000)  2912 
Crystal  Block; Colourless 
Crystal size  0.3 × 0.2 × 0.05 mm
3 
θ range for data collection  3.02 − 25.01° 
Index ranges  −12 ≤ h ≤ 8, −15 ≤ k ≤ 24, −42 ≤ l ≤ 42 
Reflections collected  43094 
Independent reflections  6648 [Rint = 0.1269] 
Completeness to θ = 25.01°  99.8 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9963 and 0.9781 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  6648 / 0 / 475 
Goodness-of-fit on F
2  1.030 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0656, wR2 = 0.1445 
R indices (all data)  R1 = 0.1318, wR2 = 0.1737 
Extinction coefficient  0.0027(4) 
Largest diff. peak and hole  0.275 and −0.251 e Å
−3 
   
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption correction - V2.10 Structure solution: 
SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model. 
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Table 2. Atomic coordinates [× 10
4], equivalent isotropic displacement parameters [Å
2 × 
10
3] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized U
ij tensor. 
 
Atom   x  y  z  Ueq  S.o.f. 
 
C39  1766(3)  1254(2)  3595(1)  48(1)  1 
C40  2849(3)  1218(2)  126(1)  50(1)  1 
O1  3611(2)  1056(1)  450(1)  38(1)  1 
O2  656(2)  1382(1)  3365(1)  39(1)  1 
C1  6492(2)  2354(2)  676(1)  29(1)  1 
C2  7820(3)  2416(2)  640(1)  34(1)  1 
C3  8301(3)  1838(2)  481(1)  34(1)  1 
C4  7277(3)  1420(2)  424(1)  31(1)  1 
C5  7253(3)  725(2)  287(1)  35(1)  1 
C6  6277(3)  646(2)  −34(1)  42(1)  1 
C7  8605(3)  555(2)  129(1)  45(1)  1 
C8  6966(3)  265(2)  609(1)  33(1)  1 
C9  7802(3)  −73(2)  830(1)  42(1)  1 
C10  7075(3)  −385(2)  1114(1)  42(1)  1 
C11  5793(3)  −234(2)  1064(1)  34(1)  1 
C12  4605(3)  −467(2)  1279(1)  35(1)  1 
C13  4305(3)  −1169(2)  1161(1)  43(1)  1 
C14  3443(3)  −43(2)  1202(1)  33(1)  1 
C15  2268(3)  −174(2)  1034(1)  39(1)  1 
C16  1474(3)  385(2)  1069(1)  40(1)  1 
C17  2153(3)  851(2)  1257(1)  32(1)  1 
C18  1804(3)  1540(2)  1363(1)  34(1)  1 
C19  2186(3)  1678(2)  1772(1)  37(1)  1 
C20  324(3)  1624(2)  1330(1)  43(1)  1 
C21  2466(3)  2009(2)  1099(1)  31(1)  1 
C22  1999(3)  2357(2)  800(1)  34(1)  1 
C23  3049(3)  2706(2)  641(1)  34(1)  1 
C24  4150(2)  2567(1)  842(1)  31(1)  1 
C25  5512(3)  2841(2)  823(1)  32(1)  1 
C26  5516(3)  3428(2)  557(1)  38(1)  1 
C27  5924(3)  3059(2)  1222(1)  33(1)  1 
C28  5042(3)  3579(2)  1398(1)  36(1)  1 
C29  5091(3)  3600(2)  1823(1)  38(1)  1 
C30  4401(3)  3026(2)  2004(1)  39(1)  1 
C31  4379(3)  3029(2)  2430(1)  42(1)  1 
C32  4416(3)  1832(2)  2586(1)  39(1)  1 
C33  3507(3)  1412(2)  2710(1)  33(1)  1 
C34  3576(3)  693(2)  2741(1)  49(1)  1 
C35  3572(3)  365(2)  2354(1)  54(1)  1 
C36  3841(3)  −357(2)  2354(1)  54(1)  1 
C37  3774(3)  −647(2)  1960(1)  47(1)  1 
C38  4907(3)  −445(2)  1706(1)  40(1)  1 
N1  6177(3)  1750(1)  539(1)  32(1)  1 
N2  5737(2)  160(1)  755(1)  33(1)  1   Appendix  
 
 
 
N3  3367(2)  584(1)  1335(1)  32(1)  1 
N4  3785(2)  2138(1)  1121(1)  31(1)  1 
N5  3840(2)  2415(1)  2580(1)  39(1)  1 
N6  2595(2)  2369(2)  2691(1)  43(1)  1 
N7  2391(2)  1752(1)  2773(1)  42(1)  1 
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Compound 125.(DMSO)3: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2009sot0155 (CTIV22 JAN31,09)  
Empirical formula   C44H69N7O3S3 
  C38H51N7, 3(C2H6OS) 
Formula weight   840.24 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Monoclinic 
Space group   P21/n  
Unit cell dimensions  a = 10.4348(2) Å   
  b = 22.9357(3) Å   β = 100.8400(10)° 
  c = 19.7522(3) Å   
Volume  4642.93(13) Å
3 
Z  4 
Density (calculated)  1.202 Mg / m
3 
Absorption coefficient  0.205 mm
− − − −1 
F(000)  1816 
Crystal  Block; Colourless 
Crystal size  0.2 × 0.2 × 0.2 mm
3 
θ range for data collection  3.00 − 25.03° 
Index ranges  −12 ≤ h ≤ 12, −27 ≤ k ≤ 27, −23 ≤ l ≤ 23 
Reflections collected  44419 
Independent reflections  8189 [Rint = 0.0721] 
Completeness to θ = 25.03°  99.7 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9798 and 0.9501 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  8189 / 0 / 542 
Goodness-of-fit on F
2  1.560 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0658, wR2 = 0.1078 
R indices (all data)  R1 = 0.0950, wR2 = 0.1159 
Largest diff. peak and hole  0.383 and −0.432 e Å
− − − −3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption correction - V2.10 Structure solution: 
SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: SHELXL97 (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, 
Chemical Crystallography Laboratory, University of Oxford, 1993). 
 
Special details: All hydrogen atoms were located form the difference map and then placed in geometric positions and refined using a 
riding model, except those attached to nitrogen which were freely refined. 
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Table 2. Atomic coordinates [× 104], equivalent isotropic displacement parameters 
[Å2 × 103] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom   x  y  z  Ueq  S.o.f.  
 
N1  1173(2)  2138(1)  4810(1)  19(1)  1 
N2  −1043(2)  1147(1)  4321(1)  20(1)  1 
N3  −477(2)  1231(1)  2718(1)  19(1)  1 
N4  1748(2)  2210(1)  3207(1)  18(1)  1 
N5  896(2)  4396(1)  4606(1)  27(1)  1 
N6  2183(2)  4518(1)  4670(1)  30(1)  1 
N7  2448(2)  4551(1)  4046(1)  30(1)  1 
C1  2505(3)  2115(1)  4850(1)  17(1)  1 
C2  2987(3)  1761(1)  5395(1)  22(1)  1 
C3  1934(3)  1561(1)  5692(1)  22(1)  1 
C4  811(3)  1800(1)  5318(1)  19(1)  1 
C5  −585(3)  1765(1)  5425(1)  21(1)  1 
C6  −617(3)  1465(1)  6121(1)  27(1)  1 
C7  −1463(3)  1419(1)  4861(1)  19(1)  1 
C8  −2767(3)  1307(1)  4788(2)  23(1)  1 
C9  −3150(3)  968(1)  4189(2)  23(1)  1 
C10  −2074(3)  867(1)  3901(1)  20(1)  1 
C11  −1937(3)  541(1)  3252(1)  22(1)  1 
C12  −876(3)  71(1)  3407(2)  28(1)  1 
C13  −3234(3)  227(1)  2973(2)  31(1)  1 
C14  −1659(3)  957(1)  2698(1)  22(1)  1 
C15  −2469(3)  1153(1)  2114(2)  29(1)  1 
C16  −1761(3)  1555(1)  1785(2)  29(1)  1 
C17  −532(3)  1597(1)  2166(1)  20(1)  1 
C18  630(3)  1937(1)  2012(1)  19(1)  1 
C19  1036(3)  1666(1)  1369(1)  26(1)  1 
C20  202(3)  2579(1)  1866(1)  22(1)  1 
C21  1779(3)  1921(1)  2603(1)  17(1)  1 
C22  3009(3)  1697(1)  2653(1)  22(1)  1 
C23  3734(3)  1853(1)  3313(1)  21(1)  1 
C24  2938(3)  2174(1)  3644(1)  19(1)  1 
C25  3193(3)  2449(1)  4357(1)  19(1)  1 
C26  4666(3)  2428(1)  4636(2)  25(1)  1 
C27  2764(3)  3090(1)  4320(2)  23(1)  1 
C28  −1152(3)  2392(1)  5434(1)  21(1)  1 
C29  −450(3)  2783(1)  6017(2)  25(1)  1 
C30  −567(3)  3436(1)  5846(2)  24(1)  1 
C31  231(3)  3611(1)  5310(2)  24(1)  1 
C32  293(3)  4266(1)  5200(2)  29(1)  1 
C33  349(3)  4350(1)  3931(2)  26(1)  1 
C34  1331(3)  4445(1)  3581(1)  21(1)  1 
C35  1314(3)  4379(1)  2829(2)  27(1)  1 
C36  1418(3)  3740(1)  2625(1)  26(1)  1   Appendix  
 
 
 
C37  1071(3)  3624(1)  1853(1)  25(1)  1 
C38  1248(3)  2983(1)  1671(2)  24(1)  1 
S1  2841(1)  762(1)  4206(1)  23(1)  1 
O1  1502(2)  1000(1)  3949(1)  23(1)  1 
C39  2667(3)  232(1)  4845(2)  40(1)  1 
C40  3126(3)  265(1)  3553(2)  34(1)  1 
S2  3059(1)  2050(1)  8534(1)  23(1)  1 
O2  4490(2)  2204(1)  8639(1)  26(1)  1 
C41  2200(3)  2707(1)  8277(2)  37(1)  1 
C42  2658(3)  1683(1)  7725(2)  32(1)  1 
S3  933(1)  581(1)  8704(1)  40(1)  1 
O3  2338(2)  568(1)  8650(2)  64(1)  1 
C43  861(3)  775(2)  9569(2)  43(1)  1 
C44  435(3)  −157(1)  8747(2)  37(1)  1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Appendix  
 
 
 
Compound 125.(DMSO)2: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2009sot0158     
Empirical formula   C42H63N7O2S2 
  C38H51N7, 2(C2H6OS) 
Formula weight   762.11 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Triclinic 
Space group   P−1  
Unit cell dimensions  a = 10.5958(3) Å  α = 84.7310(10)° 
  b = 11.3296(3) Å  β = 89.8080(10)° 
  c = 17.7452(4) Å  γ  = 76.5870(10)° 
Volume  2063.03(9) Å
3 
Z  2 
Density (calculated)  1.227 Mg / m
3 
Absorption coefficient  0.173 mm
− − − −1 
F(000)  824 
Crystal  Fragment; Colourless 
Crystal size  0.3 × 0.2 × 0.04 mm
3 
θ range for data collection  3.01 − 27.48° 
Index ranges  −13 ≤ h ≤ 13, −14 ≤ k ≤ 14, −22 ≤ l ≤ 23 
Reflections collected  36159 
Independent reflections  9378 [Rint = 0.0691] 
Completeness to θ = 27.48°  99.2 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9931 and 0.9498 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  9378 / 15 / 462 
Goodness-of-fit on F
2  2.012 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.1338, wR2 = 0.3323 
R indices (all data)  R1 = 0.1744, wR2 = 0.3578 
Largest diff. peak and hole  4.558 and −1.762 e Å
− − − −3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: 
DirAx (Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. 
Hooft, Nonius B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in 
Enzymology (1997) Vol. 276: Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., 
Academic Press). Absorption correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption 
correction - V2.10 Structure solution: SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure 
refinement: SHELXL97 (G. M. Sheldrick (1997), University of Göttingen, Germany). Graphics: Cameron - A Molecular 
Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, Chemical Crystallography Laboratory, University of Oxford, 
1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model. 
One of the DMSO molecules is disordered and is  surrounded by various significant electron density peaks. Various attempts 
were made to refine a number of DMSO PARTS using rigid body restraints. However, even with 4 PARTS there were still 
residual peaks. It was decided to revert to the  original model as adding extra parameters had not improved the fit.  
 
The triazole ring is disordered over the two possible configurations 
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Table 2. Atomic coordinates [× 104], equivalent isotropic displacement parameters 
[Å2 × 103] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom   x  y  z  Ueq  S.o.f.  
 
N7A  4045(10)  3650(9)  5253(6)  40(1)  0.348(5) 
N6A  3607(10)  4204(9)  5922(4)  40(1)  0.348(5) 
N5A  2549(9)  5208(9)  5721(5)  40(1)  0.348(5) 
C32A  2332(11)  5276(10)  4927(5)  40(1)  0.348(5) 
C33A  3256(12)  4313(11)  4638(4)  40(1)  0.348(5) 
C32B  4037(5)  3595(6)  5277(4)  40(1)  0.652(5) 
N6B  3038(6)  3535(5)  5804(3)  40(1)  0.652(5) 
N5B  1963(5)  4520(5)  5596(3)  40(1)  0.652(5) 
N7B  2298(6)  5189(5)  4939(3)  40(1)  0.652(5) 
C33B  3580(6)  4617(6)  4742(3)  40(1)  0.652(5) 
N1  2295(4)  3611(4)  824(2)  18(1)  1 
N2  1073(4)  3342(3)  2491(2)  19(1)  1 
N3  3511(4)  1001(3)  3007(2)  18(1)  1 
N4  4752(4)  1227(3)  1322(2)  17(1)  1 
C1  3257(4)  3603(4)  296(2)  17(1)  1 
C2  3273(5)  4804(4)  101(3)  22(1)  1 
C3  2313(5)  5543(4)  523(3)  22(1)  1 
C4  1722(5)  4780(4)  972(3)  20(1)  1 
C5  553(5)  5104(4)  1483(3)  22(1)  1 
C6  −620(5)  5765(5)  973(3)  30(1)  1 
C7  264(5)  4004(4)  1916(3)  20(1)  1 
C8  −820(5)  3539(5)  1922(3)  27(1)  1 
C9  −655(5)  2571(4)  2507(3)  24(1)  1 
C10  539(4)  2449(4)  2851(3)  22(1)  1 
C11  1216(5)  1580(5)  3500(3)  23(1)  1 
C12  1645(6)  2309(5)  4105(3)  31(1)  1 
C13  249(5)  880(5)  3858(3)  35(1)  1 
C14  2370(4)  685(4)  3227(3)  20(1)  1 
C15  2551(5)  −532(5)  3135(3)  25(1)  1 
C16  3824(5)  −953(4)  2848(3)  21(1)  1 
C17  4411(4)  13(4)  2776(3)  18(1)  1 
C18  5773(4)  76(4)  2562(3)  19(1)  1 
C19  6596(5)  −1221(5)  2507(3)  25(1)  1 
C20  5809(4)  805(4)  1799(3)  19(1)  1 
C21  6844(4)  1143(5)  1452(3)  23(1)  1 
C22  6390(4)  1791(5)  743(3)  22(1)  1 
C23  5086(4)  1822(4)  670(3)  17(1)  1 
C24  4109(4)  2439(4)  41(2)  18(1)  1 
C25  4845(5)  2764(5)  −667(3)  24(1)  1 
C26  3308(5)  1542(4)  −178(3)  21(1)  1 
C27  829(5)  5969(5)  2048(3)  28(1)  1 
C28  −269(6)  6388(5)  2599(3)  36(1)  1 
C29  144(6)  6888(6)  3304(3)  38(1)  1 
C30  998(7)  5858(7)  3804(4)  53(2)  1   Appendix  
 
 
 
C31  1376(6)  6190(6)  4553(3)  45(2)  1 
C34  5190(6)  2688(5)  5290(3)  33(1)  1 
C35  5180(5)  1861(5)  4659(3)  26(1)  1 
C36  6450(5)  937(5)  4591(3)  26(1)  1 
C37  6401(5)  73(5)  3985(3)  26(1)  1 
C38  6351(5)  704(4)  3173(3)  22(1)  1 
O1  1999(3)  1237(3)  1477(2)  21(1)  1 
S1  970(1)  521(1)  1480(1)  22(1)  1 
C39  1728(5)  −895(5)  1124(3)  29(1)  1 
C40  −31(5)  1180(5)  665(3)  28(1)  1 
S2  4550(2)  4534(2)  2703(1)  55(1)  1 
O2  3754(3)  3637(3)  2919(2)  28(1)  1 
C41  6086(12)  4043(11)  3019(5)  175(7)  1 
C42  5198(7)  4173(7)  1806(3)  49(2)  1 
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Syn-isomer of compound 133: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2008sot0125 (mgf246b)     
Empirical formula   C26H20O6 
Formula weight   428.42 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Orthorhombic 
Space group   Pna21  
Unit cell dimensions  a = 15.9180(5) Å   
  b = 27.8591(8) Å   
  c = 13.8758(2) Å   
Volume  6153.4(3) Å
3 
Z  12 (3 molecules) 
Density (calculated)  1.387 Mg / m
3 
Absorption coefficient  0.099 mm
−1 
F(000)  2688 
Crystal  Block; Colourless 
Crystal size  0.2 × 0.12 × 0.09 mm
3 
θ range for data collection  2.92 − 27.48° 
Index ranges  −20 ≤ h ≤ 20, −27 ≤ k ≤ 36, −17 ≤ l ≤ 16 
Reflections collected  42521 
Independent reflections  7324 [Rint = 0.0753] 
Completeness to θ = 27.48°  99.7 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9912 and 0.9705 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  7324 / 155 / 904 
Goodness-of-fit on F
2  1.052 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0679, wR2 = 0.1686 
R indices (all data)  R1 = 0.1260, wR2 = 0.2055 
Largest diff. peak and hole  0.643 and −0.531 e Å
− − − −3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: 
DirAx (Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. 
Hooft, Nonius B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in 
Enzymology (1997) Vol. 276: Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., 
Academic Press). Absorption correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption 
correction - V2.10 Structure solution: SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure 
refinement: SHELXL97 (G. M. Sheldrick (1997), University of Göttingen, Germany). Graphics: Cameron - A Molecular 
Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, Chemical Crystallography Laboratory, University of Oxford, 
1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model. Absolute 
structure not determined. The structure is pseudo centrosymmetric (Pnma) but refinement in this  space-group proved 
unsatisfactory. One of the 3 molecules in the asymmetric unit shows disorder of its ester groups. 
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Table 2. Atomic coordinates [× 104], equivalent isotropic displacement parameters 
[Å2 × 103] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom   x  y  z  Ueq  S.o.f.  
 
O101  −2879(2)  −210(2)  3211(3)  27(1)  1 
O102  −2086(2)  314(2)  2401(3)  20(1)  1 
O103  −829(3)  1089(2)  1699(3)  38(1)  1 
O104  −524(3)  1095(2)  133(3)  30(1)  1 
O105  −1224(2)  828(2)  4107(3)  28(1)  1 
O106  −472(3)  1184(2)  5271(3)  27(1)  1 
C101  −2719(4)  676(2)  2541(5)  30(1)  1 
C102  −2217(4)  −101(3)  2820(4)  21(2)  1 
C103  −1471(4)  −431(2)  2788(4)  21(2)  1 
C104  −1671(5)  −923(3)  2796(5)  24(2)  1 
C105  −1027(5)  −1271(3)  2779(5)  25(2)  1 
C106  −201(5)  −1124(3)  2764(5)  28(2)  1 
C107  −2(4)  −640(3)  2748(4)  18(2)  1 
C108  −637(4)  −288(3)  2738(4)  18(2)  1 
C109  861(4)  −431(2)  2750(4)  19(2)  1 
C110  935(4)  −97(3)  1887(5)  21(2)  1 
C111  1514(4)  −132(3)  1162(5)  20(2)  1 
C112  1485(4)  185(3)  376(5)  24(2)  1 
C113  835(4)  529(3)  335(5)  24(2)  1 
C114  254(4)  575(2)  1099(5)  23(2)  1 
C115  299(4)  260(3)  1885(5)  19(2)  1 
C116  −279(4)  224(2)  2753(4)  16(1)  1 
C117  −405(5)  950(3)  1037(5)  26(2)  1 
C118  −1173(5)  1456(3)  27(6)  37(2)  1 
C119  896(4)  −97(3)  3652(5)  21(2)  1 
C120  1473(4)  −140(3)  4399(5)  23(2)  1 
C121  1402(4)  173(2)  5180(5)  22(2)  1 
C122  758(4)  506(3)  5211(5)  21(2)  1 
C123  163(4)  542(2)  4462(4)  17(2)  1 
C124  274(4)  239(3)  3665(5)  18(2)  1 
C125  −577(4)  872(2)  4554(4)  21(2)  1 
C126  −1181(4)  1480(2)  5476(5)  25(2)  1 
O21A  3964(8)  711(6)  1816(9)  96(3)  0.50 
C22A  4511(4)  779(2)  1205(3)  40(2)  0.50 
O22A  4472(9)  538(6)  393(9)  32(3)  0.50 
C21A  3802(12)  205(7)  227(18)  35(3)  0.50 
O21B  3878(7)  762(6)  1700(10)  96(3)  0.50 
C22B  4511(4)  779(2)  1205(3)  40(2)  0.50 
O22B  4586(9)  471(6)  479(9)  32(3)  0.50 
C21B  3910(13)  139(7)  322(17)  35(3)  0.50 
O25A  2079(4)  1878(3)  3242(6)  29(2)  0.50 
C25A  2778(4)  1758(2)  2962(4)  24(2)  0.50 
O26A  2929(4)  1342(2)  3409(5)  21(1)  0.50   Appendix  
 
 
 
C26A  2297(7)  976(4)  3284(10)  32(2)  0.50 
O25B  2120(4)  1896(3)  2582(6)  29(2)  0.50 
C25B  2778(4)  1758(2)  2962(4)  24(2)  0.50 
O26B  2926(4)  1330(2)  2536(6)  21(1)  0.50 
C26B  2284(7)  970(4)  2639(10)  32(2)  0.50 
O23A  4228(5)  546(3)  4059(5)  32(2)  0.50 
C27A  4518(4)  766(2)  4739(4)  24(2)  0.50 
O24A  4543(8)  492(4)  5525(7)  29(3)  0.50 
C28A  3800(30)  214(19)  5730(30)  38(2)  0.50 
O23B  3852(4)  800(3)  4261(5)  32(2)  0.50 
C27B  4518(4)  766(2)  4739(4)  24(2)  0.50 
O24B  4396(8)  604(5)  5631(6)  29(3)  0.50 
C28B  3800(30)  219(18)  5730(30)  38(2)  0.50 
C203  5221(4)  1115(2)  1315(4)  27(2)  1 
C204  5782(4)  1163(3)  542(5)  27(2)  1 
C205  6409(5)  1505(3)  551(5)  31(2)  1 
C206  6484(4)  1817(3)  1330(5)  22(2)  1 
C207  5917(4)  1777(3)  2107(5)  21(2)  1 
C208  5271(4)  1422(3)  2103(5)  22(2)  1 
C209  5873(4)  2105(3)  2958(5)  21(2)  1 
C210  5923(4)  1770(3)  3848(4)  23(2)  1 
C211  6517(4)  1808(3)  4585(5)  23(2)  1 
C212  6442(4)  1491(3)  5356(5)  26(2)  1 
C213  5817(4)  1152(3)  5397(5)  22(2)  1 
C214  5221(4)  1124(2)  4655(4)  23(2)  1 
C215  5301(4)  1429(3)  3868(5)  20(2)  1 
C216  4713(4)  1448(3)  2982(5)  26(2)  1 
C219  4982(4)  2307(3)  2989(5)  26(2)  1 
C220  4792(4)  2798(3)  2988(5)  25(2)  1 
C221  3964(5)  2936(3)  2969(5)  31(2)  1 
C222  3337(4)  2590(3)  2960(5)  21(2)  1 
C223  3510(4)  2102(3)  2999(5)  22(2)  1 
C224  4362(4)  1957(3)  2983(5)  22(2)  1 
O301  1172(3)  2449(2)  6697(4)  55(2)  1 
O302  453(3)  2162(2)  5451(4)  42(2)  1 
O303  754(4)  2212(2)  9016(4)  54(2)  1 
O304  496(3)  2215(2)  10585(4)  39(1)  1 
O305  2869(3)  3529(2)  7570(5)  47(1)  1 
O306  2077(3)  3004(2)  8365(4)  51(1)  1 
C301  1178(5)  1864(3)  5236(6)  40(2)  1 
C302  543(5)  2455(3)  6198(4)  28(2)  1 
C303  −200(4)  2774(3)  6303(5)  26(2)  1 
C304  −778(4)  2811(3)  5554(5)  31(2)  1 
C305  −1431(4)  3136(3)  5584(5)  29(2)  1 
C306  −1497(4)  3453(3)  6374(5)  26(2)  1 
C307  −929(4)  3432(2)  7106(5)  22(2)  1 
C308  −265(4)  3083(3)  7105(5)  21(2)  1 
C309  −889(4)  3752(3)  7971(5)  25(2)  1 
C310  −924(4)  3433(3)  8865(5)  23(2)  1 
C311  −1507(4)  3478(3)  9603(5)  33(2)  1   Appendix  
 
 
 
C312  −1443(4)  3163(3)  10363(5)  28(2)  1 
C313  −839(4)  2817(3)  10405(5)  24(2)  1 
C314  −251(4)  2771(3)  9657(4)  23(2)  1 
C315  −311(4)  3085(3)  8878(5)  21(2)  1 
C316  293(4)  3109(2)  7985(5)  21(1)  1 
C317  404(4)  2390(3)  9684(5)  27(2)  1 
C318  1153(5)  1860(3)  10682(6)  44(2)  1 
C319  3(4)  3971(3)  7985(5)  22(2)  1 
C320  186(4)  4454(3)  7981(5)  20(1)  1 
C321  1044(4)  4596(3)  7951(5)  25(2)  1 
C322  1657(4)  4265(3)  7927(5)  24(2)  1 
C323  1482(4)  3762(3)  7977(4)  20(2)  1 
C324  644(4)  3620(3)  7989(5)  21(1)  1 
C325  2214(4)  3436(3)  7913(4)  19(2)  1 
C326  2714(4)  2633(3)  8158(7)  54(2)  1 
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Anti-isomer of compound 133: 
Table 1. Crystal data and structure refinement details. 
   
Identification code   2008sot0100 (mgf246)     
Empirical formula   C26H20O6 
Formula weight   428.42 
Temperature   120(2) K 
Wavelength   0.71073 Å 
Crystal system   Triclinic 
Space group   P−1  
Unit cell dimensions  a = 8.3873(3) Å  α = 93.812(2)° 
  b = 9.5325(4) Å  β = 103.380(3)° 
  c = 13.8215(6) Å  γ  = 110.196(2)° 
Volume  995.91(7) Å
3 
Z  2 
Density (calculated)  1.429 Mg / m
3 
Absorption coefficient  0.102 mm
− − − −1 
F(000)  448 
Crystal  Fragment; Colourless 
Crystal size  0.18 × 0.1 × 0.03 mm
3 
θ range for data collection  2.97 − 27.48° 
Index ranges  −10 ≤ h ≤ 10, −12 ≤ k ≤ 12, −17 ≤ l ≤ 17 
Reflections collected  17844 
Independent reflections  4539 [Rint = 0.0692] 
Completeness to θ = 27.48°  99.3 %  
Absorption correction  Semi−empirical from equivalents 
Max. and min. transmission  0.9970 and 0.9719 
Refinement method  Full-matrix least-squares on F
2 
Data / restraints / parameters  4539 / 0 / 292 
Goodness-of-fit on F
2  1.002 
Final R indices [F
2 > 2σ(F
2)]  R1 = 0.0997, wR2 = 0.2076 
R indices (all data)  R1 = 0.1533, wR2 = 0.2428 
Largest diff. peak and hole  1.534 and −0.762 e Å
−3 
 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit ). Cell determination: 
DirAx (Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. 
Hooft, Nonius B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in 
Enzymology (1997) Vol. 276: Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., 
Academic Press). Absorption correction: Sheldrick, G. M. SADABS - Bruker Nonius area detector scaling and absorption 
correction - V2.10 Structure solution: SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure 
refinement: SHELXL97 (G. M. Sheldrick (1997), University of Göttingen, Germany). Graphics: Cameron - A Molecular 
Graphics Package. (D. M. Watkin, L. Pearce and C. K. Prout, Chemical Crystallography Laboratory, University of Oxford, 
1993). 
 
Special details:  All hydrogen atoms were placed in idealised positions and refined using a riding model. An unidentified 
electron density peak exists ca 1.3Å from C11. 
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Table 2. Atomic coordinates [× 104], equivalent isotropic displacement parameters 
[Å2 × 103] and site occupancy factors. Ueq is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom   x  y  z  Ueq  S.o.f.  
 
C1  2459(6)  3467(6)  −343(4)  42(1)  1 
C2  3742(5)  2013(5)  659(3)  24(1)  1 
C3  5331(5)  1604(4)  960(3)  24(1)  1 
C4  6661(5)  2092(4)  467(3)  27(1)  1 
C5  8157(5)  1748(5)  715(3)  28(1)  1 
C6  8386(5)  896(5)  1491(3)  26(1)  1 
C7  7080(5)  404(4)  1979(3)  22(1)  1 
C8  5544(5)  740(4)  1723(3)  22(1)  1 
C9  7177(5)  −476(4)  2860(3)  22(1)  1 
C10  8233(6)  −5624(5)  3211(4)  35(1)  1 
C11  7023(5)  −3778(4)  2822(3)  27(1)  1 
C12  5407(5)  −3426(4)  2539(3)  24(1)  1 
O3  6717(4)  −5193(3)  2961(3)  44(1)  1 
O4  8492(5)  −2954(4)  2819(4)  60(1)  1 
C13  3730(5)  −4585(5)  2257(3)  27(1)  1 
C14  2218(5)  −4264(5)  1988(3)  29(1)  1 
C15  2327(5)  −2772(5)  2006(3)  25(1)  1 
C16  3975(5)  −1603(4)  2283(3)  21(1)  1 
C17  5512(5)  −1926(4)  2544(3)  22(1)  1 
C18  4283(5)  75(5)  2371(3)  24(1)  1 
C19  2114(6)  3707(5)  4357(4)  41(1)  1 
C20  3358(5)  1954(5)  3942(3)  26(1)  1 
C21  4988(5)  1600(4)  4177(3)  22(1)  1 
C22  6157(5)  2101(4)  5145(3)  24(1)  1 
C23  7668(5)  1757(4)  5397(3)  24(1)  1 
C24  8049(5)  924(4)  4681(3)  23(1)  1 
C25  6905(5)  433(4)  3717(3)  21(1)  1 
C26  5361(5)  745(4)  3459(3)  21(1)  1 
O1  3979(4)  3065(4)  50(2)  38(1)  1 
O2  2410(4)  1506(4)  913(2)  38(1)  1 
O5  3616(4)  3253(3)  4509(3)  37(1)  1 
O6  1975(4)  1187(4)  3347(2)  39(1)  1 
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Appendix 2 – Proton-NMR Titration Curves 
 
Where reported, anion stability constants have been elucidated through 
1H-NMR 
titration experiments with anions in the form of their tetrabutylammonium salts at 298K in 
an appropriate deuterated solvent. 
Data from these titration experiments has been fitted to the appropriate binding 
model with the resulting binding profile reported here for completeness. 
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1H-NMR Titrations in Chapter 2 
Receptor 59 with tetrabutylammonium bromide in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  1.36708E+02 1.000E-01 3.185E+00 1.844E+00 BETA1 
   2  1  1.87754E+03 2.000E+00 1.018E+03 9.842E+02 BETA2 
   3  1  6.41751E+00 1.000E+00 1.659E-03 6.138E+00 M SHIFT 
   4  1  6.47611E+00 1.000E-01 4.686E-03 6.341E+01 ML SHIFT 
   5  1  6.63639E+00 5.000E-01 5.838E-02 6.708E+02 ML2 SHIFT 
  
0RMS ERROR = 1.36E-03  MAX ERROR = 3.11E-03 AT OBS.NO. 20 
 RESIDUALS SQUARED = 2.76E-05 
 RFACTOR =     0.0181 PERCENT 
 
Receptor 59 with tetrabutylammonium dihydrogen phosphate in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
1  1  1.00587E+04 1.000E-01 2.802E+02 5.511E+00 BETA1 
2  1  6.20300E+05 2.000E+00 7.861E+03 2.439E+00 BETA2 
3  1  9.08337E+00 1.000E+00 3.698E-03 1.310E+00 M SHIFT 
4  1  9.23128E+00 1.000E-01 2.224E-03 2.768E+00 ML SHIFT 
5  1  9.66752E+00 5.000E-01 5.535E-03 4.878E+00 ML2 SHIFT 
 
0RMS ERROR = 3.60E-03  MAX ERROR = 4.90E-03 AT OBS.NO. 18 
RESIDUALS SQUARED = 1.68E-04 
RFACTOR =     0.0328 PERCENT 
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Recetpor 59 with tetrabutylammonium acetate in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  5.32935E+04 1.000E-01 9.876E+02 8.955E+00 BETA1 
   2  1  2.85559E+06 2.000E+00 2.770E+04 2.202E+00 BETA2 
   3  1  6.42031E+00 1.000E+00 1.069E-02 1.279E+00 M SHIFT 
   4  1  6.93949E+00 1.000E-01 5.612E-03 3.007E+00 ML SHIFT 
   5  1  9.00524E+00 5.000E-01 1.209E-02 5.805E+00 ML2 SHIFT 
  
0RMS ERROR = 1.02E-02  MAX ERROR = 1.96E-02 AT OBS.NO.  4 
 RESIDUALS SQUARED = 2.18E-03 
 RFACTOR =     0.1205 PERCENT 
 
Receptor 70 with tetrabutylammonium chloride in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  2.35114E+03 1.000E-01 1.239E+01 1.476E+00 BETA1 
   2  1  1.05903E+06 2.000E+00 4.407E+03 1.237E+00 BETA2 
   3  1  8.86569E+00 1.000E+00 1.712E-03 1.664E+00 M SHIFT 
   4  1  9.53818E+00 1.000E-01 2.604E-03 2.771E+00 ML SHIFT 
   5  1  1.01109E+01 5.000E-01 1.252E-03 1.980E+00 ML2 SHIFT 
  
0RMS ERROR = 2.31E-03  MAX ERROR = 4.55E-03 AT OBS.NO.  6 
 RESIDUALS SQUARED = 8.04E-05 
 RFACTOR =     0.0208 PERCENT 
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Receptor 70 with tetrabutylammonium bromide in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  9.42176E+02 1.000E-01 9.415E+00 1.442E+00 BETA1 
   2  1  1.23308E+05 2.000E+00 6.041E+03 4.648E+00 BETA2 
   3  1  8.88545E+00 1.000E+00 2.740E-03 1.948E+00 M SHIFT 
   4  1  9.16721E+00 1.000E-01 3.303E-03 4.265E+00 ML SHIFT 
   5  1  9.36296E+00 5.000E-01 2.800E-03 4.576E+00 ML2 SHIFT 
  
0RMS ERROR = 2.59E-03  MAX ERROR = 4.46E-03 AT OBS.NO. 10 
 RESIDUALS SQUARED = 7.36E-05 
 RFACTOR =     0.0233 PERCENT 
 
Receptor 70 with tetrabutylammonium iodide in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  1.61269E+02 1.000E-01 2.428E+00 4.746E+00 BETA1 
   2  1  2.58997E+03 2.000E+00 2.685E+02 5.358E+02 BETA2 
   3  1  9.73874E+00 1.000E+00 2.370E-03 5.018E+00 M SHIFT 
   4  1  1.02654E+01 1.000E-01 6.556E-03 4.600E+01 ML SHIFT 
   5  1  1.12036E+01 5.000E-01 6.159E-02 3.606E+02 ML2 SHIFT 
  
0RMS ERROR = 2.08E-03  MAX ERROR = 3.85E-03 AT OBS.NO. 14 
 RESIDUALS SQUARED = 5.61E-05 
 RFACTOR =     0.0174 PERCENT 
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Receptor 60 with tetrabutylammonium chloride in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  6.83854E+03 1.000E-01 1.859E+02 1.071E+01 BETA1 
   2  1  4.08534E+05 2.000E+00 4.428E+03 1.938E+00 BETA2 
   3  1  1.15802E+01 1.000E+00 2.517E-03 1.316E+00 M SHIFT 
   4  1  1.17644E+01 1.000E-01 1.593E-03 2.725E+00 ML SHIFT 
   5  1  1.22017E+01 5.000E-01 6.028E-03 1.157E+01 ML2 SHIFT 
  
0RMS ERROR = 2.63E-03  MAX ERROR = 4.72E-03 AT OBS.NO.  4 
 RESIDUALS SQUARED = 9.66E-05 
 RFACTOR =     0.0190 PERCENT 
 
Receptor 60 with tetrabutylammonium dihydrogen phosphate in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  1.92162E+03 1.000E-01 5.729E+01 8.663E+00 BETA1 
   2  1  5.68065E+04 2.000E+00 5.961E+03 9.843E+01 BETA2 
   3  1  9.84794E+00 1.000E+00 1.069E-02 1.814E+00 M SHIFT 
   4  1  1.01842E+01 1.000E-01 1.209E-02 6.923E+00 ML SHIFT 
   5  1  1.23239E+01 5.000E-01 1.158E-01 7.534E+01 ML2 SHIFT 
  
0RMS ERROR = 1.46E-02  MAX ERROR = 3.11E-02 AT OBS.NO. 23 
 RESIDUALS SQUARED = 4.24E-03 
 RFACTOR =     0.1248 PERCENT 
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Receptor 60 with tetrabutylammonium benzoate in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  1.51898E+04 1.000E-01 2.865E+02 1.179E+01 BETA1 
   2  1  5.90432E+05 2.000E+00 8.479E+03 6.417E+00 BETA2 
   3  1  1.16017E+01 1.000E+00 3.683E-03 1.331E+00 M SHIFT 
   4  1  1.18883E+01 1.000E-01 2.801E-03 2.739E+00 ML SHIFT 
   5  1  1.32523E+01 5.000E-01 1.550E-02 1.556E+01 ML2 SHIFT 
  
0RMS ERROR = 5.35E-03  MAX ERROR = 9.60E-03 AT OBS.NO.  7 
 RESIDUALS SQUARED = 5.45E-04 
 RFACTOR =     0.0393 PERCENT 
 
Receptor 60 with tetrabutylammonium acetate in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  1.66148E+03 1.000E-01 3.703E+01 1.023E+00 BETA1 
   2  1  3.27237E+05 2.000E+00 1.330E+04 1.488E+00 BETA2 
   3  1  9.80378E+00 1.000E+00 8.065E-03 1.904E+00 M SHIFT 
   4  1  1.02012E+01 1.000E-01 9.344E-03 2.877E+00 ML SHIFT 
   5  1  1.05736E+01 5.000E-01 7.160E-03 2.267E+00 ML2 SHIFT 
  
0RMS ERROR = 1.10E-02  MAX ERROR = 3.04E-02 AT OBS.NO. 24 
 RESIDUALS SQUARED = 2.31E-03 
 RFACTOR =     0.0959 PERCENT 
 
 
 
 
 
 
 
   Appendix  
 
 
 
Receptor 61 with tetrabutylammonium benzoate in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  7.79475E+03 1.000E-01 1.181E+02 2.692E+01 BETA1 
   2  1  3.18645E+05 2.000E+00 3.235E+03 1.236E+01 BETA2 
   3  1  1.14080E+01 1.000E+00 1.706E-03 1.189E+00 M SHIFT 
   4  1  1.17737E+01 1.000E-01 1.453E-03 2.837E+00 ML SHIFT 
   5  1  1.29994E+01 5.000E-01 1.078E-02 3.575E+01 ML2 SHIFT 
  
0RMS ERROR = 2.48E-03  MAX ERROR = 4.35E-03 AT OBS.NO.  5 
 RESIDUALS SQUARED = 9.86E-05 
 RFACTOR =     0.0181 PERCENT 
 
Receptor 61 with tetrabutylammonium acetate in DMSO-d6. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  1.80856E+02 1.000E-01 4.867E+00 1.805E+01 BETA1 
   2  1  8.27326E+03 2.000E+00 4.619E+02 1.524E+02 BETA2 
   3  1  9.00195E+00 1.000E+00 1.302E-03 6.048E+00 M SHIFT 
   4  1  9.09162E+00 1.000E-01 3.297E-03 2.878E+01 ML SHIFT 
   5  1  9.45015E+00 5.000E-01 9.257E-03 1.118E+02 ML2 SHIFT 
  
0RMS ERROR = 1.09E-03  MAX ERROR = 1.60E-03 AT OBS.NO. 13 
 RESIDUALS SQUARED = 1.67E-05 
 RFACTOR =     0.0103 PERCENT 
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1H-NMR Titrations in Chapter 3 
Receptor 88 with urea in 20%DMSO-d6/MeNO2-d3.  
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  2.74745E+01 2.000E-01 1.658E+00 6.961E+01    K1 
   2  1  1.29487E+01 2.000E-01 1.399E-03 4.865E+00   SHIFT M 
   3  1  1.33741E+01 1.000E+00 1.381E-02 5.321E+01    SHIFT ML 
  
0RMS ERROR = 2.09E-03  MAX ERROR = 3.95E-03 AT OBS.NO. 11 
 RESIDUALS SQUARED = 6.58E-05 
 RFACTOR =     0.0146 PERCENT 
 
Receptor 88 with imidizolidone in 20%DMSO-d6/MeNO2-d3. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  4.45422E+01 2.000E-01 3.339E+00 5.803E+01    K1 
   2  1  1.29449E+01 2.000E-01 2.946E-03 4.967E+00   SHIFT M 
   3  1  1.34874E+01 1.000E+00 1.857E-02 4.323E+01    SHIFT ML 
  
0RMS ERROR = 3.99E-03  MAX ERROR = 6.39E-03 AT OBS.NO. 16 
 RESIDUALS SQUARED = 2.38E-04 
 RFACTOR =     0.0278 PERCENT 
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Receptor 88 with barbital in 30%DMSO-d6/MeNO2-d3. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  5.91465E+01 2.000E-01 2.068E+00 3.270E+01    K1 
   2  1  1.29615E+01 2.000E-01 2.093E-03 3.263E+00   SHIFT M 
   3  1  1.23051E+01 1.000E+00 9.290E-03 2.482E+01    SHIFT ML 
  
0RMS ERROR = 3.61E-03  MAX ERROR = 7.98E-03 AT OBS.NO. 22 
 RESIDUALS SQUARED = 2.48E-04 
 RFACTOR =     0.0264 PERCENT 
 
Receptor 88 with imidizolidone in 30%DMSO-d6/MeNO2-d3. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  1.30281E+01 2.000E-01 9.027E-01 3.099E+02    K1 
   2  1  1.29563E+01 2.000E-01 8.627E-04 6.452E+00   SHIFT M 
   3  1  1.35920E+01 1.000E+00 3.024E-02 2.606E+02    SHIFT ML 
  
0RMS ERROR = 1.25E-03  MAX ERROR = 2.20E-03 AT OBS.NO. 14 
 RESIDUALS SQUARED = 2.34E-05 
 RFACTOR =     0.0087 PERCENT 
 
   Appendix  
 
 
 
Receptor 88 with urea in 30%DMSO-d6/MeNO2-d3. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  9.55761E+01 2.000E-01 1.067E+01 3.915E+01    K1 
   2  1  1.29582E+01 2.000E-01 1.380E-03 2.931E+00   SHIFT M 
   3  1  1.31076E+01 1.000E+00 6.377E-03 3.202E+01    SHIFT ML 
  
0RMS ERROR = 1.82E-03  MAX ERROR = 3.51E-03 AT OBS.NO.  5 
 RESIDUALS SQUARED = 3.33E-05 
 RFACTOR =     0.0123 PERCENT 
 
 Receptor 96 with imidazolidone in 20%DMSO-d6/MeNO2-d3. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  5.09494E+01 2.000E-01 1.659E+00 3.760E+01    K1 
   2  1  1.28517E+01 2.000E-01 1.474E-03 3.589E+00   SHIFT M 
   3  1  1.34124E+01 1.000E+00 7.733E-03 2.847E+01    SHIFT ML 
  
0RMS ERROR = 2.53E-03  MAX ERROR = 6.23E-03 AT OBS.NO. 14 
 RESIDUALS SQUARED = 1.22E-04 
 RFACTOR =     0.0180 PERCENT 
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Receptor 96 with urea in 20%DMSO-d6/MeNO2-d3. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  3.30488E+01 2.000E-01 2.886E+00 1.113E+02    K1 
   2  1  1.28532E+01 2.000E-01 1.758E-03 4.499E+00   SHIFT M 
   3  1  1.32745E+01 1.000E+00 1.943E-02 8.983E+01    SHIFT ML 
  
0RMS ERROR = 2.91E-03  MAX ERROR = 5.00E-03 AT OBS.NO. 18 
 RESIDUALS SQUARED = 1.61E-04 
 RFACTOR =     0.0209 PERCENT 
 
Receptor 100 with TBA acetate in DMSO-d6/0.5% water. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  9.40380E+01 2.000E-01 9.942E+00 2.586E+01    K1 
   2  1  1.13401E+01 2.000E-01 6.931E-02 6.414E+00   SHIFT M 
   3  1  1.48632E+01 1.000E+00 7.342E-02 1.271E+01    SHIFT ML 
  
0RMS ERROR = 5.54E-02  MAX ERROR = 1.25E-01 AT OBS.NO.  1 
 RESIDUALS SQUARED = 4.91E-02 
 RFACTOR =     0.3788 PERCENT 
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Receptor 100 with TBA benzoate in DMSO-d6/0.5% water. 
 
NO.  A   PARAMETER    DELTA     ERROR    CONDITION   DESCRIPTION 
   1  1  6.55206E+01 2.000E-01 5.988E+00 3.009E+01    K1 
   2  1  1.10575E+01 2.000E-01 3.298E-02 4.122E+00   SHIFT M 
   3  1  1.44031E+01 1.000E+00 8.913E-02 1.995E+01    SHIFT ML 
  
0RMS ERROR = 4.15E-02  MAX ERROR = 1.04E-01 AT OBS.NO.  3 
 RESIDUALS SQUARED = 2.58E-02 
 RFACTOR =     0.3017 PERCENT 
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Appendix 3 – Proton-NMR Titration Stack 
Plots for Chapter 4 
 
  These 
1H-NMR titrations were conducted with compound 125 in acetonitrile-d3 
with  a  selections  of  anions  as  their  tetrabutylammonium  salts  except  for  hydrogen 
carbonate (tetraethylammonium salt). Only the partial spectra of the regions of interest are 
shown. 
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Compound 125 with acetate: 
3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0
0 eqv.
0.3 eqv.
0.6 eqv.
0.8 eqv.
1 eqv.
1.2 eqv.
 
Compound 125 with hydrogen carbonate: 
2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5
0 eqv.
0.2 eqv.
0.5 eqv.
0.7 eqv.
1 eqv.
1.2 eqv.
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Compound 125 with bromide: 
2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5
0 eqv.
0.3 eqv.
0.5 eqv.
0.7 eqv.
1 eqv.
1.2 eqv.
 
Compound 125 with dihydrogen phosphate: 
2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5
0 eqv.
0.3 eqv.
0.5 eqv.
0.7 eqv.
1 eqv.
1.3 eqv.
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Appendix 4 – Isothermal Calorimetry 
Titration Curves for Chapter 4 
  The ITC titrations were conducted by Prof. Franz Schmidtchen of the Technical 
University of Munich, Germany. They were all carried out with compound 125 in dry 
solvents at 303K with a selection of anions as their tetraalkylammonium salts. The curves 
are reported here for completeness. 
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Compound 125 in acetonitrile: 
Table 1:   acetonitrile, 303 K; guest-into-host 
entry  salt  conc. 
in cell 
Kass [M
-1]  ∆G
o  [cal 
K
-1 mol
-1] 
∆H
o  [cal 
K
-1 mol
-1] 
∆S
o  [cal K
-
1 mol
-1] 
remarks 
1  TEA
+ chloride
-  0.94  1.3  e6  -8.47  e3  -12.0  e3  -11.6  n = 0.97 
2  TEA
+ benzoate
-  0.94  6.0  e3  -5.23  e3  -9.90  e3  -15.4  n = 0.96 
3  TBA
+ 
dihydrogenphosphate
- 
0.94  8.2  e3  -5.42  e3  -4.61  e3  +2.7  n = 1.44 
4  TBA
+ 
dihydrogenphosphate
- 
0.96  7.77  e3  -5.39  e3  -5.14  e3  +0.8  n = 1.46 
5  TEA
+ isocyanate
-  0.96  1.12  e6  -8.38  e3  -13.35 e3  -16.3  n = 0.95 
6  TBA
+ hydrogencarbonate
-  0.96  2.03  e5  -7.36  e3  -11.40 e3  -13.3  n = 1.09 
 
 
 
Table 2: acetonitrile, 303 K; host-into-guest; 
entry  salt  conc. in 
cell 
Kass [M
-
1] 
∆G
o  [cal 
K
-1 mol
-1] 
∆H
o  [cal K
-
1 mol
-1] 
∆S
o  [cal K
-1 
mol
-1] 
remarks 
7  TEA
+ chloride
-  0.327  2.6  e6  -8.89  e3  -11.88  e3  -9.8  n = 1.07 
8  TBA
+  fluoride
-    ×  3 
H2O 
0.500  1.55  e5  -7.19  e3  -11.34  e3  -13.6  n = 0.90 
9  TBA
+ acetate
-  0.574  1.64  e5  -7.23  e3  -13.12  e3  -19.4  n = 1.05 
10  TBA
+ p-nitrobenzoate
-  0.522  1.30  e3  -4.32  e3  -8.54  e3  -13.9  n = 1.0 
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Compound 125 in DCM: 
Table 3:   dichloromethane,    303 K; host into guest 
entry  salt  conc. in 
cell 
Kass [M
-
1] 
∆G
o  [cal 
K
-1 mol
-1] 
∆H
o  [cal K
-1 
mol
-1] 
∆S
o  [cal K
-
1 mol
-1] 
remarks 
11  TEA
+ chloride
-  0.294  2.68  e6  -8.91  e3  -13.2e3  -14.2  n = 1.2 
12  TBA
+ chloride
-  0.655  4.7  e5  -7.86  e3  -11.8  e3  -13.0  n = 0.96 
13  TEA
+ nitrate
-  0.598  6.07e3  -8.38  e3  -7.68 e3  -8.0  n = 0.99 
14  TEA
+ hydrogencarbonate
-  0.62  1.77  e5  -7.27  e3  -9.93 e3  -8.7  n = 1.03 
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